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ABSTRACT
Genomic imprinting is a specialized transcriptional mechanism resulting in the
unequal expression of alleles based on their parent-of-origin. Imprinted genes are critical
for embryonic and fetal development and their dysregulation is linked to a group of
human diseases called imprinting disorders, including Beckwith-Wiedemann Syndrome,
Angelman Syndrome and Silver-Russell Syndrome.

Two critical phases of genomic

imprinting exist. The acquisition phase occurs in developing germ cells, asynchronously
for different imprinted loci, while the maintenance phase takes place during
preimplantation development, while the rest of the genome is undergoing demethylation.
Increased frequencies of human imprinting disorders are observed in children following
the use of assisted reproductive technologies (ARTs). The timing of ARTs during the
critical periods of imprint acquisition and maintenance provides a mechanism for their
disruption. At the onset of this project, I hypothesized that superovulation alone, and
embryo culture alone, disrupt imprinting acquisition and maintenance mechanisms,
respectively, and that disruption of genomic imprinting correlates with rates of
preimplantation embryo development. I have determined the effects of superovulation,
and embryo culture using five commercially available media, on the key imprinted loci
H19, Snrpn, Peg3, Kcnq1ot1 and Peg1/Mest, and correlated rates of preimplantation
development with loss of genomic imprinting. Superovulation alone disrupted genomic
imprinting, in a dose-dependent manner. Embryo culture in all media was sub-optimal in
maintaining genomic imprints. Embryos developing at a moderate pace showed levels of
imprinted methylation most similar to in vivo-derived controls. In addition, these studies
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suggest that superovulation does not affect the acquisition of imprinted methylation, but
rather maintenance throughout preimplantation development.

Data presented in this

thesis suggests that superovulation disrupts one or more key maternal-effects genes
necessary for imprint maintenance, and that superovulation and embryo culture disrupt
the same pathway.

Future studies delineating the mechanisms mediating embryonic

adaptation to the environmental insult caused by ARTs, and improving current techniques
to minimize the amount of adaptation required for embryo growth and survival outside
the female reproductive tract, will lead to a decreased incidence of disease and improve
the long term health of children born following ARTs.

KEYWORDS:
Genomic Imprinting, H19, Snrpn, Peg3, Peg1/Mest, Kcnq1ot1, Assisted Reproductive
Technologies, Superovulation, Embryo Culture
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Chapter 1: Introduction
1.1 - Epigenetics
1.1.1 Early Epigenetics
While the concept of genes and their role in development is well known, the
concept of epigenetics is a relatively recent idea, and as such, much remains to be
discovered in the field.

The term “epigenetics” was originally coined by C. H.

Waddington in the 1940s, resulting from a combination of the words “epigenesis”,
referring to the theory of animal development whereby development occurs in a step-wise
manner resulting from successive differentiation rather than enlargement of preformed
structures, and “genetics”, the theories and information originally derived from
Mendelian ideology (Van Speybroeck, 2002). Waddington’s ideas brought the concepts
of genetics into the study of embryology, suggesting that genes interact in a number of
ways, which are not static in every individual, to create unique organisms (Waddington,
1939).

The frequency of discordance between genotype, the genetic makeup of the

individual, and phenotype, the observed physical characteristics, began to demand an
addendum to Mendel’s laws of inheritance, which could account for these disagreements.
Waddington suggested that the genotype of an individual did not dictate the phenotype,
but simply provided a range of possible phenotypes, governed by some other processes
(Waddington, 1939). In addition, Waddington postulated that these other processes not
only played a role in inter-individual variation, but were also responsible for regulating
the development of different tissues within the same individual (Waddington, 1939).
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Essentially, the phenotype was a result of interactions between genetic processes and their
cytoplasmic and external environments (Waddington, 1939).

1.1.2 Modern Epigenetics
Today, this concept has evolved, and we understand the term epigenetics as a
combination of the word “genetics” and the prefix “epi”, meaning “on top of”.

In

essence, epigenetics encompasses the study of heritable and reversible modifications of
chromatin that influence the accessibility of genes and regulate gene transcription
(Rodenhiser and Mann, 2006).

The plastic nature of epigenetics recapitulates

Waddington’s ideas of cytoplasmic and external environments modulating the genetics of
an organism. Over the course of the last 50 years, as our understanding of the nuclear
microenvironment and the composition and organization of the genome rapidly expanded,
many advancements have been made that elucidated the core epigenetic mechanisms
modulating these nuclear components resulting in modulation of gene expression.

1.1.3 Mechanisms of Epigenetic Regulation

Epigenetic mechanisms can modulate every aspect of the genetic material, from
the ionic microenvironment of chromatin to the sub-nuclear localization of entire
chromosomes. Known mechanisms include histone modifications, DNA methylation and
long non-coding RNAs, which, along with chromatin looping and the formation of
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chromatin territories (CT), result in changes to chromatin structure and localization within
the nucleus (Figure 1.1).

1.1.3.1 Histone Modifications
The basic unit of DNA is the nucleosome which consists of double-stranded DNA
wrapped around octamers of histone proteins (Kornberg, 1974), two each of H2A, H2B,
H3, and H4, with H1 linker histones establishing spacing between nucleosomes (Figure
1.1, 1.2). These histone proteins contain specific amino acid residues that can undergo
post-translational modifications that modulate their charge and hydrophobicity
(Lehninger et al., 2005). Modulation of these two factors can change the local, or the
global structure of chromatin organization resulting in local areas of open or closed
chromatin, or silencing of entire chromosomes. A number of histone modifications have
been extensively studied and are consistently associated with either open (active), or
closed (repressed) chromatin conformations. Acetylation of lysine tails, such as H3K9,
and H3K14, (Turner and Fellows, 1989; Schiltz et al., 1999; Vaquero et al., 2004), and
phosphorylation of serine and threonine residues such as H3S10 (Sassone-Corsi et al.,
1999; Anest et al., 2003), result in a more active chromatin state. Other modifications
such as methylation, sumoylation, and ubiquitination have more diverse functions in
chromatin organization, and depending on their location, can act as either repressive or
activating marks. Histone methylation can occur on either lysine or arginine residues, and
can be mono-, di-, or tri-methylated. For example, tri-methylation of H3K4 results in an
active chromatin conformation, while tri-methylation of H3K9 and H3K27 are repressive
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Figure 1.1: Mechanisms of Epigenetic Regulation
Epigenetic modifications include chromatin looping, histone modifications and DNA
methylation. Chromatin looping allows binding of transcription factors (TF) to active
regions of chromatin, while inactive regions are more likely located in the core of the
chromosome territories. DNA is made up of a series of nucleosomes, which contains
histones and DNA. Histone can be post-translationally modified in a number of ways, a
few of which are methylation (Me), acetylation (Ac) and phosphorylation (P). These
marks can be activating or repressive depending on their nature and location. DNA can
be methylated on the 5’ carbon of cytosine residues by DNA methyl transferase enzymes
(DNMTs), which is most often a repressive mark.

Long non-coding RNAs mediate

epigenetic modifications in cis and trans through interactions with chromatin complexes
and transcription factors. Figure adapted from: Rodenhiser and Mann, 2006, Epigenetics
and human disease: translating basic biology into clinical applications. CMAJ; 174(3):
341-348, Luong, P. 2009. Basic Principles of Genetics., http://web.me.com/marschalf/
classes-taught/apbiology/Spry-resources.htm, and Fraser, P., and Bickmore, W., 2007,
Nuclear organization of the genome and the potential for gene regulation, Nature 447,
413-417
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Figure 1.2
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Figure 1.2: The Nucleosome and Histone Modifications
The nucleosome consists of an octamer of dimers of H2A, H2B, H3, and H4, with the H1
linker protein establishing the space between nucleosomes. DNA is wrapped around each
nucleosome twice, resulting in approximately 147 bp of DNA per nucleosome.

This

figure indicates the most common modifications of the H3 protein resulting in activation
or repression of gene expression. Ac: acetylation, Me: methylation, P: phosphorylation
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(Lehninger et al., 2005).

Importantly, all of the above histone modifications are

reversible, and therefore allow for temporal as well as spatial control of chromatin
structure.

It is evident that control of chromatin state by histone modifications is a

complex process, involves a large network of proteins and has the capacity to finely
modulate gene expression throughout the life cycle.
In early embryos, the paternal genome also acquires repressive histone
modifications, including histone 3 lysine 9 and lysine 27 methylation (H3K9me2,
H3K27me2, and H3K27me3). By comparison, the maternal genome possesses both active
(H4Ac, H3K4me1) and repressive histone modifications (H3K9me2, H3K9me3, and
H4K20me3) (Adenot et al., 1997; Cowell et al., 2002; Lepikhov and Walter, 2004).
These covalent modifications are proposed to initiate the transcriptionally repressed state
that coincides with embryonic genomic activation.

This potential for chromatin

bivalency, where both activating and repressive marks occupy the same stretch of
chromatin, is likely a major factor in establishing the correct gene expression profile for
embryonic development (Schultz, 2002).

1.1.3.2 DNA Methylation

DNA methylation is another important epigenetic mechanism regulating gene
expression and consists of the covalent addition of a methyl group to the C5 position of
cytosine residues within CpG dinucleotides (Figure 1.1). DNA methylation is most often
associated with repression of gene expression (Lehninger et al., 2005).
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A family of

enzymes known as the DNA methyltransferases (DNMTs) is responsible for the addition
of these methyl groups (Figure 1.3), while the mechanism of de-methylation is less clear.
De novo DNA methyltransferases that add methyl groups to unmethylated CpGs are
DNMT3A and DNMT3B (Okano et al., 1998; Okano et al., 1999).

As such, these

enzymes are responsible for the establishment of DNA methylation during early
development and differentiation, in conjunction with other enzymes such as DNMT3L,
and other regulatory complexes (Lehninger et al., 2005). DNA methylation is heritable
throughout successive rounds of DNA replication due to the action of DNMT1, the
maintenance methyltransferase, which recognizes hemi-methylated DNA and adds a
methyl group to the daughter strand (Figure 1.3). With regards to DNA demethylation,
our current understanding suggests that passive demethylation occurs through the absence
of maintenance methylation (DNMT1) (Morgan et al., 2005), while active demethylation
either utilized a multistep DNA repair mechanism, or converts methylated cytosines to
different compounds to facilitate direct removal.

These modifications include DNA

glycosylation or 5‘hydroxy methylation through the Tet family of enzymes (Morgan et al.,
2005; Schar and Fritsch, 2011).
Acquisition of DNA methylation occurs in the developing gametes and is acquired
differentially between the two parental genomes (Hajkova et al., 2002; Kageyama et al.,
2007) (Figure 1.4). Following fertilization, there is a wave of demethylation that erases
gamete-specific methylation patterns and ensures the totipotency of the early embryo
(Mayer et al., 2000; Dean et al., 2001; Santos et al., 2002; Beaujean et al., 2004). The
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Figure 1.3
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Figure 1.3: DNA Methylation by DNMTs
DNA methylation is performed by DNA methyltransferases. CpG dinucleotides are
methylated de novo by DNMT3A/B in conjunction with DNMT3L. Hemi-methylated
DNA is fully methylated by DNMT1 following DNA replication. Me: methyl group.
Adapted from http://images.yourdictionary.com/DNA.
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Figure 1.4
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Figure 1.4: DNA Methylation Throughout Germ Cell and Preimplantation Embryo
Development.
Acquisition of DNA methylation begins in the developing oocyte and spermatocytes, and
is complete prior to fertilization.

At fertilization, the paternal pronucleus undergoes

active demethylation, while the maternal pronucleus undergoes passive demethylation
throughout the early stages of preimplantation development. Imprinted methylation is
maintained throughout preimplantation development, despite the demethylation occurring
in the rest of the genome. Superovulation occurs during the time of imprint acquisition,
and embryo culture takes place during maintenance of genomic imprinting.

Figure

adapted from Mann, M.R.W. and Bartolomei, M.S., Genome Biology. 3(2) 1003.1-1003.4
2002.
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paternal genome is actively demethylated within hours after fertilization, while the
maternal genome is passively demethylated during early cleavage divisions in a
replication-dependent manner through a lack of maintenance methylation (Rougier et al.,
1998; Oswald et al., 2000). The end result is that the two parental genomes undergo
extensive changes in global methylation during preimplantation development.

Post-

implantation, de novo methylation gradually increases in accordance with cellular
differentiation (Monk et al., 1987).

1.1.3.3 Long Non-Coding RNA
Studies of the human genome have revealed that only 1-2% of the DNA sequences
carry protein-coding information, leading scientists to question the function of the other
98% (Lee, 2010).

Recently, a class of RNAs have been discovered that are not

transcribed into protein products, but instead play an important role in epigenetic
regulation (Guttman et al., 2009; Khalil et al., 2009). Transcription of these long noncoding RNAs occurs throughout the genome, overlapping with, and between other
protein-coding genes (Carninci et al., 2005; Kapranov et al., 2007). Many long noncoding RNAs have been identified which show significant evolutionary conservation
(Guttman et al., 2009) and differences in expression across tissue types indicating a
functional role in genomic regulation (Dinger et al., 2008; Guttman et al., 2009). Longnon coding RNAs can affect the expression of other protein-coding genes using both cisand trans-acting mechanisms. They can associate with chromatin modifying complexes,
resulting in the addition of activating or repressive histone marks to these areas (Bracken
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et al., 2006; Dinger et al., 2008; Ku et al., 2008; Nagano et al., 2008; Pandey et al., 2008),
or RNA-binding proteins and transcription factors, resulting in recruitment to specific
areas of the genome in cis or trans (Feng et al., 2006; Rinn et al., 2007; Wang et al., 2008;
Zhao et al., 2008; Khalil et al., 2009). Additional evidence suggests that elongation of the
transcript, or the act of transcription through the domain itself is important for domain
regulation.

While the exact mechanism is unknown, silencing may occur though the

interaction of RNA polymerase and the tethered non-coding RNA, leading to recruitment
of repressive chromatin complexes to areas of elongation in cis (Mancini-Dinardo et al.,
2006), or through the interaction of the transcript with mRNAs in the domain generating
double-stranded RNA, thereby activating RNA interference mechanisms (Dykxhoorn et
al., 2003).

1.1.3.4 Nuclear Territories and Chromatin Looping
Both histone modifications and DNA methylation can result in local alterations of
chromatin structure, but also alter gene expression on a larger scale. Within the nucleus,
chromosomes are organized into a number of chromosome territories (CTs) and it was
initially postulated that active regions (euchromatin) lie in chromatin loops at the surface
and inactive regions are located deep within the territories (heterochromatin) (Zirbel et
al., 1993) (Figure 1.1). This sequestration of inactive regions to the core of the territory
presumably prevents access to the transcriptional machinery, and these heterochromatic
regions replicated later in S phase than their euchromatin counterparts (Gilbert, 2002).
We now know that gene-poor regions tend to localize to the core of CTs, while gene-rich
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regions tend to cluster at the surface (Shopland et al., 2006). Studies also suggest that
“looping out” of specific chromatin regions is associated with activation of transcription,
and that these active regions, on the same or on different chromosomes, interact with one
another (Chambeyron and Bickmore, 2004; Wurtele and Chartrand, 2006). In addition,
regions of constitutively high activity are often found “looped out”, in regions outside
their normal CT (Mahy et al., 2002; Brown et al., 2006). However, not all “looped out”
regions of chromatin are active, but instead represent regions poised for transcription,
with additional chromatin modifications necessary for active transcription to occur (Heard
and Bickmore, 2007).

1.2 - Genomic Imprinting
1.2.1 Brief History of Genomic Imprinting
Genomic imprinting is an epigenetic phenomenon whose investigation is still in
its infancy. The term “imprint” was originally coined by H. V. Crouse from experiments
on the insect Sciara. During sperm, but not oocyte development, Sciara selectively
eliminate the paternal X chromosome (Crouse, 1960). After fertilization, one or both
remaining X chromosomes are eliminated, depending on the sex of the offspring. This
was the first description of the ability of a cell to distinguish between maternal and
paternal chromosomes, and Crouse used the term “imprint” to describe the phenomenon
that marked a given chromosome “based solely on the sex of the germline through which
the chromosome had been inherited” (Crouse, 1960).
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The field of genomic imprinting follows from experiments on mammalian
parthenogenotes, embryos possessing maternal but not paternal genomes. Activation of
oocytes in non-mammalian species resulted in the production of viable offspring
(Engelstadter, 2008).

However, mammalian parthenotes are unable to complete

development and die (Kaufman et al., 1977), suggesting an unequal contribution of
maternal and paternal alleles. This was confirmed by further experiments constructing
uniparental embryos, either from exclusively maternal or exclusively paternal DNA.
Work by McGrath and Solter demonstrated that mammalian embryos generated from
either two female pronuclei (gynogenotes) or two male pronuclei (androgenotes) fail to
complete normal embryogenesis, dying shortly after implantation, confirming that
contributions from both maternal and paternal chromosomes are necessary to support
mammalian development (Markert, 1982; McGrath and Solter, 1984; Surani et al., 1984).
Since then, many imprinted genes have been identified, and while general mechanisms
regulating this phenomenon have been elucidated, much remains to be discovered about
the control of imprinted gene expression.

1.2.2 Overview of Genomic Imprinting
Genomic imprinting is a phenomenon whereby certain genes are expressed
exclusively from one parental allele (Figure 1.5). To date, there are approximately 150
known imprinted genes ((http://www.mousebook.org/catalog.php?catalog=imprinting;
(Morison et al., 2005)). Imprinted genes are often found clustered together in regions
known as imprinting domains, where multiple imprinted genes are under the control of
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Figure 1.5
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Figure 1.5: Genomic Imprinting
Expression from both the maternal and paternal alleles is characteristic of the majority of
the genes in the genome. A subset of genes are expressed in a parent-of-origin specific
manner. Some are expressed from the paternal allele, and methylated on the maternal
allele, while other are expressed from the maternal allele and methylated on the paternal
allele.
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one or a few regulatory elements (Reinhart and Chaillet, 2005).

Within imprinted

domains, genes may be expressed from either the maternal or paternal allele, and,
paradoxically, non-imprinted genes may be interspersed within these domains.

In

addition, some genes within a given imprinted domain may display imprinted expression
in certain tissues, but not in others.

Many imprinted genes play critical roles in the

development of the embryo, or influence behaviour after birth (Varrault et al., 2006;
Wilkinson et al., 2007; Champagne et al., 2009), and their dysregulation is linked to a
group of human diseases called imprinting disorders.
The acquisition and maintenance of genomic imprinting is controlled through
various epigenetic mechanisms. DNA methylation, histone modifications and chromatin
looping all play a role in imprinted gene regulation. Imprinted domains are coordinately
regulated in cis by DNA elements known as imprinting centers, or imprinting control
regions (ICR) (Rodenhiser and Mann, 2006).

These ICRs are often rich in CpG

dinucleotides, which can be methylated on the 5’ carbon, providing binding sites for
various proteins involved in imprinting regulation (Wan and Bartolomei, 2008) and are
differentially methylated depending on their parent-of-origin (Reinhart and Chaillet,
2005).
Although the specific mechanisms controlling the acquisition and maintenance of
genomic imprinting at each imprinting domain is not known, research into a few key
domains has led to the discovery of two key regulatory models, the insulator/enhancer
model and long non-coding RNA-mediated silencing model (Wan and Bartolomei, 2008;
Koerner et al., 2009) (Figure 1.6, Table 1.1).
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Figure 1.6: Models of Epigenetic Regulation
(A) The H19 imprinted domain is an example of the insulator/enhancer model of genomic
imprint regulation. The maternal allele is unmethylated at the imprinting control center
(ICR), allowing insulator (Ins) proteins, such as CTCF to bind. Binding of these insulator
proteins prevents the interaction of the enhancer elements (E) with the upstream Igf2 gene
promoter, allowing interaction with the H19 promoter.

H19 is expressed and Igf2 is

repressed. On the paternal allele, methylation (Me) of the ICR represses H19 expression
and prevents binding of insulator proteins.

This allows the downstream enhancer

elements to interact with the Igf2 promoter, resulting in expression at this locus.
Methylation spreads to the H19 promoter, preventing interaction with the enhancers.
(B) The Kcnq1ot1 imprinted domain is an example of the long non-coding RNAmediated silencing model.

On the maternal allele, the ICR is methylated, preventing

expression of Kcnq1ot1 non-coding RNA. Lack of expression of the long non-coding
RNA results in an active domain, and expression of Kcnq1, Cdkn1c and other genes. The
paternal allele is unmethylated at the ICR, allowing expression of Kcnq1ot1, which in
turn represses of the domain.

17

Genomic Imprinting

(A)

Enhancer/Insulator
Model and DNA Methylation
Expression

Igf2
DMR1

ICR

CH3

Genomic Imprinting
Ins

E

H19

DMR2

Expression and DNA Methylation
CH3

Expression

Maternal
Paternal
Ins

Me
Methylation
Igf2

DMR1

Me

None

Paternal

Maternal

Maternal

Paternal

CH3

ICR
DMR2

Expression

E

H19
CH3

Me
Paternal

Maternal
Paternal

Maternal

(B)
Methylation
MaternalModel Paternal
Long Non-codingNone
RNA-Mediated Silencing

Genomic Imprinting

Expression and DNA Methylation
Active Domain

Genomic Imprinting

Friday, April 22, 2011

Me

Expression and DNA Methylation
ICR Kcnq1
CH
Cdkn1c
3

CH3

CH3

Repressed Domain

Expression
Maternal
ICR
Cdkn1cPaternal
Methylation
Expression

None
Maternal
Paternal

Methylation

None

Paternal

Kcnq1

Maternal
CH3

Kcnq1ot1
Maternal
Paternal

Paternal
Maternal

Maternal

Paternal

18

Table 1.1: Imprinted Genes, their Imprinted Domains and Associated Human
Disorders
Gene

Expression

Regulatory
Model

Imprinted
Domain
(Human)

Human
Syndrome

H19

Maternal

Insulator/
Enhancer

11p15.5

BeckwithWiedemann
Syndrome,
Silver-Russell
Syndrome

Peg1/Mest

Paternal

Unknown

7q32

Silver-Russell
Syndrome

Snrpn

Paternal

Long noncoding RNAmediated
silencing

15q11-13

Angelman
Syndrome,
Prader-Willi
Syndrome

Kcnq1ot1

Paternal

Long noncoding RNAmediated
silencing

11p15.5

BeckwithWiedemann
Syndrome

Peg3

Paternal

Unknown

19q13.4

None
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1.2.3 Imprinted Domains of Interest, their Regulation and Associated Syndromes
1.2.3.1 H19 Imprinted Domain 1.2.3.1.1 Structure and Regulation of the Domain
One of the first imprinting domains to be discovered, and one of the most well
understood, is the H19 imprinted domain, which is regulated through an enhancer/
insulator model. This domain contains an imprinting control region (ICR), located 2 kb
upstream of the H19 transcription start site, and enhancer elements located downstream of
the H19 gene, all of which are necessary for genomic imprinting in this domain (Figure
1.6) (Srivastava et al., 2000). Differential methylation is observed at the H19 ICR, as
well as at the Igf2 DMRs on the maternal and paternal alleles. However, only the H19
ICR acquires gamete-derived DNA methylation.

On the maternal allele, the ICR is

unmethylated, allowing for binding of the insulator protein CTCF (Figure 1.6). CTCF
binding forms a long-range intrachromosomal loop and recruits chromatin modifying
complexes that result in repressive histone modifications at the Igf2 promoter,
suppressing gene expression (Li et al., 2008).

Essentially, CTCF binding acts as an

insulator, preventing the interaction between downstream enhancer elements and the
upstream Igf2 gene promoter, resulting in silencing of Igf2, and expression of H19 on the
maternal allele (Hark et al., 2000).

On the paternal allele, DNA methylation of the

upstream ICR prevents CTCF binding, allowing enhancer elements to interact with the
Igf2 gene promoter, resulting in expression of Igf2 (Figure 1.6). Methylation at the ICR
also directs methylation at the H19 promoter, resulting in silencing of the H19 gene
(Srivastava et al., 2000; Kaffer et al., 2001).
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In the mouse, four CTCF binding sites exist in the H19 ICR. Mutation of one of
these four sites results in biallelic expression of Igf2 (Pant et al., 2004). Abolishing all
four sites results in a dramatic shift in histone modifications (Han et al., 2008). On the
maternal allele, there is loss of the activating modifications H3K9 acetylation and H3K4
methylation at the H19 ICR and promoter, and loss of repressive H3K27 trimethylation at
the Igf2 promoter and DMRs. In addition, the maternal allele acquires a paternal histone
configuration, with activating H3K9 acetylation and H3K4 methylation at the Igf2
promoter and DMRs, and repressive H3K27 trimethylation at the H19 promoter (Han et
al., 2008).
Targeted deletion of the H19 ICR results in activation of H19 and reduced
expression of Igf2 when inherited paternally, while maternal deletion reduces H19
expression and activates Igf2 expression (Thorvaldsen et al., 1998). Deletion of the H19
ICR and transcription unit of the H19 gene (Leighton et al., 1995), or of the transcription
unit alone (Ripoche et al., 1997) results in biallelic expression of Igf2.

Phenotypic

consequences of these dysregulations result in embryonic growth restriction, or an
overgrowth phenotype.

1.2.3.1.2 Beckwith-Wiedemann Syndrome and the H19 Domain
The similarity of the overgrowth phenotype noted above to the human overgrowth
disorder Beckwith-Wiedemann Syndrome (BWS; OMIM #130650) led to the
identification of a causative relationship between the H19 domain and BWS. Clinically,
BWS is an overgrowth disorder characterized by macroglossia, abdominal wall defects,
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postnatal growth above the 90th percentile, neonatal hypoglycemia (Elliott et al., 1994)
and an increased incidence of Wilm’s tumour (DeBaun and Tucker, 1998; Rump et al.,
2005), and is estimated to affect 1 in 13 700 children (Shuman et al., 1993). A number of
studies have linked perturbations of the H19 domain with clinical BWS in human patients
(Gicquel et al., 2003; Arnaud and Feil, 2005; Chang et al., 2005; Doornbos et al., 2007).
Hypermethylation of the maternal allele, microdeletions of the CTCF binding sites and
resulting overexpression of IGF2 has been shown in BWS patients, (Brown et al., 1996;
Sparago et al., 2004; Prawitt et al., 2005; Cerrato et al., 2008; Riccio et al., 2009).
Overall, 5% of BWS patients possess imprinting defects at the maternal H19 imprinting
center (Choufani et al., 2010).
The H19 domain has also been implicated in the development of another
imprinting disorder, Silver-Russell syndrome, discussed below (Chou et al., 2004;
Kagami et al., 2007; Eggermann et al., 2010).

1.2.3.2 Kcnq1ot1 Imprinted Domain
1.2.3.2.1 Structure and Regulation of the Domain
The Kcnq1ot1 imprinted domain is regulated by long non-coding RNA-mediated
silencing, through the non-coding RNA Kcnq1ot1. The imprinting control region for this
domain is located in intron 11 of the Kcnq1 gene and is oriented in the antisense direction
(Figure 1.6). The promoter region of Kcnq1ot1 non-coding RNA is embedded in the ICR
(Mancini-DiNardo et al., 2003; Pandey et al., 2004). The ICR is unmethylated on the
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paternal allele, resulting in transcription of Kcnq1ot1 through the imprinted domain.
Recent studies from our lab have suggested that this transcript may extend up to 470 kb in
length (unpublished data).

It is currently unclear if the act of Kcnq1ot1 RNA

transcription through the domain results in recruitment of protein complexes that then
silence the domain, or if the non-coding RNA itself plays a role in silencing of the
domain, similar to the mechanism of X-inactivation through Xist.

However, recent

studies show that Kcnq1ot1 helps to move the silenced allele into a nuclear compartment
characterized by repressive histone marks (Pandey et al., 2008; Terranova et al., 2008).
Methylation at the Kcnq1 ICR on the maternal allele results in repression of
Kcnq1ot1 transcription, allowing expression of Kcnq1, Cdkn1c and other maternally
expressed genes. Further complexity exists at this domain as a number of genes display
differential imprinted expression between embryonic and extraembryonic tissues (Lewis
et al., 2004).

1.2.3.2.2 Beckwith Wiedemann Syndrome and the Kcnq1ot1 Domain
Mutations of the KCNQ1OT1 imprinted domain are thought to account for ~50%
of molecular defects in patients with BWS (Weksberg et al., 2001; Cooper et al., 2005),
most of which are epigenetic, and not genetic, in nature. In these cases, BWS results
from loss of methylation at the KCNQ1OT1 ICR on the maternal allele, causing biallelic
expression of KCNQ1OT1 and biallelic repression of KCNQ1 and CDKN1C (Horike et
al., 2000). CDKN1C is a cyclin-dependent kinase inhibitor, and is a negative regulator of
the cell cycle (Matsuoka et al., 1996; Tsugu et al., 2000). Although the exact molecular
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etiology of BWS has not yet been confirmed, CDKN1C is an attractive candidate gene, as
~10% of patients with BWS harbour mutations of this gene (Choufani et al., 2010).
1.2.3.3 Peg1/Mest Imprinted Domain
1.2.3.3.1 Structure and Regulation of the Domain
The Peg1/Mest imprinted domain is located on mouse chromosome 6 and human
chromosome 7. A CpG island spanning from the putative promoter region to exon 1 is
methylated in a parent-of-origin specific manner: the maternal allele is methylated, while
the paternal allele remained unmethylated (Riesewijk et al., 1997; Nishita et al., 1999).
The Peg1/Mest imprinted domain contains three confirmed imprinted genes, two maternal
(Klf14 and Copg2) and one paternally expressed gene (Peg1/Mest).
Mechanisms regulating the Peg1/Mest imprinted domain remain largely unknown,
however neither YY1 nor CTCF are known to play a role.

The only study to date

investigating regulation specifically at this locus showed that TIF1beta and its interaction
with the chromatin modifier HP1 is essential for maintaining the repressed state of the
silenced allele, characterized by DNA methylation, H4K20 trimethylation, and H3K9
trimethylation. Interestingly, this was only necessary at the repressed allele, and a loss of
this interaction resulted in the silenced allele acquiring an active phenotype characterized
by DNA hypomethylation, and loss of H3K9 trimethylation with gain of H3K27
trimethylation (Riclet et al., 2009).
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1.2.3.3.2 Silver-Russell Syndrome and the Peg1/Mest Domain
Misregulation of the PEG1/MEST domain has been proposed as one of the
causative agents of Silver-Russell Syndrome (SRS) (Hannula et al., 2001; Chou et al.,
2004; Kagami et al., 2007).

SRS is a growth retardation syndrome characterized by

intrauterine and postnatal growth restriction, low birth weight, triangular shaped face,
pointed chin and body asymmetry (Silver et al., 1953; Russell, 1954). Up to 44% of SRS
cases are associated with hypomethylation of the 11p15 region (Eggermann et al., 2010),
which harbours imprinted genes such as H19 and IGF2, while maternal uniparental
disomy of chromosome 7 is implicated in approximately 5% of cases of SRS (Kotzot et
al., 1995; Eggermann et al., 2010), which harbours the PEG1/MEST gene.

Paternal

inheritance of a null Peg1/Mest allele results in severe IUGR in the offspring, while
maternal inheritance of the null allele does not (Lefebvre et al., 1998). On the other hand,
high levels of Peg1/Mest expression has been found in adipocytes from obese mice, and
transgenic overexpression of Peg1/Mest results in enlargement of adipocytes (Takahashi
et al., 2005). This suggests a key role for Peg1/Mest in regulating fetal growth.

1.2.3.4 Snrpn Imprinted Domain
1.2.3.4.1 Structure and Regulation of the Domain
The Snrpn imprinted domain contains both maternally and paternally expressed
genes, and is regulated by a bipartite imprinting center located within the Snrpn gene.
The primary imprinting center (IC) for this domain, the Snrpn ICR, consists of an ~35kb
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region within the Snrpn promoter and exon 1. The Snrpn ICR is differentially methylated
in oocytes and sperm, with maternal specific methylation maintained into adulthood
(Shemer et al., 1997). Two distinct regions have been identified within this IC, PWS-IC
and AS-IC, giving it a bipartite structure. Mutations in the AS-IC result in Angelman
Syndrome (AS; OMIM #105830), while mutations in the PWS-IC result in Prader-Willi
Syndrome (PWS; OMIM #176279). The PWS-IC is necessary for a paternal epigenetic
pattern (El-Maarri et al., 2001), resulting in expression of MKRN3, MAGEL2, NDN, and
SNRPN. A maternal epigenetic pattern with expression of UBE3A and ATP10A requires
the AS-IC, however in the absence of both PWS- and AS-ICs a maternal epigenotype is
observed (Horsthemke and Wagstaff, 2008), indicating that a maternal epigenetic pattern
is the default state of this domain. The current model of regulation at the Snrpn imprinted
domain indicates that in spermatocytes, the PWS-IC and AS-IC are unmethylated, while
in oocytes, methylation at the PWS-IC is directed by protein complex (yet to be
identified) binding at the AS-IC.

Following fertilization, maternal methylation of the

PWS-IC is maintained, while the paternal allele remains unmethylated.

On the

unmethylated paternal allele, Snrpn generates a long non-coding RNA (Snrpn-longtranscript [Snrpnlt] also known as Ube3a-as) that harbours a number of snoRNAs, and
directs expression of the other paternally expressed genes (Mkrn3, Magel2, Ndn) through
an unknown mechanism. Expression of the Snrpnlt transcript results in silencing of the
Ube3a gene in the brain. Methylation at the PWS-IC on the maternal allele prevents
activation of paternally expressed genes including the Snrpnlt transcript, allowing
expression of Ube3a from the maternal allele (Horsthemke and Wagstaff, 2008).
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1.2.3.3.2 PWS, AS and the Snrpn Domain
The SNRPN imprinted domain was initially discovered from studies mapping the
chromosomal regions implicated in Prader-Willi and Angelman Syndromes to the
15q11-13 region. It is estimated that approximately 70% of patients harbour a deletion in
this region (Horsthemke, 1997). Maternally inherited deletions of the AS-IC result in the
AS, and paternally inherited deletions of the PWS-IC result in PWS (Knoll et al., 1989).
Maternal and paternal uniparental disomy (Nicholls et al., 1989; Mascari et al., 1992), or
uniparental methylation patterns (Buiting et al., 1990; Buiting et al., 1994) have also been
reported in patients that do not harbour deletions.
PWS is a neurological disorder characterized by hypotonia and failure to thrive in
the neonatal period, hyperphagia in early childhood leading to obesity as well as
hypogonadism, short stature, behavioural problems and varying levels of mental
retardation (Goldstone, 2004).

AS is a neurological disorder characterized by

microcephaly, ataxia, severe mental retardation, absence of speech, sleep disorders, and
seizure disorders (Williams et al., 2006). While no single gene has been found solely
responsible for the development of PWS, biallelic repression of the UBE3A gene in the
brain has been identified as the causative disruption in AS (Horsthemke and Wagstaff,
2008).
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1.2.3.5 Peg3 Imprinted Domain
The Peg3 imprinted domain consists of a 500 kb region, and contains three
maternally expressed (Zim1, Zim2, and Zim3) and 3 paternally expressed genes (Peg3,
Usp29, and Zfp264). The transcriptional start sites of Peg3 and Usp29 lie very close to
one another, with a bidirectional promoter in the intervening region, directing expression.
A 3.8 kb region surrounding both transcriptional start sites contains a CpG island that is
differentially methylated in sperm and oocytes, and is maintained into adulthood (Li et
al., 2000; Huang and Kim, 2009). Methylation of the CpG island located within the Peg3
promoter and exon 1 on the maternal allele results in repression of Peg3 and the other
paternally expressed genes, while the unmethylated paternal allele expresses these genes
(Huang and Kim, 2009). Two conserved sequence elements have been identified within
this 3.8 kb region and have been shown to act as binding sites for the chromatin modifier
YY1 (Kim et al., 2007; Kim and Kim, 2008).

Expression of YY1 is necessary for

establishment of maternal methylation patterns and binding of YY1 to the maternal allele
has been suggested to target the region for de novo methylation (Kim et al., 2009).
The Peg3 gene is involved in modulating growth and behaviour. Loss of Peg3
expression in mice results in growth retardation, an increase in total body fat, lower
metabolic rate and lower core body temperature, and overall delayed development
(Curley et al., 2005). In addition, an increase in apoptosis in the developing brain through
p53-mediated pathways (Broad et al., 2009) and aberrant maternal behaviour
(Champagne et al., 2009) is observed with loss of Peg3 expression. No human imprinting
disorders have been associated with aberrant imprinting of the Peg3 locus to date.
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1.2.4 Acquisition of Genomic Imprinting in Germ Cells
Genomic imprints are established at different stages of development in male and
female germ cells, and each imprinted domain acquires its mark at slightly different times
(Figure 1.4).

In primordial germ cells, a wave of DNA demethylation occurs, and

imprinted methylation marks on the maternal and paternal alleles are erased (Hajkova et
al., 2002; Lee et al., 2002; Yamazaki et al., 2003). Parent-of-origin specific methylation
patterns are then re-established, leading to the presence of maternal-specific methylation
patterns in oocytes, and paternal-specific methylation patterns in spermatocytes.
Although the exact imprinting mark is unknown, thus far, DNA methylation is the most
well examined, and the most likely candidate, and its pattern of acquisition in developing
germ cell is well known for a number of imprinted loci (Lucifero et al., 2002).

1.2.4.1 Acquisition in Oocytes
Parent-of-origin specific genomic imprints must be erased in the developing fetus
in order to establish maternal genomic imprints in the developing oocyte. This erasure
occurs between day 10.5 and day 11.5 in mouse primordial germ cells (Lee et al., 2002).
Reestablishment of maternal DNA methylation occurs during the postnatal growth phase
of oogenesis, and is complete by the MII stage (Lucifero et al., 2002).

Maternally

methylated ICRs acquire de novo methylation, while paternally methylated ICRs must be
protected from methylation. In the former case, the de novo methyltransferase DNMT3A
functions in conjunction with DNMT3L to methylate ICRs in the developing oocyte
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(Hata et al., 2002; Lucifero et al., 2004).

Acquisition of methylation occurs

asynchronously for different imprinted loci (Lucifero et al., 2004), and this acquisition is
correlated with increasing oocyte diameter (Hiura et al., 2006).

The latter process is

thought to occur by binding of transcription factors and other unknown proteins to the
ICRs, blocking the action of the de novo methyltransferases at these ICRs, thereby
protecting them from DNA methylation (Brandeis et al., 1994).

1.2.4.2 Acquisition in Spermatocytes
Acquisition of methylation imprints in the male germ line occurs during pre-natal
development, between 15.5 and 18.5 days of gestation.

Acquisition begins in

prospermatogonia and is completed before the end of the pachytene phase of meiosis.
(Kafri et al., 1992; Walsh et al., 1998; Davis et al., 1999; Davis et al., 2000; Ueda et al.,
2000; Lees-Murdock et al., 2003). De novo methylation is mediated by DNMT3A and
3B, in conjunction with DNMT3L, similar to what is observed in oocytes (Kelly and
Trasler, 2004).

While some overlap in the function of DNMT3A and 3B has been

suggested, both are required for proper imprint acquisition in the developing male germ
cells (Okano et al., 1999).

1.2.5 Maintenance of Genomic Imprinting
Following fertilization, dramatic epigenetic remodeling occurs on both the
maternal and paternal chromosomes, which is critical to the establishment of totipotency,
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the ability of an individual embryonic cell to generate all cell types in an organism
(Edwards and Beard, 1997) (Figure 1.4). Immediately after fertilization, remodeling of
the sperm chromatin begins and consists of the replacement of protamines by acetylated
histones, and active, genome-wide demethylation (Oswald et al., 2000). On the other
hand, the maternally inherited genome is passively demethylated over the course of the
next several rounds of cell division, which is thought to be due to a lack of maintenance
methylation (Carlson et al., 1992).

During this early stage of preimplantation

development, methylation is lost from all areas of the genome except imprinted genes and
retroviral sequences (Lucifero et al., 2004).
Maintenance of DNA methylation at imprinted loci relies on DNMT1, which
recognized and methylates hemi-methylated DNA (Fatemi et al., 2001). A number of
isoforms of DNMT1 have been identified (Pradhan et al., 1997). The longer isoform,
DNMT1s is most predominant in somatic cells (Hermann et al., 2004), while the shorter
DNMT1o is present in growing oocytes and during preimplantation development (Howell
et al., 2001).

The majority of the time, DNMT1s is localized within the nucleus,

associated with the DNA replication machinery at replication foci during S-phase (Szyf,
2001).

During preimplantation development, DNMT1s is excluded from the nucleus,

allowing for passive demethylation of the maternal genome (Carlson et al., 1992). The
oocyte-specific isoform localizes to the nucleus at the 8-cell stage, and along with
DNMT1s activity, is thought to be responsible for maintaining methylation at imprinted
loci throughout preimplantation development (Ding and Chaillet, 2002).

In addition,

disruption of number of maternal-effect genes, that are transcribed and stored in the
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developing oocyte and are required for preimplantation development, have been shown to
result in loss of methylation at a number of imprinted loci including Snrpn, Peg3, Peg1/
Mest and H19 (Nakamura et al., 2007; .Li et al., 2008).
As preimplantation development proceeds, different cell lineages begin to emerge.
As such, de novo methylation begins around the time of implantation to allow for
differentiation of embryonic and extraembryonic lineages, and further differentiation into
the numerous tissue types of the adult organism (Monk et al., 1987).

1.3 - Assisted Reproductive Technologies
1.3.1 Prevalence of ARTs and Their Sequelae
Since the first reported birth through the use of assisted reproductive technologies
(ART) in 1978, the use of these technologies has dramatically increased. It is estimated
that 1-3% of total births in developed countries result from some form of ART (Klemetti
et al., 2002; Wright et al., 2008). The field of assisted reproduction is broad and consists
of a variety of techniques, from non-invasive procedures such as ovarian
hyperstimulation, to highly invasive interventions such as intracytoplasmic sperm
injection (ICSI) of retrieved oocytes. However, all involve the manipulation of human
gametes and preimplantation embryos, and many involve embryo culture during
preimplantation development.

As described above, germ cell and preimplantation

development are critical periods in the erasure and maintenance of proper imprinted
methylation patterns (Santos and Dean, 2004). As such, the timing of ARTs during these
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critical periods provides a mechanism for the disruption of imprinting establishment and
maintenance through the environmental insult caused by the use of these procedures.
In addition to epigenetic consequences of ARTs, a number of other sequelae have
been observed. Couples who undergo ART carry intrinsic subfertility, which itself is a
risk factor for early pregnancy loss (Gray and Wu, 2000), and are on average 5 years
older than those who conceive naturally (Katalinic et al., 2004). In addition, ART carries
a higher risk of multiple births, which itself is associated with higher rates of prematurity,
low birth weight, neonatal mortality, congenital malformations and disability (Koivisto et
al., 1975; Fauser et al., 2005). However, all of the risk associated with ARTs cannot be
attributed to intrinsic subfertility of the couples and risk of multiple births. Singleton
pregnancies occurring through the use of ARTs have an increased risk of prematurity, low
birth weight, neonatal mortality, and neonatal intensive care unit admission (Helmerhorst
et al., 2004; Jackson et al., 2004; McDonald et al., 2005), as well as an increased risk of
congenital malformations (Lancaster, 1985; Rimm et al., 2004; Bonduelle et al., 2005;
Hansen et al., 2005; Klemetti et al., 2005; Olson et al., 2005), and cerebral palsy (Ericson
et al., 2002; Lidegaard et al., 2005; Hvidtjorn et al., 2006) and epilepsy (Ericson et al.,
2002; Sun et al., 2007). Most important for the studies contained in this thesis is the
increase in the incidence of the human imprinting disorders Angelman Syndrome (AS)
(Cox et al., 2002; Orstavik et al., 2003) and Beckwith-Wiedemann Syndrome (BWS)
(DeBaun et al., 2003; Gicquel et al., 2003; Maher et al., 2003) with the use of ARTs.
The incidence of AS in the general population is approximately one case per
16,000 births, with only 5% of these cases related to imprinting abnormalities (Cox et al.,
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2002; Williams, 2007). As the prevalence of AS is low, large-scale studies containing
sufficient numbers of patients have been difficult to achieve. However, seven cases of AS
following the use of ARTs have been reported to date, 5 of which displayed imprinting
abnormalities (71%) (Cox et al., 2002; Orstavik et al., 2003; Ludwig et al., 2005; Sutcliffe
et al., 2006). This is a significantly higher proportion than in the non-ART population.
Beckwith-Wiedemann Syndrome is a second imprinting disorder that is
associated with ARTs and is estimated to affect 1 in 13 700 children (Shuman et al.,
1993). As with AS, in a number of studies, parents of children with BWS were more
likely to have undergone fertility treatments than the general population (Chang et al.,
2005; Doornbos et al., 2007) and a higher incidence of BWS was seen in ART children
than in the general population (Gicquel et al., 2003; Arnaud and Feil, 2005). The link
between BWS and ARTs has been strongly established, and the relative risk of ART use is
4-9 times greater for BWS patients. Silver-Russell Syndrome has also been associated
with the use of ARTs (Hitchins et al., 2001; Svensson et al., 2005; Bliek et al., 2006;
Kagami et al., 2007; Galli-Tsinopoulou et al., 2008; Chopra et al., 2010).

Taken all

together, ARTs may impose inherent risk for normal development.
Attributing any of these risks to specific forms of ART has proven difficult, and as
procedures vary from clinic to clinic, and protocols vary between patients, most studies
simply group the observed effects under the umbrella of “ARTs”. The remainder of this
work will focus specifically on the effects of superovulation and embryo culture on
genomic imprinting.
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1.3.2 Superovulation and Effects on Genomic Imprinting
Superovulation, or ovarian stimulation, is the administration of exogenous
hormones resulting in the concurrent maturation of a large number of ovarian follicles to
produce an increased number of ovulated oocytes when compared to spontaneous
ovulation (Hrometz and Gates, 2009)

It is commonly used in both the treatment of

human infertility (Jewelewicz, 1976; Lonergan, 2007), and in the production of livestock
(Seidel, 1981) and laboratory animals (Ozgunen et al., 2001) to obtain large numbers of
offspring.

Ovarian stimulation regiments differ between clinics, and within clinics

between patients, with varying doses and types of hormones (Reid et al., 1988; Edwards,
2007).
It has been speculated that ovarian stimulation may prevent atresia of sub-optimal
follicles, leading to ovulation of low-quality oocytes (Van der Auwera and D'Hooghe,
2001), or may accelerate the growth rate of ovarian follicles (Baerwald et al., 2009).
Global perturbations in DNA methylation have been observed following superovulation
(Shi and Haaf, 2002). In the case of genomic imprinting, shortened oocyte maturation
time may lead to improper or incomplete acquisition of imprinting marks on the maternal
alleles.

Loss of maternal methylation following superovulation has been observed in

individual human oocytes (Sato et al., 2007; Khoueiry et al., 2008). In addition, it has
been suggested that both maternal and paternal alleles may be affected by superovulation
(Sato et al., 2007; Stouder et al., 2009), however, the frequency and severity of this
disruption remains unknown. Regardless, for both human imprinting disorders BWS and
AS, children have been identified where the only form of ARTs used in the treatment of

35

their parents’ infertility was ovarian stimulation (Young et al., 1998; Chang et al., 2005;
Ludwig et al., 2005).

1.3.3 Embryo Culture and Effects on Genomic Imprinting
The suggestion that culture of the early embryo may lead to epigenetic
perturbations, specifically with respect to genomic imprinting, was discovered in the
mouse model.

A subset of cultured embryos (analyzed in pools) displayed biallelic

expression of H19, which was maintained in extraembryonic tissues post-implantation
(Sasaki et al., 1995). Since then, it has been determined that preimplantation culture of
mouse embryos results in biallelic expression of the H19 gene and loss of imprinted
methylation at the H19, Snrpn, and Peg3 genes in blastocyst stage embryo (Doherty et al.,
2000; Khosla et al., 2001; Fernandez-Gonzalez et al., 2004; Mann et al., 2004; Fauque et
al., 2007).

However, the extent of this effect, measured by the percent of embryos

affected, varied with the type of culture medium used. This lead to the hypothesis that
embryo culture media vary in their ability to maintain the correct epigenetic landscape of
the early embryo (Doherty et al., 2000). However, as with the previous study, the authors
noted that not all embryos were affected by culture - some differences existed between
embryos in their ability to compensate for the sub-optimal preimplantation environment
to which they were subjected. Subsequent observations of post-implantation embryos
indicated that epigenetic alterations induced by embryo culture persist.

At day 9.5,

following embryo culture and embryo transfer, loss of methylation and biallelic
expression was observed for H19, Snrpn, Peg3 and Kcnq1ot1 in extraembryonic tissues,
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indicating that imprinting perturbations are inherited through to midgestation, long after
embryos have been removed from the culture medium (Mann et al., 2004). It is now well
understood that embryo culture, the act of maintaining pre-implantation embryos outside
the female reproductive tract, as well as the components of the embryo culture medium,
affect genomic imprinting at multiple loci.
Significant advancements have been made in the culture of preimplantation
embryos to date (Bolton et al., 1991; Fischer and Bavister, 1993; Li and Foote, 1993;
Gardner, 1994; Bavister, 1995; Gardner and Lane, 1996; Bavister, 2004; Rinaudo and
Schultz, 2004), and many different media are currently available. The majority of embryo
culture media are based on physiological saline solutions (Quinn, 1998; Summers and
Biggers, 2003). Early development of chemically-defined culture media was based on
classic formulations for somatic cell culture. For example, Whitten’s medium is a saline
solution based on Krebs-Ringer’s solution supplemented with a carbohydrate energy
source. More recent formulations have adjusted concentrations of various components
based either on optimized response by the embryo or to approximate values of known
constituents present in the oviductal/uterine environment (Summers and Biggers, 2003).
One example is KSOM (for K+ modified, simplex optimized medium); identification of
amino acids in oviducts led to supplementation of culture media with amino acids (AA).
To date, various media types are used to culture preimplantation embryos, including in
ART clinics (Gardner, 1994; Bavister, 1995; Summers and Biggers, 2003; Pool, 2004).
What needs to be emphasized is that preimplantation embryos survive embryo culture by
adapting to the environment (Summers and Biggers, 2003). The full consequences of
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these adaptations are unknown. The fact remains that oviductal fluid is more complex
and subsequently better than culture medium currently used for human and mouse
embryos (Roberts, 2005). Further development of culture media was based on the idea
that media components should be altered during culture to reflect the in vivo environment
and led to the development of “sequential media systems”. Culture formulations mimic
the changing environment as embryos transverse the oviduct to the uterus/uteri. Thus, a
switch from high pyruvate, low glucose to high glucose, low pyruvate was implemented
in these media systems to meet the temporal nutritional needs of the developing
preimplantation embryo (Gardner and Lane, 1998; Cooke et al., 2002).
Many studies have attempted to show superiority of one media or another, with
respect to various measures of developmental competence (Leese and Barton, 1984;
Quinn et al., 1985; Ho et al., 1995; Gardner and Lane, 1998; Roberts, 2005; Lane and
Gardner, 2007; Biggers and Summers, 2008). The effects of various culture media on
genomic imprinting have been evaluated by many groups, however it is nearly impossible
to compare between studies due to differences in other aspects of their embryo
manipulation techniques. In the mouse model, M16 medium was shown to cause greater
perturbation of H19 imprinting than G1.2/G2.2 (Fauque et al., 2007). Human tubal fluid
(HTF) caused loss of H19 imprinting, including aberrant histone modifications with an
increase in H3K4 dimethylation on the paternal allele and an increase in H3K9
trimethylation on the maternal allele (Li et al., 2005).

KSOMaa was better able to

maintain genomic imprinting than Whitten’s medium (Doherty et al., 2000; Mann et al.,
2004) although culture in KSOMaa also resulted in disruptions of genomic imprinting
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(Rivera et al., 2008).

In the bovine, alterations in imprinting of Snrpn have been

associated with the non-sequential SOF medium (Suzuki et al., 2005) as well as Sgce and
Ata3 in the sequential Vitro Cleave/Vitro Blast medium (Tveden-Nyborg et al., 2008). In
humans, a recent study reported loss of methylation at the H19 locus in ~19% of a cohort
of human embryos cultured in Cleavage Medium (Chen et al., 2010), supporting the
translation of aberrant imprinting noted in animal models as a caution to human embryo
culture.

However, all of the above studies employed ovarian stimulation to retrieve

embryos prior to culture. As such, as noted above, it is not possible to tease out the
effects of one type of ART from another based on the current literature. My thesis aims to
provide the necessary experimental protocols and analyses to begin to elucidate the
individual effects of different forms of ART.

1.5 - Rationale
As described above, germ cell and preimplantation development are critical
periods in the erasure, establishment and maintenance of proper imprinted methylation
patterns (Santos and Dean, 2004). As such, the timing of ARTs during these critical
periods provides a mechanism for the disruption of imprinting establishment and
maintenance through the environmental insult caused by the use of these procedures. It is
of critical importance to evaluate the effects of these techniques on genomic imprinting,
and assess the safety and risks associated with each technique (Mann et al., 2004). In
addition, due to the stochastic nature of environmental effects on genomic imprinting,
analysis at the individual embryo levels is necessary to gain a clear understanding of the
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prevalence and frequency of disruption. Multiple analyses in the same individual embryo
conducted in these studies also allows for correlation of multiple characteristics with the
environmental effects of genomic imprinting.

1.6 - Hypothesis
I hypothesize that multiple imprinted loci are disrupted by superovulation alone or
embryo culture alone, and that this disruption results from perturbations in the
mechanisms regulating the acquisition and maintenance of genomic imprinting
throughout preimplantation development.

In addition, I hypothesize that rates of

preimplantation development correlate with loss of genomic imprinting.

1.7 - Objectives
This thesis addresses the following objectives:
(1) To evaluate the effects of superovulation on genomic imprinting in the mouse
embryo
(2) To determine the differential effects of embryo culture media on genomic imprinting.
(3) To determine the relationship between rates of preimplantation development and
maintenance of genomic imprinting
All studies were performed using a technique developed during the course of my graduate
work with which I was able to analyze multiple parameters in individual preimplantation
embryos.
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Chapter 2: The Effects of Superovulation on Genomic Imprinting

The work in this chapter originates from the following peer-reviewed article:
Market-Velker, B.A., Zhang, L., Magri, L.S., Bonvissuto, A.C. & Mann, M.R. Dual
effects of superovulation: loss of maternal and paternal imprinted methylation in a dosedependent manner. Hum Mol Genet 19, 36-51 (2010).

2.1 Introduction
The use of assisted reproductive technologies (ARTs) for the treatment of human
subfertility / infertility contributes 1-2% of all children born in developed countries
(Gosden et al., 2003; Roberts, 2005). However, the safety of these technologies has yet to
be fully evaluated. Children conceived through various forms of ART are at an increased
risk of low birth weight, intrauterine growth restriction, premature birth, and have a
higher incidence of genetic and epigenetic disorders, including genomic imprinting
disorders such as Beckwith-Wiedemann Syndrome and Angelman Syndrome (Cox et al.,
2002; DeBaun et al., 2003; Gicquel et al., 2003; Maher et al., 2003; Orstavik et al., 2003;
Sunderam et al., 2009).

While the absolute risk of developing a genomic imprinting

disorder in children born through ART as a result of an epigenetic defect is low, the
relative risk when compared to non-ART children is significantly higher (Maher, 2005;
Bowdin et al., 2007).
Genomic imprinting is a mechanism of transcriptional regulation that restricts
expression to either the maternally- or paternally-inherited copy of the gene; the opposite
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parental copy is silent (Verona et al., 2003). Imprinting may be envisaged as a multigenerational process that begins in parental gametes, where previous DNA modifications
are erased, and sex-specific modifications that differentially mark the parental alleles are
acquired (Szabo and Mann, 1995; Kato et al., 1999; Lee et al., 2002). Maternal imprints
are established in the oocyte, during maturation from primordial to antral follicles.
Imprinting marks are then stably inherited and maintained in the developing embryo,
amidst genome-wide changes in DNA methylation, where they are translated into
parental-specific monoallelic expression (Pfeifer, 2000). Disruptions in any of these steps
may lead to loss of parental-specific expression and the development of imprinting
disorders.
DNA methylation of CpG dinucleotides is the most widely investigated epigenetic
"mark" associated with genomic imprinting.

It has generally been linked to

transcriptional repression, is both heritable and reversible, and has been shown to interact
with, and recruit, chromatin-modifying complexes to silence or activate specific genes
(Razin and Riggs, 1980; Berger, 2007; Cedar and Bergman, 2009). DNA methylation
occurs at regions called differentially methylated regions (DMRs) that display differential
methylation of maternal and paternal alleles, or imprinting control regions (ICRs), if it
has been ascertained that differential methylation is acquired during gametogenesis and
maintained during preimplantation development.

Although the exact mechanisms of

imprinted gene regulation have yet to be elucidated, DNA methylation at DMR/ICRs has
been correlated with allelic expression of many imprinted genes (Verona et al., 2003).
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Superovulation, or ovarian stimulation, is an assisted reproductive technology
commonly used to treat subfertility in women, for basic research in animal models, and in
the production of livestock to obtain large numbers of offspring. Increased frequencies of
imprinting disorders have been correlated with ARTs, and loss of imprinting is more often
the cause of imprinting disorders in affected ART populations than in non-ART children.
Significantly, for both Angelman and Beckwith-Wiedemann Syndromes, patients have
been identified where the only ART procedure used was ovarian stimulation (Young et al.,
1998; Chang et al., 2005; Ludwig et al., 2005).
To distinguish between the effects of superovulation and other contributing factors
on genomic imprinting, carefully controlled experiments are required on spontaneouslyovulated, in vivo-fertilized oocytes, and their induced-ovulated counterparts, thereby
minimizing effects of in vitro manipulations. Additionally, effects of superovulation on
genomic imprinting need to be evaluated in an animal model system, where subfertility is
not a confounding issue.
We propose that superovulation alone increases the risk of developing imprinting
disorders. To address this, we evaluated imprinted methylation of multiple genes from
individual mouse preimplantation embryos. This work represents the first comprehensive
examination of the overall effect of ovarian stimulation on genomic DNA methylation
imprints at four imprinted loci, Snrpn, Peg3, Kcnq1ot1 and H19, in individual blastocyst
stage embryos, and is the first to utilize low and high doses of hormones to assess their
effects on genomic imprinting. We report that superovulation resulted in a loss of Snrpn,
Peg3 and Kcnq1ot1 imprinted methylation, and a gain of imprinted H19 methylation in
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preimplantation embryos, and that this perturbation was dose-dependent; dysregulation of
imprinted methylation was more frequent at the high hormone dosage. Additionally, we
show that maternal- as well as paternal-specific H19 methylation imprints were perturbed
by superovulation, suggesting that superovulation disrupts acquisition of imprints in
growing oocytes, as well as maternal-effect gene products subsequently required for
imprint maintenance during preimplantation development.

2.2 Methods
2.2.1 Ovarian Stimulation and Embryo Collection
Embryos were obtained from crosses of C57BL/6 (CAST7) females and C57BL/6
(B6) males (Jackson Laboratory or Charles River).

B6(CAST7) mice contain Mus

musculus castaneus chromosome 7 on a B6 background (Mann et al., 2003).

Two

hormone regimens were used for ovarian stimulation, 6.25 IU (low dose) and 10 IU (high
dose).

Low or high doses of PMSG (Pregnant Mare’s Serum Gonadotropin, Intervet

Canada) were administered to female B6(CAST7) mice, followed by the same dose of
hCG (Human Serum Chorionic Gonadotropin, Intervet Canada) 40-44 hours later.
Females were mated with B6 males, and pregnancy was determined by the presence of a
vaginal plug the following morning (day 0.5). F1 hybrid embryos were flushed from the
genital tract of females ~96 hours post-hCG to recover blastocyst stage embryos.
Additionally, females were set up in timed-matings that allow for spontaneous ovulation
cycles (untreated controls). B6(CAST7) females were crossed with B6 stud males. As
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well, B6 females were mated with Mus musculus castaneus (CAST) males (spontaneous
ovulation). Embryos were recovered at day 3.5 postcoitum; all analyzed embryos were
blastocysts, except for B6(CAST7) X B6 E6 (spontaneous ovulation group), E29 (6.25 IU
group) and E23 (10 IU group) which were late stage morulae. Embryos were flushed in
pre-warmed M2 media (Sigma), washed 3x in 30 µL, and individually snap frozen in 1-5
µL of M2. Individual embryos were stored at -80˚C. For each control and experimental
group, embryo collections were performed multiple times, and embryos analyzed were
recovered from multiple litters.

Experiments were performed in compliance with the

guidelines set by the Canadian Council for Animal Care, and the policies and procedures
approved by the University of Western Ontario Council on Animal Care.

2.2.2 DNA Isolation and Bisulfite Mutagenesis for Individual Embryos
Bisulfite Mutagenesis with agarose embedding was conducted on single embryos
as described (58,59), with modification.

Individual embryos were lysed with 0.1%

IGEPAL (Biochemika), and 2 mg/mL Proteinase K (Sigma) in 10 µL of lysis buffer [100
mM Tris-HCl pH 7.5 (Bioshop), 500 mM LiCl (Sigma), 10 mM EDTA pH 8.0 (Sigma),
1% LiDS (Bioshop), 5 mM DTT (Sigma)] for 1 hour at 50˚C.

Lysed embryos were

embedded in 2% low melting point agarose (Sigma) under mineral oil at 95˚C. DNA/
agarose beads were allowed to solidify for 10 minutes on ice. Oil was removed and
denaturation of DNA was performed in 0.1 M NaOH (Sigma) at 37˚C for 15 minutes with
shaking. Agarose beads were placed in 2.5 M bisulfite solution [0.125 M hydroquinone
(Sigma), 3.8 g sodium hydrogensulfite (Sigma), 5.5 mL water, 1 mL 3 M NaOH] at 50˚C
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for 3.5 hours to allow bisulfite mutagenesis to occur.

Following incubation, agarose

beads were washed once in TE pH 7.5, and desulphonated with 0.3 M NaOH at 37˚C for
15 minutes with shaking. Agarose beads were washed twice with TE pH 7.5, and twice
with water. Beads were incubated under oil at 65˚C and ~60 µL of pre-warmed water was
added. Agarose beads were mixed by pipetting and 20 µL of diluted agarose was added
to one Ready-to-go PCR Bead (GE) containing gene-specific primers and 1 µL of 240 ng/
mL tRNA as a carrier. PCRs were split in half allowing two independent PCR reactions
to be completed for each gene analyzed.

Nested primer sequences and associated

information for each gene can be found in Table 2.1. Negative controls (no embryo) were
processed alongside each bisulfite reaction.

2.2.3 Allele-Specific DNA Methylation Analysis of Individual Embryos for Snrpn,
Peg3, Kcnq1ot1, and H19
Gene-specific primers used for nested PCR amplification of Snrpn, Peg3,
Kcnq1ot1 and H19 as well as melting temperatures for each primer set can be found in
Table 2.1.
reaction.

Five µL of first round product was seeded into each second round PCR
Second round products were digested with restriction enzymes that cleave

methylated bisulfite converted DNA to ensure no bias in the amplification of methylated/
unmethylated products, or with restriction enzymes that cleave species-specific SNPs to
ensure no allelic bias was introduced during PCR amplification. PCR amplified products
were directly cloned without intervening gel extraction steps, as we observed that column
purification drastically decreases the variability of DNA strands recovered (data not
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Table 2.1. Regions and Conditions for PCR Analysis Following Bisulfite
Mutagenesis.
Gene

Accession

Position Primer Primer Sequence (5'-3')
Annealing
Type
Temp
Snrpn
AF081460
2151 OF
TAT GTA ATA TGA TAT AGT TTA GAA ATT
52
AG
-2570 OR
AAT AAA CCC AAA TCT AAA ATA TTT TAA
TC
IF
AAT TTG TGT GAT GTT TGT AAT TAT TTG G
54
IR
ATA AAA TAC ACT TTC ACT ACT AAA ATC
C
Peg3 NT_039413.7 3683033 OF
TTT TGA TAA GGA GGT GTT T
50
-3682588 OR
ACT CTA ATA TCC ACT ATA ATA A
IF
AGT GTG GGT GTA TTA GAT T
53
IR
TAA CAA AAC TTC TAC ATC ATC
Kcnq1ot1 AJ271885 141392 OF
GTG TGA TTT TAT TTG GAG AG
52
-141598 OR
CCA CTC ACT ACC TTA ATA CTA ACC AC
IF
GGT TAG AAG TAG AGG TGA TT
52
IR
CAA AAC CAC CCC TAC TTC TAT
H19
U19619
1304 OF
GAG TAT TTA GGA GGT ATA AGA ATT
55
-1726 OR
ATC AAA AAC TAA CAT AAA CCT CT
IF
GTA AGG AGA TTA TGT TTA TTT TTG G
50
IR
CCT CAT TAA TCC CAT AAC TAT

OF Outer Forward, OR Outer Reverse, IF Inner Forward, IR Inner Reverse.
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Reference
24; 25

This study;
15

This study;
26

25; 27

shown). One µL of second round PCR product was used for ligation with the pGEMTEASY DNA ligation kit (Promega).

Ligation was performed overnight at 4˚C and

transformed into competent E. coli cells (Invitrogen or Zymo Research).

Blue/white

selection (100 mg/mL IPTG, 50 mg/mL X-gal) was used to select bacterial colonies with
ligated products.

Individual sequences were obtained by colony PCR of individual

bacterial colonies. The pGEMT-EASY vector contains M13 primer sites flanking the
multiple cloning site, which were used for amplification of inserted DNA fragments.
Approximately 2 µL of PCR product was used for agarose gel electrophoresis to verify
amplicon size, and the remainder of the PCR reaction was sent to the Nanuq Sequencing
Facility located at McGill University (Montreal, QC) or BioBasic Inc (Markham, ON) for
sequencing. As Kcnq1ot1 was the last gene in each set to be analyzed, a proportion of
embryos did not produce a sufficient number of DNA strands to be included in the
analysis.

2.2.4 Sequence Analysis
For each sample and gene analyzed, 40-50 clones were sequenced to obtain a
representative number of DNA strands.

Chromatograms from each sequence were

visualized using FinchTV. Ambiguous base pairs were manually reviewed and assigned a
designation (where possible). Each sequence was analyzed for total number and location
of CpG associated cytosines, as well as location and number of converted and
unconverted non-CpG associated cytosines to obtain conversion rates (number of
converted non-CpG cytosines/total number of non-CpG cytosines). Sequences with less
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than 85% conversion rates were not included. Identical clones (identical location and
number of unconverted CpG associated cytosines, and identical location and number of
unconverted non-CpG associated cytosines) were not included. Multiple polymorphisms
are present between B6 and CAST sequences at each gene analyzed, allowing parental
alleles to be discriminated. Clones possessing both B6 and CAST polymorphisms were
determined to be due to crossover during PCR amplification, and were not included.
Methylation levels across the region of analysis were determined by calculating the
number of methylated CpG / total number of CpG for each individual CpG site as a
percentage. Total DNA methylation for each gene was calculated as a percentage of the
total number of methylated CpG / the total number of CpG dinucleotides.

2.2.5 Statistical Analysis
To compute the significance of nonrandom association between groups of
embryos, we used the Fisher's exact test.

As changes in methylation status were

anticipated to be in only one direction (increase or decrease), a one-sided test was
utilized.

P-values were calculated using software provided online (http://

www.langsrud.com/fisher.htm), and were considered to be significant at p < 0.05.
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2.3 Results
2.3.1 Methylation levels of Snrpn, Peg3, Kcnq1ot1, and H19 in spontaneously
ovulated embryos
Prior to examining the effects of superovulation on genomic imprinting, the
methylation status of the Snrpn, Kcnq1ot1, and H19 ICRs, and the Peg3 DMR was first
determined in individual blastocysts derived from spontaneously ovulating females. The
regions analyzed included 16 CpGs located in the Snrpn ICR (Lucifero et al., 2004; Mann
et al., 2004), 24 CpGs located in the Peg3 DMR (Lucifero et al., 2004), 20 CpGs located
in the Kcnq1ot1 ICR (26), and 17 CpGs located in the H19 ICR (25,27) (Figure 2.1).
Methylation analyses using bisulfite mutagenesis and sequencing were performed on
B6(CAST7) X B6 F1 individual blastocysts. Ten individual embryos were analyzed at the
four loci. The Kcnq1ot1 and Snrpn ICRs, and the Peg3 DMR acquire maternal-specific
methylation during oogenesis, while the H19 ICR acquires paternal-specific methylation
during spermatogenesis; oocytes are unmethylated at the H19 ICR in mice (Davis et al.,
2000; Lucifero et al., 2004).

Similar DNA methylation patterns are observed for the

human SNRPN and H19 genes (Geuns et al., 2003; Borghol et al., 2006). Therefore, in
B6(CAST7) X B6 blastocyst stage embryos, the maternal (CAST) alleles of Kcnq1ot1,
Snrpn, and Peg3 should be methylated, while the paternal (B6) allele of H19 should be
methylated. As anticipated from previous reports of pools of blastocysts (Tremblay et al.,
1995; Tremblay et al., 1997; Mann et al., 2003; Mann et al., 2004; Reese et al., 2007), the
maternal DNA strands of Snrpn, Peg3, and Kcnq1ot1 were hypermethylated
(Supplementary Figure 2.1-2.3), while the maternal H19 DNA strands were
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Figure 2.1. Schematic Diagram of Regions Analyzed by Bisulfite Mutagenesis and
Sequencing Assay.
Maternal methylated Snrpn, Peg3, and Kcnq1ot1 alleles, and the paternal methylated H19
allele are indicated. ICR, Imprinted Control Region. DMR, Differentially Methylated
Region. Open circles, CpGs. Blunt arrow designates transcription start site of nontranscribed allele. Regions analyzed are as follows: Snrpn ICR, 16 CpGs (15 CpGs in
CAST) located in the promoter and first exon of the Snrpn gene; Peg3 DMR, 24 CpGs
(23 CpGs in B6) located in the promoter and first exon of the Peg3 gene; Kcnq1ot1 ICR,
20 CpGs located in the Kcnq1ot1 ICR; and H19 ICR, 17 CpGs (16 CpGs in B6) in the
ICR located 2-4 kb upstream of the transcriptional start site of H19.
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hypomethylated (Supplementary Figure 2.4).

Only maternal strands are shown as

superovulation is thought to affect genomic imprinting during oocyte development, hence
only affecting the maternal allele (Supplementary Figures 2.1-2.4). From the analysis of
embryos derived from spontaneously ovulated females, baseline total CpG methylation
levels were determined to be greater than 65%, 70% and 85% for Snrpn, Peg3 and
Kcnq1ot1, respectively, and less than 25% for H19.
The reciprocal B6 X CAST cross was also performed to ensure that B6(CAST7) X
B6 F1 embryos from spontaneously ovulated females were representative of normal
imprinted methylation. Maternal Snrpn strands displayed baseline total CpG methylation
levels of 65% (Supplementary Figure 2.5). Levels of baseline total CpG methylation on
maternal Peg3 and Kcnq1ot1 DNA strands in B6 X CAST F1 embryos were 75% and
75%, respectively (Supplementary Figures 2.6, 2.7). The maternal H19 DNA strands
were hypomethylated (Supplementary Figure 2.8), with less than 15% total CpG
methylation.

As no statistical difference was observed between embryos displaying

aberrant methylation from the two crosses as determined by the Fisher’s Exact test, these
two spontaneously ovulating groups were combined for statistical calculations.

We

conservatively set the baseline total CpG methylation level to greater than 65%, 70%, and
75% for Snrpn, Peg3, and Kcnq1ot1, respectively, and less than 25% for H19. These
values were used to determine loss or gain of methylation in embryos from superovulated
females.
Interestingly, for all imprinted genes investigated, at least one embryo displayed a
drastic loss of methylation at the normally methylated maternal allele.
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For the

B6(CAST7) X B6 F1 embryos, one embryo displayed loss of methylation at the normally
methylated maternal allele for Snrpn (E5, 60% methylation), Peg3 (E114, 55%), and
Kcnq1ot1 (E112, 23%) (Supplementary Figures 2.1-2.3). For B6 X CAST F1 embryos,
spontaneous loss of methylation was observed at one embryo at the Snrpn ICR (E80, 50%
methylation), the Peg3 DMR (E79, 34%), and at the Kcnq1ot1 ICR (E74, 58%)
(Supplementary Figure 2.5-2.7). None of the F1 embryos displayed spontaneous gain of
methylation at the H19 ICR. One embryo (E83) was observed to have reversed Kcnq1ot1
methylation; the maternal B6 strand had acquired a paternal imprinted methylation
pattern, while the paternal CAST strand had acquired a maternal imprinted pattern
(Supplementary Figure 2.7). This is a rare event that has been observed previously for
H19 imprinted expression (Mann et al., 2004).

2.3.2 Superovulation results in loss of maternal Snrpn, Peg3, and Kcnq1ot1
methylation in a dose-dependent manner
To determine the effects of superovulation on imprinted methylation, we
examined embryos derived following both low and high dosages of hormonal stimulation.
Hormone dosages typically employed for superovulation in the mouse range from 2.5 to
10 IU, with 5 IU being the recommended dose for most mouse strains (Nagy et al, 2003).
We chose 6.25 IU to represent to the low hormone dose, as lower concentrations were not
as ineffective at inducing superovulation in the B6(CAST7) mice, and 10 IU for the high
hormone dose (Nagy et al, 2003). Snrpn, Peg3 and Kcnq1ot1 are normally paternally
expressed and maternally methylated. Data were obtained from 10 embryos each in the
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6.25 and 10 IU hormone treatment groups for Snrpn, and from 9 embryos in each
hormone treatment group for Peg3, while 5 embryos from the 6.25 IU group, and 9
embryos from the 10 IU group were analyzed for Kcnq1ot1 imprinted methylation.
Forty-50 clones were sequenced and analyzed for each gene. Methylation levels were
analyzed at individual CpG dinucleotide across each ICR/DMR, as well as for the total
number of methylated CpGs for each gene per embryo.
Snrpn displayed a loss of maternal methylation at both hormone dosages
(Supplementary Figure 2.9), with the loss more frequent at the high hormone dosage
(Figure 2.2 and 2.3). Analysis of total CpG methylation revealed that Snrpn exhibited a
loss of methylation at the low hormone dosage on the maternal allele for four embryos
(E29 31%, E13 63%, E13 45%, and E33 54% total CpG methylation of DNA strands)
(Figure 2.2), and a loss of methylation at the high hormone dosage on the maternal allele
for nine embryos (E10 57%, E8 55%, E1 42%, E4 63%, E23 53%, E5 59%, E6 49%, E13
63%, and E11 61% total CpG methylation) (Figure 2.3), when compared to embryos from
spontaneously ovulated females (baseline of 65% methylation). This loss of methylation
at the high dosage was significantly different from control embryos (p = 0.001) as
calculated by the Fisher's exact test.
A similar pattern of loss of methylation was observed for Peg3 when compared to
Snrpn; both hormone dosages displayed a loss of methylation on maternal DNA strands
(Supplementary Figure 2.10), with a greater frequency of loss in the high hormone dosage
group (Figure 2.4 and 2.5).

Peg3 displayed a loss of maternal methylation for four

embryos (E14 67%, E29 49%, E18 67%, and E33 66% total CpG methylation) at the low
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Figure 2.2. Methylation of the Maternal Snrpn ICR in B6(CAST7) X B6 F1 Embryos
Derived from Low Dosage Superovulated Females.
Methylation status of individual DNA strands in the Snrpn ICR (maternal, CAST strands
shown) in blastocysts derived from females superovulated with a 6.25 IU hormone
dosage. Unmethylated CpGs are represented as empty circles while methylated CpGs are
depicted as filled circles. Each line denotes an individual strand of DNA. Clones with
identical methylation patterns and non-CpG conversion rates representing the same DNA
strand were included once. Each group of DNA strands represents data from a single
embryo, with the embryo designation indicated at the top left. Percent methylation is
indicated above each set of DNA strands, and was calculated as the number of methylated
CpGs / total number of CpG dinucleotides. The region analyzed contains 15 CpGs; a
base pair change in the maternal CAST allele eliminates CpG dinucleotide 1.
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Figure 2.3: Methylation of the Maternal Snrpn ICR in B6(CAST7) X B6 F1 Embryos
Derived from High Dosage Superovulated Females.
Methylation status of individual DNA strands in the Snrpn ICR (maternal, CAST strands
shown) in blastocysts derived from females superovulated with a 10 IU hormone dosage.
The region analyzed contains 15 CpGs; a base pair change in the maternal CAST allele
eliminates CpG dinucleotide 1. Details are as described in Figure 2.2.
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Figure 2.4. Methylation of the Maternal Peg3 DMR in B6(CAST7) X B6 F1 Embryos
Derived from Low Dosage Superovulated Females.
Methylation status of individual DNA strands in the Peg3 DMR (maternal, CAST strands
shown) in blastocysts derived from females superovulated with a 6.25 IU hormone
dosage. The region analyzed contains 24 CpGs. Details are as described in Figure 2.2.
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Figure 2.5. Methylation of the Maternal Peg3 DMR in B6(CAST7) X B6 F1 Embryos
Derived from High Dosage Superovulated Females.
Methylation status of individual DNA strands in the Peg3 DMR (maternal, CAST strands
shown) in blastocysts derived from females superovulated with a 10 IU hormone dosage.
The region analyzed contains 24 CpGs. Details are as described in Figure 2.2.
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hormone dosage (Figure 2.4), and a loss of methylation for five embryos (E10 50%, E8
67%, E1 64%, E4 47%, and E11 42% CpG methylation) at the high hormone dosage
(Figure 2.5), when compared to embryos from spontaneously ovulated females (baseline
of 70% total CpG methylation).

This loss of imprinted methylation was statistically

significant in the higher hormone treatment group when compared to the spontaneous
ovulation group (p = 0.03).
Kcnq1ot1, a third paternally expressed gene, also exhibited a similar loss of
methylation on maternal DNA strands at both hormone dosages (Supplementary Figure
2.11), with a greater frequency of loss in the high hormone dosage group (Figure 2.6 and
2.7). Kcnq1ot1 exhibited a loss of maternal methylation for two embryos (E5 54%, and
E33 52% CpG methylation) at the low hormone dosage (Figure 2.6), and five embryos
(E2 64%, E8 56%, E4 43%, E5 62%, and E13 53% total CpG methylation) at the high
hormone dosage (Figure 2.7), when compared to embryos from spontaneously ovulated
females (baseline of 75% CpG methylation). Loss of Kcnq1ot1 imprinted methylation
was not statistically significant for either hormone treatment group when compared to
controls (p = 0.4 for the 6.25 IU treatment group and p = 0.08 for the high hormone
dosage), although the high hormone dosage group approached statistical significance.
Analysis of additional embryos may be required to achieve significance.

2.3.3 Superovulation results in gain of maternal H19 methylation in a dosedependent manner
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Figure 2.6. Methylation of the Maternal Kcnq1ot1 ICR in B6(CAST7) X B6 F1
Embryos Derived from Low Dosage Superovulated Females.
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (maternal, CAST
strands shown) in blastocysts derived from females superovulated with a 6.25 IU
hormone dosage. Details are as described in Figure 2.2.
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Figure 2.7. Methylation of the Maternal Kcnq1ot1 ICR in B6(CAST7) X B6 F1
Embryos Derived from High Dosage Superovulated Females.
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (maternal, CAST
strands shown) in blastocysts derived from females superovulated with a 10 IU hormone
dosage. Details are as described in Figure 2.2.
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The same ten embryos analyzed for imprinted methylation of the Snrpn, Peg3 and
Kcnq1ot1 ICR/DMRs were also used for analysis of the H19 ICR. H19 displayed a gain
of maternal methylation at both hormone dosages, particularly for CpG dinucleotides
8-17 (Supplementary Figure 2.12), with the loss more frequent at the high hormone
dosage(Figure 2.8 and 2.9). At the low hormone dose, one of ten embryos displayed a
gain of maternal methylation, as seen by the presence of greater than 25% baseline CpG
methylation of DNA strands (E14 32% methylation) (Figure 2.8). At the higher hormone
dosage (10 IU), 4 of 10 embryos displayed a gain of maternal methylation (E8 66%, E4
43%, E13 67%, and E11 53% CpG methylation) (Figure 2.9). This gain of methylation at
the higher dosage was significantly different from control embryos (p = 0.003). These
embryos acquired a more paternal-like pattern of methylation at the H19 ICR.

2.3.4 Superovulation results in loss of paternal H19 methylation in a dose-dependent
manner
Studies of the effects of superovulation on genomic imprinting focused on the
maternal allele, as superovulation is thought to affect genomic imprinting during oocyte
development. Using our protocol, methylation data was obtained for both maternal and
paternal of the four imprinted genes from individual preimplantation embryos.
Surprisingly, not only did we observe significant effects of superovulation on imprinted
methylation of maternal alleles as described above, we also observed a loss of
methylation on the normally methylated paternal H19 allele at both hormone dosages,
especially for CpG dinucleotides 1-7 (Supplementary Figure 2.13), with more frequent
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Figure 2.8. Methylation of the Maternal H19 ICR in B6(CAST7) X B6 F1 Embryos
Derived from Low Dosage Superovulated Females.
Methylation status of individual DNA strands in the H19 upstream ICR (maternal, CAST
strands shown) in blastocysts derived from females superovulated with a 6.25 IU
hormone dosage. The region of the maternal CAST H19 allele analyzed contains 17
CpGs. Details are as described in Figure 2.2.
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Figure 2.9. Methylation of the Maternal H19 ICR in B6(CAST7) X B6 F1 Embryos
Derived from High Dosage Superovulated Females.
Methylation status of individual DNA strands in the H19 upstream ICR (maternal, CAST
strands shown) in blastocysts derived from females superovulated with a 10 IU hormone
dosage. The region of the maternal CAST H19 allele analyzed contains 17 CpGs. Details
are as described in Figure 2.2.
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Figure 2.10. Methylation of the Paternal H19 ICR in B6(CAST7) X B6 F1 Embryos
Derived from Low Dosage Superovulated Females.
Methylation status of individual DNA strands in the H19 upstream ICR (paternal, B6
strands shown) in blastocysts derived from females superovulated with a 6.25 IU
hormone dosage. The region of the paternal B6 H19 allele analyzed contains 16 CpGs
due to a polymorphism that eliminates CpG8. Details are as described in Figure 2.2.
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Figure 2.11. Methylation of the Paternal H19 ICR in B6(CAST7) X B6 F1 Embryos
Derived from High Dosage Superovulated Females.
Methylation status of individual DNA strands in the H19 upstream ICR (paternal, B6
strands shown) in blastocysts derived from females superovulated with a 10 IU hormone
dosage. The region of the paternal B6 H19 allele analyzed contains 16 CpGs due to a
polymorphism that eliminates CpG8. Details are as described in Figure 2.2.
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loss of methylation at the high hormone dosage (Figure 2.10 and 2.11).

For both

B6(CAST7) X B6 (Supplementary Figure 2.14), and B6 X CAST F1 embryos
(Supplementary Figure 2.15) from spontaneously ovulated females, H19 displayed 79%
and 77% total CpG methylation on paternal DNA strands. Thus, the baseline level of
total CpG methylation on the paternal H19 allele was set at 75%. Of the above embryos
derived from spontaneously ovulating females, two B6(CAST7) X B6 F1 embryo and two
B6 X CAST F1 embryo displayed loss of CpG methylation on paternal DNA strands (E10
71%, E113 50%, and E73 61%, E74 56% methylation). By comparison, embryos from
induced ovulations exhibited a loss of paternal H19 methylation. At the low hormone
dosage, three embryos (E18 54%, E20 69%, and E33 58% methylation) displayed a loss
of methylation on paternal DNA strands (Figure 2.10), while at the high hormone dosage,
seven embryos (E10 71%, E2 63%, E8 57%, E23 68%, E5 61%, E6 73%, and E11 47%
CpG methylation) showed a loss of paternal methylation (Figure 2.11).

This loss of

imprinted methylation on the paternal H19 strand was statistically significant in the high
hormone treatment group (p = 0.02).
For the other imprinted genes analyzed, low levels of total CpG methylation were
present on the paternal alleles Snrpn, Peg3 and Kcnq1ot1 following spontaneous and
induced ovulation (Supplementary Figures 2.16-2.27). After taking baseline levels of
total CpG methylation, one embryo from each dosage group showed a gain of paternalspecific Snrpn methylation (6.25 IU treatment E14 35%; and 10 IU treatment group E8
36%), one embryo from each hormone treatment group displayed a gain of paternalspecific Peg3 methylation (6.25 IU treatment E31 51%; and 10 IU treatment groups E11
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36%), and one embryo had a gain in paternal-specific Kcnq1ot1 methylation in the 6.25
IU treatment (E33 23%). In contrast to paternal H19 methylation, these results were not
statistically significant, and no effect of dosage was observed.

2.3.5 Perturbation of Imprinted Methylation for Multiple Genes
To determine the incidence of aberrant methylation (gain or loss) in the various
treatment groups, the number of embryos with perturbation in methylation of the maternal
Snrpn, Peg3, Kcnq1ot1 and H19 ICR/DMRs, and the paternal H19 ICR were assessed by
the Fisher’s exact test (Table 2.2). At the low hormone dosage, 4 of 10 embryos (E14,
E29, F18, and E33) showed aberrant methylation of 2 or more genes, which was
significantly different than embryos derived from spontaneously ovulated females where
only a single embryo (E74) displayed aberrant methylation of more than one gene (p =
0.05). At the high dose, 10 of 10 embryos displayed aberrant methylation for 2 or more
genes. When compared to control embryos, this difference was highly significant (p =
0.00002).

When all four genes were examined, no embryos exhibited aberrant

methylation patterns at all loci at the low hormone concentration. However at the high
hormone dosage, one embryo (E8) displayed perturbed methylation at the maternal allele
of all four genes, as well as at the paternal H19 allele. These data clearly demonstrate the
dose-dependent effect of superovulation on perturbation of imprinted methylation.
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Table 2.2. Comparison of Hormone Dosage and Aberrant Imprinted Methylation
Dosage
Genotype

0 IU
CAST7XB6

0 IU
B6XCAST

6.25 IU
CAST7XB6

10 IU
CAST7XB6

Embryo Snrpn Mat Peg3 Mat Kcnq1ot1
Loss
Loss
Mat Loss
(>65%)
(>70%)
(>75%)
E2
ND
E5
60
ND
E10
E112
23
E114
55
E113
ND
E115
E400
ND
E414
ND
E6
E73
E74
58
E79
34
E80
60
E83
R
E84
E85
E15
ND
E14
67
E29
31
49
E18
63
67
E13
45
E5
54
E7
ND
E20
ND
E33
54
66
52
E6
ND
ND
E10
57
50
E2
64
E8
55
67
56
E1
42
64
E4
63
47
43
E23
53
E5
59
62
E6
49
ND
ND
E13
63
53
E11
61
42

ND Not determined; R reversal of imprinted DNA methylation.
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H19
Mat Gain
(<25%)

H19
Pat Loss
(>75%)

71

63

61
56

32
54

69
58

66

71
63
57

43
68
61
73
67
53

47

2.4 Discussion
In this study, we utilized a mouse model system to investigate the effects of
superovulation on genomic imprinting in blastocyst stage embryos.

Blastocysts were

examined for parental-specific methylation changes to circumvent the chance of cumulus
cell contamination that otherwise could be an issue when analyzing oocytes and early
cleavage stage embryos.

Furthermore, by studying embryos instead of oocytes, we

minimized the effects of in vitro manipulations, as well as limited our analysis to those
oocytes that were capable of being fertilized and producing embryos.

We have

demonstrated that superovulation perturbed genomic imprinting of both maternally and
paternally expressed genes, and that this perturbation was dose-dependent. Previously,
superovulation had been postulated to function by affecting oocyte development, and
therefore effects were expected to be restricted to the maternal allele. In our study, we
have demonstrated that maternal-specific methylation imprints as well as paternalspecific methylation imprints were disrupted by superovulation.

Furthermore, we

observed that superovulation results in perturbation of genomic imprinting for multiple
genes within the same embryo.

2.4.1 Superovulation Perturbs Genomic Imprinting
Assisted reproduction has been linked to the generation of epigenetic errors that
result in the development of the human imprinting disorders Angelman Syndrome and
Beckwith-Wiedemann Syndrome (Cox et al., 2002; DeBaun et al., 2003; Gicquel et al.,
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2003; Maher et al., 2003; Orstavik et al., 2003; Halliday et al., 2004). Commonality
between ART-associated BWS and AS is loss of maternal-specific methylation at the
imprinting control regions at 11p15 and 15q11-13, respectively (Cox et al., 2002; DeBaun
et al., 2003; Gicquel et al., 2003; Maher et al., 2003; Orstavik et al., 2003).
Multiple studies have examined the association of ARTs and imprinting, and in all
cases examined some type of ovarian stimulation regime was consistently employed to
facilitate conception (Young et al., 1998; Van der Auwera and D'Hooghe, 2001; Gicquel
et al., 2003; Chang et al., 2005; Ludwig et al., 2005). Significantly, in both Angelman
and Beckwith-Wiedemann Syndrome studies, patients were identified where the only
ART procedure used was ovarian stimulation.
In the current study, we assessed the effects of superovulation on the ICRs of
Snrpn, Kcnq1ot1 and H19 genes that have a causal role in the etiology of BWS and AS.
Following superovulation, we observed a loss of maternal methylation in blastocyst stage
embryos at the ICRs of the paternally expressed Snrpn and Kcnq1ot1 genes in individual
mouse preimplantation embryos. While the effects of superovulation have not previously
been examined at the blastocyst stage for Snrpn, no effect on Snrpn imprinted
methylation was observed following superovulation in midgestation mouse embryo and
placentas (Fortier et al., 2008). The effects of superovulation on Kcnq1ot1 have not been
previously examined at the blastocyst stage, however a decrease in hypermethylated
Kcnq1ot1 alleles from stimulated human oocytes compared to unstimulated controls has
been observed (Khoueiry et al., 2008).

Together these observations show that

superovulation is associated with loss of DNA methylation at imprinted loci known to be
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linked to the development of AS and BWS. This study further provides a mechanistic
link between ARTs and imprinting disorders.
The effect of superovulation on maternal methylation of the Peg3 DMR has not
been previously evaluated at any stage of development. Similar to the other paternally
expressed genes examined, we observed a loss of maternal Peg3 methylation following
superovulation. Our results constitute a novel finding, and suggest that the effects of
ARTs may not be limited to a subset of imprinted genes but may affect multiple imprinted
loci.

Peg3 is a zinc finger protein thought to interact with p53 and Bax to regulate

neuronal apoptosis in response to hypoxia or DNA damage (Deng and Wu, 2000; Relaix
et al., 2000; Johnson et al., 2002). Loss of Peg3 expression is associated with aberrant
maternal nurturing behaviour and an offspring’s ability to thrive (Li et al., 1999; Murphy
et al., 2001; Curley et al., 2004), phenotypes that have been linked to increased neuronal
apoptosis during neonatal brain development (Broad et al., 2009). Furthermore, loss of
methylation at the Peg3 DMR has been linked to spontaneous abortion (Liu et al., 2008).
Our data is of interest, in light of the fact that children born through ART are at an
increased risk of neonatal mortality and intensive care unit admission (Basatemur and
Sutcliffe, 2008) and increased risk of low birth weight and premature delivery (Sunderam
et al., 2009).

Our observation that superovulation results in a loss of imprinted

methylation at the Peg3 DMR may suggest an additional mechanism contributing to the
risks of ART.
In addition to loss of maternal methylation, we observed a gain of maternal
methylation for the normally unmethylated maternally H19 allele in blastocyst stage
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embryos.

This is consistent with the report by Sato et al. (Sato et al., 2007), who

observed a gain of maternal H19 methylation following superovulation in mouse and
human oocytes, and by Borghol et al. (Borghol et al., 2006) who observed methylated
H19 alleles in oocytes obtained from women undergoing ovarian stimulation followed by
in vitro maturation.

In contrast, our data differ from those reported by Fortier et al.

(Fortier et al., 2008), who observed that H19 methylation in midgestation mouse embryos
and placentas derived from superovulated mothers did not reveal a gain of maternal H19
methylation.

This discrepancy may be explained by smaller sample size, single low

hormone dosage, or technical difficulties with the bisulfite protocol discussed by the
authors (Fortier et al., 2008). Another report cited no difference in H19 methylation
following superovulation in individual blastocysts, however, methylation analyses were
not done allelically; therefore, methylated maternal alleles would not have been
discriminated from appropriately methylated paternal alleles (Fauque et al., 2007).

2.4.2 Superovulation Perturbs Genomic Imprinting for Multiple Genes in the Same
Embryo
Analysis of the incidence of imprinted methylation defects following superovulation
revealed that many embryos harboured aberrant methylation for 2 or more genes, which
was significantly different from embryos from spontaneously ovulated females where
only a single embryo displayed aberrant methylation for more than one gene. Similar
observation were recently reported in ART-conceived children with BWS (Lim et al.,
2009); imprinting defects at multiple imprinted loci other than the Kcnq1ot1 ICR were
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more frequently observed in BWS patients whose parents had undergone some form of
ART than in non-ART BWS patients. These data suggest that developmental defects or
abnormal growth in ART children might be caused by variable combinations of epigenetic
perturbations at imprinted genes, perhaps offering an explanation for a postulated new
syndrome characterized by overgrowth and severe developmental delay (Shah et al.,
2006).

Developmental and growth abnormalities could also plausibly result from

combinations of ART-induced epigenetic perturbations at imprinted and non-imprinted
genes, indicative of broad effects of ART on DNA methylation (Katari et al., 2009).

2.4.3 Superovulation may lead to perturbation in imprint acquisition as well as
imprint maintenance
Loss of imprinted methylation in embryos derived from superovulated mothers,
but not in control females, indicates that superovulation disrupts mechanisms that
establish imprinting during oogenesis. There are a number of possible explanations for
the loss of imprinting following superovulation. Hormonal stimulation may result in the
“rescue” of subordinate follicles which may have entered the follicular atresia pathway
and that otherwise would not have been ovulated resulting in ovulation of lower quality
oocytes (Van der Auwera and D'Hooghe, 2001), it may lead to rapid oocyte maturation
that perturbs genomic imprints, or it may induce ovulation of immature oocytes that have
not completely acquired their imprints (Paoloni-Giacobino and Chaillet, 2004; Ludwig et
al., 2005). In humans, ovarian stimulation has been shown to accelerate the growth rate
of ovarian follicles when compared to non-stimulated controls (Baerwald et al., 2009). In
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the case of genomic imprinting, this shortened maturation time may lead to improper or
incomplete acquisition of imprinting marks on the maternal alleles. However, no change
in the activity or localization of DNMT1 has been noted in embryos following
superovulation (Doherty et al., 2000). Further investigations are required to distinguish
between these possibilities.
As the use of exogenous hormones occurs during oogenesis, effects of
superovulation were expected to be restricted to the maternal allele. Surprisingly, we
report that H19 displayed a loss of methylation on the paternal, sperm-contributed allele,
indicating that events that occur during oocyte maturation regulate imprinting on both the
maternal and paternal alleles. At this point, it is not known whether this effect extends to
other ICR that are unmethylated on the maternal allele, or if it is limited to the H19 ICR.
However, our data support a recent study that observed activated expression of the
normally silent, paternal H19 allele following superovulation (Fortier et al., 2008), as well
as, a second study that showed aberrant H19 imprinted methylation in F1 and F2 male
offspring of superovulated female mice (Stouder et al., 2009). Thus, we postulate that
superovulation has dual effects during oogenesis, acting to disrupt the acquisition of
imprints in the growing oocyte, as well as causing molecular changes that disrupt
maternal-effect gene products subsequently required for genomic imprint maintenance
during preimplantation development.

2.4.4 Dose-Dependent Effects of Superovulation
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Dose-dependent effects of ovarian stimulation on genomic imprinting have not
been previously reported. To evaluate this, we performed experiments using two different
dosages of hormones, 6.25 IU (low) and 10 IU (high).

All four imprinted genes

investigated displayed a dose-dependent response to superovulation. A greater number of
embryos displayed perturbed imprinted methylation on the maternal alleles of Snrpn,
Peg3, and Kcnq1ot1, and on both the maternal and paternal allele of H19, at the high
hormone dosage compared to the low hormone dosage.

Various hormone types and

regimens are currently used for the treatment of subfertility. A mild stimulation regimen
was shown to decrease the incidence of aneuploidy in resulting embryos when compared
to the standard higher dose regimen (Baart et al., 2007), and high dosages of exogenous
gonadotropins are associated with lower pregnancy rates (Stadtmauer et al., 1994). Our
study suggests that increasing hormone dosages in an effort to increase the number of
oocytes recovered may have detrimental effects on embryo development.

These

observations are particularly important in light of the movement in the field towards
single embryo transfers, where a natural cycling regime would not be detrimental to
pregnancy outcome.
A significant finding from these studies is that superovulation results in
dysregulation of genomic imprinting in the absence of other confounding factors. This is
relevant at the clinical and community-wide level, as ovarian stimulation is currently an
indispensable component of the ART protocol to treat human subfertility / infertility. As
the genes investigated in this study play an important role in early development, and
genetic and epigenetic perturbations lead to imprinting disorders, we propose that
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superovulation may increase the risk of developing these disorders in the ART population.
Our studies and others like it argue for a more conservative use of assisted reproductive
technologies, as well as more in-depth investigations of the effects of these technologies
on human populations.
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Chapter 3: The Effects of Embryo Culture on Genomic Imprinting: Comparing 5
Commercially Available Media

The work in this chapter originates from the following peer-reviewed article:
Market-Velker, B. A., Fernandes, A. D. and Mann, M. R. Side-by-side comparison of five
commercial media systems in a mouse model: sub-optimal in vitro culture interferes with
imprint maintenance. Biol Reprod 83(6): 938-50 (2010)

3.1 Introduction
Generally, assisted reproductive technologies (ARTs) are considered safe medical
treatments.

There has been little concern that children conceived by ARTs are less

healthy than naturally-conceived children. However, while absolute risks remain low,
evidence indicates that children conceived by ARTs are at an increased risk of intrauterine
growth restriction, premature birth, low birth weight (Schieve et al., 2002; Sunderam et
al., 2009), as well as genomic imprinting disorders (Cox et al., 2002; DeBaun et al., 2003;
Gicquel et al., 2003; Orstavik et al., 2003; Halliday et al., 2004; Chang et al., 2005;
Ludwig et al., 2005). Thus, it is important to monitor the consequences of manipulating
embryos especially with the rapid evolution and increased use of ARTs.
An important protocol employed in assisted reproduction is in vitro culture.
While steady progress in developing improved culture conditions for mammalian
embryos has occurred over the past 50 years (Gardner, 1994; Edwards et al., 1997; Kaffer
et al., 2001), current culture media remain suboptimal. Cultured embryos from all species
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have reduced pregnancy rates, reduced viability and growth, increased developmental
abnormalities, behavioural deviations, are prone to metabolic and growth disorders, and
display aberrant expression patterns when compared to in vivo counterparts (Bowman and
McLaren, 1970; Ho et al., 1995; Sasaki et al., 1995; Walker et al., 1996; Young et al.,
1998; Sinclair et al., 1999; Barker, 2000; Doherty et al., 2000; Khosla et al., 2001;
Bertolini et al., 2002; Ecker et al., 2004; Fernandez-Gonzalez et al., 2004; Rinaudo and
Schultz, 2004). Simply stated, oviductal fluid is more complex than any culture medium
currently used, containing key metabolites and/or growth factors that are either lacking or
are present at different concentrations in commercial media systems.

In addition,

oviductal fluid is dynamic, changing along the length of the female reproductive tract to
reflect altered metabolic preferences in the embryo (Roberts, 2005).
One of the leading explanations for these culture-induced abnormalities is
epigenetic alterations in gene expression that originate from embryo manipulation. As
preimplantation development is a critical period of developmental programming (Santos
and Dean, 2004), the ability to maintain imprinting during in vitro development has been
questioned.

Results demonstrate that imprinting can be disrupted during mouse

preimplantation development, pinpointing a critical period of susceptibility to
environmental conditions (Sasaki et al., 1995; Doherty et al., 2000; Mann et al., 2004). In
humans, assisted reproduction has been linked to epigenetic errors that produce the
human imprinting disorders Angelman and Beckwith-Wiedemann Syndromes (AS and
BWS), with loss of imprinting more often the cause of imprinting disorders in ARTcompared to non-ART children (Cox et al., 2002; DeBaun et al., 2003; Gicquel et al.,
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2003; Orstavik et al., 2003; Halliday et al., 2004; Chang et al., 2005; Ludwig et al., 2005).
Thus, the adverse influence of assisted reproductive technologies has significant clinical
ramifications.
Multiple media formulations are used for culture in animal research models as
well as human clinics (Gardner, 1994; Bavister, 1995; Gardner and Lane, 1998; Biggers
and Summers, 2008). Early development of chemically-defined culture media was based
on classic formulations for somatic cells.

For example, Whitten’s medium is a

physiological saline based on Krebs-Ringer’s solution supplemented with a carbohydrate
energy source (Whitten et al., 1971). Here, we consider Whitten’s media as a “worst case
scenario” as it produces more aberrant non-imprinted gene expression, imprinted gene
expression, and imprinted DNA methylation at the blastocyst stage (Doherty et al., 2000;
Weksberg et al., 2001; Mann et al., 2004; Rinaudo and Schultz, 2004).

More recent

formulations have adjusted concentrations of various components based on optimizedresponse by embryos or approximate values of known constituents in the oviductal/
uterine environment (Leese and Barton, 1984).

Examples are potassium modified,

simplex optimized medium (KSOM) (Lawitts and Biggers, 1993) and Human Tubal Fluid
(Quinn et al., 1985). Identification of amino acids in oviducts led to supplementation of
culture media with amino acids (Ho et al., 1995; Roberts, 2005). Further development
was based on the premise that media should be altered during culture to better represent
the changing in vivo environment. This resulted in development and implementation of
“sequential media systems” (Gardner and Lane, 1998), where high pyruvate, low glucose
medium is switched to high glucose, low pyruvate medium to reflect the embryo’s
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changing carbohydrate preference during preimplantation development (Leese and
Barton, 1984). Many sequential media systems have been developed, including growth
media, G1 and G2, and Preimplantation 1 and Multiblast media. While two-step culture
systems now predominate in human ART, it is unclear whether they are “superior” or
necessary (Leese and Barton, 1984; Quinn et al., 1985; Lawitts and Biggers, 2003;
Biggers and Summers, 2008).
We hypothesize that imprinting maintenance mechanisms are disrupted by in vitro
culture during mouse and human ARTs and that media systems better able to maintain
genomic imprinting will produce embryos that exhibit imprinting patterns more similar to
in vivo-derived than Whitten’s cultured embryos. In this study, we used a mouse model
system because few studies are performed on human preimplantation embryos due to
ethical restrictions; the effects of embryo culture need to be evaluated in a system where
subfertility is not a confounding issue; and because the mouse embryo has been and is
currently used to optimize culture conditions for human preimplantation embryos (Quinn
and Horstman, 1998; Summers and Biggers, 2003).

We compared five commercial

culture systems against a classic medium formulation, Whitten’s (“worst case scenario”),
as well as in vivo-derived embryos (“best case scenario”), to determine their effects on
genomic imprinting. Imprinted methylation and expression were examined at H19, small
nuclear ribonucleoprotein N (Snrpn) and paternally-expressed gene 3 (Peg3).

3.2 Materials and Methods
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3.2.1 Embryo Collection

Embryos were obtained from naturally-mated C57BL6(CAST7) [B6(CAST7)] females
crossed with C57BL6 (B6) males (Charles River, St Constant, Canada) as described
(Mann et al., 2004; Market-Velker et al., 2010a). Briefly, B6(CAST7) females were
checked for estrus and mated with B6 males. Pregnancy was determined (vaginal plug)
the morning following mating (0.5 days postcoitum; dpc). Embryos were flushed from
isolated oviducts at 1.5 dpc to recover 2-cell stage embryos.

For hormone treatment

groups, 6.25 IU PMSG (Pregnant Mare’s Serum Gonadotropin, Intervet Canada, Whitby,
Canada) was administered to female B6(CAST7) mice, followed by 6.25 IU hCG
(Human Serum Chorionic Gonadotropin, Intervet Canada, Whitby, Canada) 40-44 hours
later (Table 3.1).

Hormone treatment was conducted using 6.25 IU dosage, as lower

concentrations were not as effective at inducing superovulation in the B6(CAST7) mice.
Experiments were performed in compliance with guidelines set by the Canadian Council
for Animal Care, and the policies and procedures approved by the University of Western
Ontario Council on Animal Care.

3.2.2 Embryo Culture
Embryos were cultured in six different media systems, two used for mouse embryo
culture [Whitten’s (produced in-house) (Whitten, 1971), and KSOM with amino acids
(KSOMaa; Millipore, Ternecula, USA)], and four currently used in human clinics; two
non-sequential [Human Tubal Fluid (HTF; LifeGlobal, Guelph, Canada), and Global

103

940

MARKET-VELKER ET AL.

Table
Timeline
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and Culture
TABLE 1. 3.1:
Timeline
for spontaneousfor
and induced
superovulation and
for various culture
systems.
Culture system

Day %3
1600 ha

Day %1
1400–1500 ha

Day %1
.1500 hb

Day 0
900 h

Day 0
.1600 hc

Day 1
900 hc

Whittens

Spont ovul

Spont ovul

Equilibrate mineral oil

Matings

Plugs

Equilibrate culture drop

Whittens

6.25 IU eCG

6.25 IU hCG

Equilibrate mineral oil

Matings

Plugs

Equilibrate culture drop

KSOMaa/Global/HTF

Spont ovul

Spont ovul

Equilibrate mineral oil

Matings

Plugs

Equilibrate culture drop

KSOMaa/Global/HTF

6.25 IU eCG

6.25 IU hCG

Equilibrate mineral oil

Matings

Plugs

Equilibrate culture drop

P1/MB

Spont ovul

Spont ovul

Equilibrate mineral oil

Matings

Plugs
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6.25 IU eCG

6.25 IU hCG

Equilibrate culture drop
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Equilibrate mineral oil
Matings
Plugs

G1.5/G2.5

Spont ovul

Spont ovul

Equilibrate mineral oil

Matings

Equilibrate culture drop
Plugs

TABLE 1. Timeline for spontaneous and induced superovulation and for variousEquilibrate
culture systems.
culture drop
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1. system
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Medium (LifeGlobal)], and two sequential systems [Preimplantation 1/Multiblast (P1/
MB; Somagen Diagnostics Inc, Edmonton, Canada), and G1v5PLUS/G2v5PLUS (G1.5/
G2.5; Vitrolife, Goteborg, Sweden )] (Table 3.1). The commercial media systems were
used according to the manufacturer’s instructions for the Mouse Embryo Assay. Where
indicated by the manufacturer (Global 4 mg/mL; HTF 4 mg/mL; P1/MB 0.5%), media
were supplemented with BSA (Cat# A3311, Sigma, Oakville, Canada).

Mineral oil

(Sigma, Oakville, Canada) was filter sterilized and equilibrated at least 48 hours prior to
culture. Culture drops were prepared prior to 9 AM on the morning of collection for
Whitten’s and KSOMaa, or after 4 PM the day prior to collection for the remaining media
to allow for equilibration.

Embryos were cultured in drops of 20 µl containing ~20

embryos. Culture conditions for Whitten’s medium were 37°C, 5% CO2 in air, and 37°C,
5 %O2, 5% CO2, 90% N2 for the others.

For sequential culture systems, the second

medium drops (MB or G2.5) were prepared the day prior to transfer (after 4 PM), and
equilibrated overnight.

Prior to culture in G2.5, embryos were washed 2X in pre-

equilibrated GMOPS+ (Vitrolife). All embryos were scored for blastocyst development
(defined by the presence of a blastocoel cavity) at noon on day 4 of culture, frozen
individually or in pools of 5, and stored at –80°C (Table 3.1). For each media system,
embryos were recovered from multiple litters, and embryo culture was performed at least
four times.

3.2.3 Imprinted Methylation Analysis
Bisulfite mutagenesis and sequencing analysis was performed as described (Market-
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Velker et al., 2010a), with modifications for pools of 5 blastocysts. Briefly, embryo pools
were lysed in 25 µL lysis buffer for 1 hour at 50˚C, embedded in 2% low melting point
agarose (Sigma, Oakville, Canada) and split into three 30 µL beads. For each PCR
reaction, 20 µL agarose/DNA was added to one Ready-To-Go PCR Bead (RTG; GE,
Baie-d’Urfe, Canada) containing gene specific primers (Supplementary Table 3.1)
(Sigma, Oakville, Canada) (Market-Velker et al., 2010a) and 1 µL 240 ng/mL tRNA
(Sigma, Oakville, Canada).

PCR reactions were split in half allowing for two

independent PCR reactions. Negative controls (no embryo) were processed alongside
each bisulfite reaction.

For each sample and gene analyzed, 40-50 clones were

sequenced. Chromatograms from each sequence were visualized using FinchTV (Version
1.4.0, Geospiza, Seattle, USA).

Ambiguous base pairs were manually reviewed and

assigned a designation (where possible). Each sequence was analyzed for total number
and location of CpG associated cytosines, as well as location and number of converted
and unconverted non-CpG associated cytosines to obtain conversion rates (number of
converted non-CpG cytosines / total number of non-CpG cytosines). Sequences with less
than 85% conversion rates were not included. Identical clones (identical location and
number of unconverted CpG associated cytosines, and identical location and number of
unconverted non-CpG associated cytosines) were not included. Multiple polymorphisms
are present between B6 and CAST sequences at each gene analyzed, allowing parental
alleles to be discriminated. Clones possessing both B6 and CAST polymorphisms were
likely due to crossover during PCR amplification, and were not included.
Hypermethylation of a DNA strand was defined at >50% methylated CpGs on a given
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strand.

3.2.4 Imprinted Expression Analysis
RNA isolation, synthesis of a reusable cDNA library using individual embryos,
and H19 and Snrpn expression analysis using the LightCycler Real Time PCR System
(Roche Molecular Biochemicals, Mississauga, Canada) was performed as described
(Mann et al., 2004), except HotStart RTG Beads (GE, Baie-d’Urfe, Canada) and TIB
MolBiol hybridization probes (Adelphia, USA) were used (Supplementary Table 3.1).
For the Peg3 expression analysis, Peg3 primers were used to amplify a 317-bp region
(AF038939). Fluorescence resonance energy transfer hybridization probes were designed
to the CAST amplicon (Supplementary Table 3.1). The Peg3 sensor probe spans a single
nucleotide polymorphism at nucleotide 3433 between B6 (T) and CAST (C) on the
antisense strand. Following denaturation at 95°C for 2 minutes, PCR reactions were as
follows: H19 95°C 1 second, 55°C 15 seconds, 72°C 25 seconds for 45 cycles, with
melting curve analysis of 95°C 30 seconds, 50°C 2 minutes, with 0.2°C increments
thereafter; Snrpn 95°C 1 second, 52°C 15 seconds, 72°C 6 seconds for 45 cycles, with
melting curve analysis of 95°C 2 minutes, 45°C 2 minutes, with 0.2°C increments
thereafter; Peg3 95°C 1 second, 53°C 15 seconds, 72°C 8 seconds for 45 cycles, with
melting curve analysis of 95°C 15 seconds, 45°C 30 seconds, with 0.2°C increments
thereafter.

Parental allele-specific expression patterns were calculated as percent

expression of the B6 or CAST allele relative to total expression of both alleles.
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Monoallelic expression was defined as <10% expression from the normally silent allele
(Mann et al., 2004).

3.2.5 Statistical Methods
In this analysis, we tested how readily methylation patterns associated with each media
could be distinguished from one another through the following statistical model. Given a
gene with n possible methylation sites, the frequency of observing, for a given DNA
strand, i methylated sites was estimated as pi. Specifically, p0 denotes the probability of
observing no sites methylated, p1 denotes the probability of observing one methylated
site, and so on for i = 0, 1, …, n. Plots of pi versus media show in Figure 8a, for example,
three DNA strands from the in vivo pool had pi ≈ 15/16 sites methylated. Methylationlevel frequencies pi are most easily estimated from counts ni by setting pi ≈ ni /n, where ni
is the number of strands having i sites methylated and n is the total number of sites.
However, such simplistic point-estimates are well known to exhibit considerable
systematic error when ni < 3 for any i (Sokal and Rohlf, 1994). Therefore to account for
both this error and the effect of finite sample sizes, a distribution for the set of frequencies
p i was estimated using standard Bayesian methods [42,43] such that

(

)

p0 , p1 ,…, pn |n0 ,n1 ,…,nn  Dirichlet [n0 ,n1 ,…,nn ]+ 1 2 .

Therefore, if m embryos are

sampled in the future from the same media, these embryos are expected to display
methylation counts [m0, m1, …, mn] distributed according to a standard multinomial
distribution with frequencies [p0, p1, …, pn], where
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∑ m =n .
i

i

The combination of

Dirichlet posterior and multinomial likelihood is called the Multivariate Pólya distribution

(

)

for the likelihood Pr m0 ,m1 ,…,mn |n0 ,n1 ,…,nn , and it is the natural generalization of the
bivariate Beta-binomial model [44]. Although Fisher-type p-values are often used to test
if two observed data sets are "significantly" different, it is possible to instead estimate the
magnitude of difference between each data set. Such estimates, when available, are often
more informative than simple p-values alone (Goodman, 1999; Hubbard and Bayarri,
2003). Using the expected probabilities of observing counts [m0, m1, …, mn], we can ask
how distinguishable the different media are among themselves and the in vivo sample via

(
(

 Pr m ,m ,…,m |n ,n ,…,n
0
1
n
0 1
n
log-likelihood ratio log 
 Pr m0 ,m1 ,…,mn | n′0 ,n1′ ,…,n′n


methylation-level counts [n0 ,n1 ,…,nn ]
combination of counts m0 ,m1 ,…,mn

) 
) 

for two media, each with

and [n′0 ,n1′ ,…,n′n ] , respectively.

Since any

are possible as long as they add to m, this log-

likelihood must be summed over every possible combination of mi counts, conditioned on
one of either media being the actual source of the new samples.

Formally, such a

construction is known as the Kullback-Leibler Divergence (KLD) between two
alternative hypotheses (Kullback and Leibler, 1951; Kullback, 1978).

The KLD is

particularly attractive for distinguishing among alternative treatments because it is
directly interpretable as an expected (log) true-positive versus false-negative odds-ratio
for correctly classifying or distinguishing a future sample of m embryos from two
alternatives, given that one of the alternatives is correct (Neyman and Pearson, 1933;
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Fawcett, 2006). The larger the KLD between different treatments, the larger the posterior
odds-ratio that the future m embryos can be correctly classified, and hence the more
distinguishable the two treatments are. These between-treatment comparisons appear on
the off-diagonal of Figure 8. Thus the KLD can be directly interpreted as the magnitude
of treatment-effect between different treatments. Furthermore, by using the Multivariate
Pólya likelihood, sample-size variance is automatically taken into account, and these
magnitudes are resistant to artificial inflation due to sampling variance (Kass and Raftery,
1995). Lastly, using the given KLD framework at no point is the assumption of normality
required or used. The KLD is also useful for estimating statistical power by comparing
two samples from the same treatment group by estimating the ability to recognize
methylation patterns for a given treatment as having come from that treatment. These
values appear on the diagonal of Figure 8. Smaller diagonal values are indicative of
higher statistical power. If different sets of frequencies [n0 ,n1 ,…,nn ] and [n′0 ,n1′ ,…,n′n ]
are drawn media-specific counts [n0 ,n1 ,…,nn ] and [n′0 ,n1′ ,…,n′n ] , respectively, the KLD is
then interpreted as an expected (log) true-negative versus false-positive odds-ratio for
being able to recognize methylation patterns for a given treatment as having come from
that treatment. Therefore, larger diagonal values indicate larger posterior odds ratio that
m future samples from the same population will be erroneously distinguishable and are an
indication of lower than desired statistical power.

Thus, for this analysis, using the

diagonal as a guide, odds ratios below 20:1 were considered substantially
indistinguishable, between 20:1 and 30:1 to be highly distinguishable, between 30:1 and
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100:1 to be very highly distinguishable, and over 100:1 to be decisively distinguishable in
approximate accordance with standard convention (Jeffreys, 1961).
With respect to the imprinted expression analysis, to compute the signiﬁcance of
non-random association between embryos cultured in different media types, we used the
Fisher’s exact test. As changes in expression were anticipated to be in only one direction
(monoallelic or biallelic), a one-sided test was utilized. P-values were calculated using
software provided online (http://faculty.vassar.edu/lowry/fisher.html) and were considered
to be signiﬁcant at p < 0.05.

3.3 Results
In this study, we performed a side-by-side comparison of five commercial culture
systems to determine the susceptibility of mouse preimplantation embryos to cultureinduced epigenetic errors at three imprinted loci. The commercial media systems that
were investigated were three nonrenewable, non-sequential media, KSOMaa, Global, and
HTF, and two sequential systems, P1/MB and G1.5/G2.5. Commercial formulations were
used to evaluate media currently used in human ART. For comparison, Whitten’s medium
was used as the worst-case scenario, and in vivo-derived embryos as the best-case
scenario.

3.3.1 Effects of Embryo Culture on Imprinted Methylation
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For each media system, B6(CAST7) X B6 F1 embryos were cultured from the 2cell stage to the blastocyst stage (72 +1 hours after onset of culture) according to the
manufacturer’s instructions for the Mouse Embryo Assay (Table 3.1). For each media,
blastocyst development was supported at a rate >90% (Whitten’s 96%; KSOMaa 98%;
Global 91%; HTF 97%; P1/MB 92%; G1.5/G2.5 100%) (Supplementary Table 2).
To determine whether differences existed in the ability of various culture systems
to maintain genomic imprinting, DNA methylation of the H19 and Snrpn imprinting
control regions (ICRs), and the Peg3 differentially methylated region (DMR) were
analyzed (Figure 3.1). Methylation analyses using bisulfite mutagenesis and sequencing
were performed on three pools of 5 cultured embryos per media system, and on one pool
of 5 in vivo-derived blastocysts. The Snrpn ICR and the Peg3 DMR harbour maternalspecific methylation, while the H19 ICR possesses paternal-specific methylation (Verona
et al., 2003). Therefore, in B6(CAST7) X B6 embryos, the paternal B6 H19 allele and the
maternal CAST7 Snrpn and Peg3 alleles should be methylated.

As anticipated from

previous reports of pools of blastocysts (Tremblay et al., 1997; Thorvaldsen et al., 1998;
Mann et al., 2004; Reese et al., 2007), paternal H19 DNA strands, and maternal Snrpn
and Peg3 DNA strands were hypermethylated (82%, 92%, and 100%, respectively) in the
in vivo-derived embryo pool (Figure 3.1).
Analysis of the H19 ICR in cultured embryos (Figure 3.2-3.7) showed that
Whitten’s cultured embryos displayed a loss of methylation, with 54%, 67% and 63%
(mean 61%) paternal DNA strands hypermethylated (Figure 3.2). Embryos cultured in all
media revealed a loss of paternal-specific methylation, KSOMaa (55%, 94% and 75%;
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Figure 3.1. Schematic Diagram of Regions Analyzed for Imprinted Methylation.
Top: The paternal methylated H19 allele and the maternal methylated Snrpn and Peg3
alleles are indicated. ICR, Imprinted Control Region. DMR, Differentially Methylated
Region. Open circles, CpGs. Blunt arrow designates transcription start site of nontranscribed allele. Regions analyzed are as follows: H19 ICR, 17 CpGs (16 CpGs in
paternal B6 allele) in the ICR located 2-4 kb upstream of the transcriptional start site of
H19; Snrpn ICR, 16 CpGs (15 CpGs in maternal CAST alleles) located in the promoter
and first exon of the Snrpn gene; and Peg3 DMR, 24 CpGs located in the promoter and
first exon of the Peg3 gene. Bottom. Methylation of the paternal H19 ICR, and the
maternal Snrpn ICR and Peg3 DMR in B6(CAST7) X B6 F1 in vivo-derived embryos
(pool of 5 blastocysts). Methylation status of individual DNA strands in blastocysts
derived from spontaneously ovulated females was determined by bisulfite mutagenesis
and sequencing analysis. Unmethylated CpGs are represented as empty circles while
methylated CpGs are depicted as filled circles. Each line denotes an individual strand of
DNA.

The identity of clones with identical methylation patterns and non-CpG

conversion rates representing the same DNA strand were included once. Each group of
DNA strands represents data from one pool of 5 embryos.

Percent methylation is

indicated above each set of DNA strands, and was calculated as the number of
hypermethylated DNA strands / total number of DNA strands. Hypermethylated DNA
strands were those displaying >50% methylated CpGs.
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Figure 3.2. Methylation in Whitten’s Medium.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and
cultured in non-sequential Whitten’s medium. Each group of DNA strands represents
data from three pools of 5 embryos (A, B and C). See Figure 3.1 for additional details.
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Figure 3.3. Methylation in KSOMaa.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and
cultured in non-sequential KSOMaa. Each group of DNA strands represents data from
three pools of 5 embryos (A, B and C). See Figure 3.1 for additional details.
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Figure 3.4. Methylation in Global Medium.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and
cultured in non-sequential Global media. Each group of DNA strands represents data
from three pools of 5 embryos (A, B and C). See Figure 3.1 for additional details.
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Figure 3.5. Methylation in HTF Medium.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and
cultured in non-sequential HTF media. Each group of DNA strands represents data from
three pools of 5 embryos (A, B and C). See Figure 3.1 for additional details.
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Figure 3.6. Methylation in P1/MB Medium.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and
cultured in sequential media P1/MB. Each group of DNA strands represents data from
three pools of 5 embryos (A, B and C). See Figure 3.1 for additional details.
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Figure 3.7. Methylation in G1.5/G2.5 Medium.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and
cultured in sequential media G1.5/G2.5. Each group of DNA strands represents data from
three pools of 5 embryos (A, B and C). See Figure 3.1 for additional details.

120

mean 75% hypermethylation), Global (60%, 63% and 72%; mean 65%), HTF (21%, 67%
and 67%; mean 52%), P1/MB (93%, 64% and 38%; mean 65%), and G1.5/G2.5 (82%,
62% and 21%; mean 55%) (Figure 3.3-3.7). In these analyses, we attribute inter embryo
pool variation to composition of blastocysts within the pool; variable number of
blastocysts that maintained and lost imprinted methylation. This is support by our recent
report on the effects of superovulation on genomic imprinting where we observed a
stochastic response by individual embryos to superovulation (Market-Velker et al.,
2010a).
To quantify these differences in H19 imprinted methylation, the ability to
distinguish DNA strands from embryos derived in vivo from those cultured in each media
system were calculated as posterior odds ratios (Figure 3.8). Higher posterior odd ratios
indicate a greater ability to distinguish between DNA strands obtained from embryo
culture in one media compared to another (or to in vivo), while lower posterior odds ratios
indicate an inability to distinguish between culture conditions.

Using the table

representing three samples (i.e. three groups of 5 embryos), this analysis demonstrated
that the in vivo-derived embryo pool was highly distinguishable from Whitten’s cultured
embryos (Figure 3.8A). In addition, embryos cultured in KSOMaa, Global and P1/MB
were least distinguishable from in vivo-derived embryos, but highly distinguishable from
embryos cultured in Whitten’s. Embryos cultured in HTF and G1.5/G2.5 displayed
methylation levels least distinguishable from Whitten’s, but were highly distinguishable
from in vivo-derived embryos.

Therefore, for H19, KSOMaa, Global and P1/MB

appeared best able to maintain imprinted methylation. These results for embryos cultured
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Figure 3.8. Methylation Analysis
Methylation analysis of the paternal H19 ICR, the maternal Snrpn ICR and the maternal
Peg3 DMR for in vivo-derived and cultured embryos. Left, plots of the fraction of CpG
methylation per DNA strand (black oval). Vertical bars are mean hypermethylation of
embryo pools. Right, posterior odd ratios tables as calculated independently for each
gene.

Higher posterior odd ratios (dark grey-black) indicate a greater ability to

distinguish between DNA strands obtained from embryo culture in one media compared
to another (or to in vivo), while lower posterior odds ratios (white to light grey) indicate
an inability to distinguish between culture conditions. Using the diagonal as a guide,
odds ratios below 20:1 were considered substantially indistinguishable, between 20:1 and
30:1 to be highly distinguishable, between 30:1 and 100:1 to be very highly
distinguishable, and over 100:1 to be decisively distinguishable.
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in Whitten’s medium and KSOMaa are consistent with our previous analysis, which
showed better maintenance of H19 imprinted methylation in KSOMaa (Mann et al.,
2004).
The same embryo pools from the H19 analysis were examined for changes in
imprinted methylation at Snrpn and Peg3.

For Snrpn, Whitten’s cultured embryos

displayed a loss of methylation with 67%, 58% and 50% of maternal DNA strands
hypermethylated (mean 58%) (Figure 3.2).

Similar to H19, methylation loss was

observed in embryos cultured in all media, KSOMaa (60%, 89% and 69%; mean 73%),
Global (100%, 55% and 60%; mean 72%), HTF (0%, 77% and 86%; mean 54%
hypermethylation), P1/MB (56%, 62% and 78%; mean 65%) and G1.5/G2.5 (83%, 77%
and 33%; mean 64%) (Figure 3.3-3.7).
Quantification of posterior odds ratios for Snrpn revealed that the in vivo-derived
embryos were highly distinguishable from Whitten’s cultured embryos.

Furthermore,

embryos cultured in KSOMaa, Global, HTF, P1/MB, and G1.5/G2.5 were highly
distinguishable from in vivo-derived embryos. However, embryos cultured in HTF, P1/
MB, and G1.5/G2.5 were least distinguishable from those cultured in Whitten’s medium,
while KSOMaa and Global cultured embryos were highly distinguishable from Whitten’s
cultured embryos (Figure 3.8B). Therefore, for Snrpn, KSOMaa and Global appeared
better able to maintain imprinted methylation when compared to Whitten’s, HTF, P1/MB,
and G1.5/G2. Consistent with our previous study (Mann et al., 2004), we observed that
embryos cultured in KSOMaa harbored greater Snrpn methylation than those cultured in
Whitten’s medium.
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For the Peg3 DMR methylation analysis, Whitten’s cultured embryos displayed a
loss of methylation with 71%, 24% and 67% maternal DNA strands hypermethylated
(mean 54%) (Figure 3.2). Embryos cultured in G1.5/G2.5 (44%, 50% and 56%; mean
50% hypermethylation) (Figure 3.7) also produced a severe loss of Peg3 methylation,
while embryos cultured in KSOMaa (80%, 100% and 100%; mean 93%
hypermethylation), Global (70%, 89% and 73%; mean 77%), HTF (100%, 61% and 93%;
mean 85%) and P1/MB (91%, 44% and 89%; mean 75%) harbored higher maternal Peg3
hypermethylation levels (Figure 3.3-3.6).
Quantification of posterior odds ratios for Peg3 revealed that the in vivo-derived
embryo pool was highly distinguishable from Whitten’s cultured embryos (Figure 3.8C).
Embryos cultured in KSOMaa were least distinguishable from in vivo-derived embryos
and highly distinguishable from Whitten’s medium. Embryos cultured in G1.5/G2.5 were
highly distinguishable from in vivo-derived embryos and least distinguishable from
Whitten’s medium.

Global, HTF and P1/MB cultured embryos displayed levels

distinguishable from both in vivo-derived and Whitten’s cultured embryos.

Thus, for

Peg3, KSOMaa culture appeared best able to maintain imprinted methylation,
From the imprinted methylation analysis, we conclude that all commercial media
systems are suboptimal in their ability to maintain genomic imprinting as none displayed
methylation levels comparable to in vivo-derived embryos for all three genes (Figure 3.8).
Having said this, some media systems were better able to maintain imprinted methylation;
KSOMaa, Global and P1/MB for H19, KSOMaa and Global for Snrpn; and KSOMaa
followed by Global, HTF and P1/MB for Peg3. As well, there was a differential response
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of imprinted genes to various culture systems as evidenced by the response of the three
loci to HTF medium where the most severe loss of H19 and Snrpn methylation was
observed compared to other media systems, while higher methylation levels were seen for
Peg3.

3.3.2 Effects of Embryo Culture on Imprinted Gene Expression
To investigate the effects of the commercial media systems on imprinted gene
expression, individual embryos were analyzed for H19, Snrpn and Peg3 imprinted
expression. Approximately 20-30 individual embryos were analyzed from each media
system as well as for in vivo-derived control embryos. For Snrpn, in vivo-derived control
embryos displayed paternal-specific Snrpn expression (100% Snrpn expression, 100%
monoallelic expression) (Supplementary Table 3.3). For Peg3, 23 of 24 control embryos
(96%) expressed Peg3 with all but one embryo exhibiting paternal-specific expression
(96% monoallelic) (Supplementary Table 3.3).

Analysis of cultured embryos

demonstrated that Snrpn and Peg3 also maintained monoallelic expression following
embryo culture in all media systems, similar to in vivo-derived embryos, although a small
percentage of embryos exhibited biallelic Peg3 expression (4-11%), however this
difference was not statistically significant (Table 3.2). These results are similar to our
previous study where monoallelic Snrpn and Peg3 expression were maintained in
Whitten’s and KSOMaa cultured embryos at the blastocyst stage (Mann et al., 2004).
Maintenance of Snrpn and Peg3 imprinted expression following culture contrasted
sharply with that of H19. Analysis of H19 imprinted expression showed that 100% of in
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Table 3.2: Expression Analysis of Cultured and Superovulation and Cultured
Embryos
TABLE 2. Expression analysis of cultured and superovulated/cultured embryos.
Snrpn
Culture media
Whittens
KSOMaa
HTF
Global
P1/MB
G1.5/G2.5
6.25 IU/Whittens
6.25 IU/KSOMaa
6.25 IU/Global
6.25 IU/HTF
6.25 IU/P1/MB
6.25 IU/G1.5/G2.5

Analyzed
29
22
22
25
24
19
23
21
21
22
19
13

Expressed
29
22
22
25
24
19
23
21
21
22
19
13

(100%)
(100%)
(100%)
(100%)
(100%)
(100%)
(100%)
(100%)
(100%)
(100%)
(100%)
(100%)

Peg3
Biallelic

Analyzed

0
0
0
0
0
0
0
0
0
0
1 (5%)
0

23
22
28
25
24
19
23
22
21
22
19
13
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Expressed

Biallelic

22
18
26
24
22
18
23
21
21
21
19
13

2
0
1
1
0
0
0
0
0
1
2
0

(96%)
(82%)
(93%)
(96%)
(92%)
(95%)
(100%)
(95%)
(100%)
(95%)
(100%)
(100%)

(9%)
(4%)
(4%)

(5%)
(11%)

vivo-derived controls displayed maternal-specific expression (Supplementary Table 3.3),
while 40% of Whitten’s cultured embryos displayed loss of imprinting (LOI, defined as
biallelic / abnormal paternal H19 expression) (Figure 3.9). Similar to Whitten’s, all five
commercial culture systems had increased numbers of embryos with loss of imprinted
H19 expression; KSOMaa 60%, Global 50%, HTF 47%, P1/MB 53%, and G1/G2 41%
(Figure 3.9).

No statistically significant difference in LOI was observed between all

media analyzed, however there was a significant difference between all media and in
vivo-derived embryos with respect to biallelic expression using Fisher’s exact test (p <
0.05, Supplementary Table 3.4). These results are discordant from our previous study
where better maintenance of H19 imprinted expression was observed in KSOMaa
compared to Whitten’s culture (Mann et al., 2004). While the reason for this discordance
is not clear, we do note that our current cultured embryos possess fewer cell numbers
compared to those in our previous analysis.

We are currently investigating the

relationship between cell number and loss of imprinting.
A change in frequency of embryos expressing H19 was also observed between
experimental and control groups. Thirteen percent of in vivo-derived embryos expressed
H19 (9/68 embryos) (Supplementary Table 3.3), while 69% of Whitten’s cultured
embryos expressed H19 (Figure 3.9). Snrpn was expressed in all these embryos, acting as
a control for RNA isolation and cDNA synthesis. Similar to Whitten’s, H19 expression
was more frequent in embryos cultured in all commercial media systems compared to in
vivo-derived embryos; KSOMaa 91%, Global 80%, HTF 54%, P1/MB 79%, and G1/G2
89% (p < 0.05, Supplementary Table 3.5) (Figure 3.9).
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Figure 3.9. Imprinted Expression of H19 - Spontaneous Ovulation and Culture
Imprinted expression of H19 in B6(CAST7)xB6 embryos derived from spontaneously
ovulated females and cultured in six different media systems. Embryo designations are
indicated on the X-axis; percent allelic expression from each allele is indicated on the Yaxis. Grey bar height indicates percent of maternal expression while black bar height
represents the percent of paternal-specific expression. Percent expressed (% Exp) was
calculated as number of embryos displaying H19 expression / total number of embryos
analyzed, and percent loss of imprinted expression (% LOI) was calculated as number of
embryos displaying >10% expression from the normally silenced allele / total number of
embryos expressing H19.
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3.3.3 Effects of Superovulation and Embryo Culture on Imprinted Expression
In a recent study, we demonstrated that superovulation (without culture) perturbed
H19, Snrpn, and Peg3 imprinted methylation (Market-Velker et al., 2010a). To examine
the effect of superovulation in combination with embryo culture, we examined H19,
Snrpn and Peg3 imprinted expression in individual embryos derived from superovulated
females and cultured in each of the five commercial media systems. Since our primary
goal was to determine the synergistic effects of superovulation and embryo culture, we
used low hormone dosages; this treatment had less effect on imprinted methylation
patterns compared to high hormone dosage (Market-Velker et al., 2010a).

Blastocyst

development was supported at a rate >85% in the various culture systems in combination
with superovulation (6.25 IU/Whitten’s 92%; 6.25 IU/KSOMaa 96%; 6.25 IU/Global
97%; 6.25 IU/HTF 89%; 6.25 IU/P1/MB 86%; 6.25 IU/G1.5/G2.5 96%) (Supplementary
Table 3.2).
Similar to non-hormone treated groups, Snrpn and Peg3 imprinted expression was
maintained in superovulated-cultured groups (Table 3.2). For H19, hormone treatment in
conjunction with Whitten’s culture resulted in a dramatic increase in the number of
embryos with loss of imprinted H19 expression from 40% to 81% (Figure 3.9-3.10). A
similar increase was observed in all five culture systems; KSOMaa 60% vs 81%; Global
50% vs 71%; HTF 47% vs 76; P1/MB 53% vs 79%; and G1.5/G2.5 41% vs 67% for
culture alone compared to combined treatment, respectively.
An overall comparison of the three paradigms, in vivo-derived (68 embryos),
spontaneously ovulated-cultured (147 embryos) and superovulated-cultured (120
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Figure 3.10. Imprinted Expression of H19 - Superovulation and Cultured Embryos
Imprinted expression of H19 in B6(CAST7)xB6 embryos derived from superovulated
females and cultured in six different media systems. Details are as described in Figure
3.9.
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embryos) groups, revealed that loss of imprinted expression occurred more frequently in
the superovulated-cultured treatment group (73%) compared to the spontaneously
ovulated-cultured treatment group (47%) and to controls (0%) (p < 0.01) (Supplementary
Table 3.6). Furthermore, H19 was expressed in a greater percentage of embryos in the
superovulated-culture group (94%) than in the spontaneously ovulated-cultured group
(75%) and in in vivo-derived embryos (13% expression) (Supplementary Table 3.6) (p <
0.05). These results indicated that superovulation together with embryo culture results in
greater H19 expression perturbations.

3.4 Discussion
In this study, we performed a side-by-side comparison of five commercial culture
systems to determine their effects on genomic imprinting. All five culture systems had
compromised ability to maintain genomic imprinting compared to in vivo-derived
embryos, although in comparison to Whitten’s culture, some media systems were better
able to maintain imprinted methylation. We also observed that combined treatment of
superovulation and embryo culture resulted in increased disruption of genomic
imprinting, as evidenced by increased loss of imprinted H19 expression.

Thus, we

conclude that minimizing times in culture and number of ART procedures is important to
ensure the fidelity of imprinted gene expression during preimplantation development.

3.4.1 Comparison of Media Systems
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Many studies have been performed to evaluate culture systems with respect to
developmental competence, epigenetic status, embryo grade (quality), development rate,
implantation rate, and pregnancy rate in humans (Staessen et al., 1998; Mauri et al., 2001;
Artini et al., 2004; Ben-Yosef et al., 2004; Zollner et al., 2004; Sepulveda et al., 2009;
Xella et al., 2010) and mouse (Sasaki et al., 1995; Doherty et al., 2000; Ecker et al., 2004;
Fernandez-Gonzalez et al., 2004; Mann et al., 2004; Li et al., 2005; Fauque et al., 2007;
Rivera et al., 2008). However, comparisons between studies, even those evaluating the
same culture system, remain problematic due to variations in culture parameters including
type of overlay, oxygen tension, culture drop volume, serum supplement, combined
procedures such as IVF/ICSI, and many more.

This study is the first to provide a

comparative analysis of five different, commercially available culture systems. To allow
reliable comparison between media systems, all embryos were cultured with the same oil
overlay and drop volume, and in the same incubator, under the same oxygen conditions
(except Whitten’s medium, which requires different oxygen tension than the other media
formulations). Embryos were flushed from oviducts in their respective culture media,
supplemented with the same lot of serum substitute (according to manufacturer’s
instructions for mouse embryo assay), and were handled by the same individual. Our
strategy was to introduce as little variation between culture conditions as possible to
allow true comparisons between systems.
Furthermore, confusion has arisen, as controversy exists in the literature regarding
the best embryo culture system (Summers and Biggers, 2003; Lane and Gardner, 2007;
Biggers and Summers, 2008). However, no significant advantage has been shown for one
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system over another with respect to blastocyst development, implantation rates or
pregnancy rates (Staessen et al., 1998; Mauri et al., 2001; Fauque et al., 2007). While
blastocyst formation and embryo morphology are currently the best predictors available
for assessing embryo quality, they may not necessarily be predictive of epigenetic health.
Thus, understanding effects of embryo culture at the molecular level is essential. As such,
we set out to determine whether one culture media system was more favourable for
imprint maintenance during preimplantation development.
An important finding from these experiments is that culture media actively used
for both mice and humans generated a loss of imprinting following in vitro culture of
mouse embryos. Previous studies have shown aberrant imprinted methylation following
mouse embryo culture using KSOMaa and Whitten’s media systems, with KSOMaa being
named the better media system (Doherty et al., 2000; Mann et al., 2004). These data
support our results, as we demonstrate greater H19, Snrpn and Peg3 imprinted
methylation levels in embryos cultured in KSOMaa compared to the other media system
for which lower methylation levels were observed for at least one imprinted gene.
However, these differences in methylation did not translate into differences in the ability
to maintain H19, Snrpn or Peg3 imprinted expression at the blastocyst stage. Imprinted
expression was maintained for Snrpn and Peg3 in all media systems while H19 displayed
similar levels of biallelic expression in all media systems when compared to control
embryos.
There are number of explanations for this discordance. Firstly, H19 imprinted
expression is restricted to the trophectoderm in blastocyst stage embryos (Poirier et al.,
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1991). As we observed greater imprinting perturbations in the placenta compared to the
embryo proper in midgestation embryos, it may indicate that greater methylation loss
occurs in trophectoderm cells than in inner mass cells. Alternatively, differences in the
ability to maintain imprinted expression in culture may relate to Snrpn and Peg3 being
protein-coding genes, while H19 is a noncoding RNA. Finally, DNA methylation is but
one indicator of chromatin status. As a combination of DNA methylation and histone
modifications likely direct parental-specific expression, adverse effects of in vitro culture
on histone modifications may also lead to greater misregulation of imprinted gene
expression. Combined expression and methylation analyses in single blastocyst stage
embryos will allow direct comparison of imprinted DNA methylation loss and loss of
imprinted expression. Analysis of histone modification in blastocyst stage embryos will
also provide greater insight into the effects of embryo culture on imprinted gene
regulation.
A second finding from this study is that results from one gene cannot be
generalized to all imprinted genes. For H19, embryos cultured in KSOMaa, Global and
P1/MB displayed levels of H19 imprinted methylation more similar to in vivo-derived
embryos than other media systems. Embryos cultured in HTF and G1.5/G2.5 displayed
H19 methylation levels least distinguishable from Whitten’s, but were highly
distinguishable from in vivo-derived embryos. For Snrpn, while distinguishable from in
vivo-derived embryos, KSOMaa and Global better maintained imprinted methyation than
the other media systems.

For Peg3, levels of imprinted methylation for KSOMaa

cultured embryos were least distinguishable from in vivo, while methylation levels for
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G1.5/G2.5 cultured embryos were most distinguishable from in vivo and least
distinguishable from Whitten’s.

These finding illustrate the point that certain media

appear to support levels of imprinted methylation similar to in vivo-derived embryos at
some but not at all loci.
The five commercial media systems used in this study post the compounds present
in the medium. However, specific concentrations are proprietary, preventing an in-depth
comparison of the media systems. Based on components, KSOMaa and Global are likely
the most similar media. Thus, it is not surprising that they performed similarly. HTF is
likely more similar to Whitten’s in that it lacks amino acids, possibly accounting for the
more severe loss of methylation produced by these media. The rest of the media systems
contain amino acids with the caveat that of the two-step systems, P1 contains no amino
acids and G1.5 has nonessential amino acids plus methionine while both MB and G2.5
harbor essential and nonessential amino acids. For these two sequential systems, it is not
readily apparent why they did not generate more similar effects on imprinted methylation
loss, although it may lie in their differences. P1/MB contains the antioxidant sodium
citrate while G1.5/G2.5 contains vitamins.

What can be concluded is that sequential

media systems did not seem to confer an advantage with respect to maintenance of
genomic imprinting compared to their single step counterparts, nor did medium renewal.

3.4.2 Combined effects of ART treatments
Experiments presented in Chapter 2 showed that superovulation alone can perturb
imprint acquisition at multiple imprinted loci, in a dose-dependent manner. Thus, we set
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out to determine whether a combination of ART treatments would lead to greater
perturbation of imprinting. We observed that increased loss of H19 imprinted expression
as a result of embryo culture was exacerbated by the use of superovulation. A study by
Rivera et al. also demonstrated an increase in biallelic expression of many imprinted
genes following superovulation with embryo transfer compared to controls, with a further
increase in biallelic expression following embryo culture combined with superovulation
and embryo transfer (Rivera et al., 2008).

Together, these studies demonstrate that

combined ART procedures result in greater perturbation of genomic imprinting compared
to single interventions.
One critical question that must be answered is how transferable these results and
those of other studies are to human embryo culture. The main aim of this study was to
employ commercial formulations of various culture systems to allow for evaluation of
media currently used in human ART.

However, the possibility remains that human

embryos may not be as susceptible to culture-induced errors, or may display different
sensitivities to these culture systems than the mouse.

To address the question of

proclivity of ART procedures to induced epigenetic errors, retrospective studies were
performed on BWS children born after ARTs (DeBaun et al., 2003; Chang et al., 2005).
Variable ART procedures were reported in ART-associated BWS children with no
common factor emerging.

Differences were observed in cause of infertility, embryo

culture media (varied in glucose, amino acid and human serum albumin content), day of
transfer, and ART method (IVF, ICSI, ovarian stimulation regime) employed (DeBaun et
al., 2003; Chang et al., 2005). These data suggest that human embryos are susceptible to
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ART-induced errors but that it is not a specific system that generates epigenetic errors.
Instead, it is multiple ART procedures, such as ovarian stimulation combined with
embryo culture, that pose greater risks for developing imprinting disorders. As the genes
investigated in this study play an important role in early development, and genetic and
epigenetic perturbations lead to imprinting disorders, we propose that culture time and
number of ART procedures should be minimized to ensure fidelity of genomic imprint
maintenance during development.
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Chapter 4: Rates of Embryo Development Correlate with Loss of Genomic
Imprinting

The work in this chapter originates from the manuscript:
Market Velker, B. A., Denomme, M. M., and Mann, M. R. Loss of Genomic Imprinting in
Embryos with Rapid Rates of Preimplantation Development, submitted for publication in
the journal Human Reproduction in June 2011.

4.1 Introduction
One of the first observations of deleterious effects of embryo culture is that
development of mouse embryos in vitro results in an 18 to 24 hour lag in reaching the
blastocyst stage (Bowman and McLaren, 1970; Harlow and Quinn, 1982). Since then,
while culture conditions for preimplantation embryos have steadily improved (Biggers
and Summers, 2008; Gardner, 2008), even the best media currently available are
suboptimal for embryo development.

Cultured embryos from all mammalian species

have reduced viability and reduced pregnancy rates following embryo transfer, display
aberrant patterns and levels of gene expression, developmental abnormalities and
deviations in behaviour, and are prone to metabolic and growth disorders (Sasaki et al.,
1995; Sinclair et al., 1999; Barker, 2000; Boerjan et al., 2000; Doherty et al., 2000;
Khosla et al., 2001; Summers and Biggers, 2003; Ecker et al., 2004; Fernandez-Gonzalez
et al., 2004; Rinaudo and Schultz, 2004; Morgan et al., 2005). Preimplantation embryos
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survive in vitro culture by adapting to the culture environment and stresses it imposes
(Niemann and Wrenzycki, 2000).
We and others have also demonstrated that preimplantation embryo culture
disrupts genomic imprinting in mice (Sasaki et al., 1995; Doherty et al., 2000; Mann et
al., 2004; Market-Velker et al., 2010b).

In vitro culture of mouse preimplantation

embryos results in loss of imprinted gene regulation with biallelic expression of the H19
gene and loss of H19, Snrpn and Peg3 imprinted methylation (Sasaki et al., 1995;
Doherty et al., 2000; Mann et al., 2004; Market-Velker et al., 2010b). In Chapter 3, the
comparison of six embryo culture media showed that while all were suboptimal in their
ability to maintain imprinting, some media systems performed better and others were
decidedly worse, such as Whitten’s medium, HTF Medium and G1/G2 (Market-Velker et
al., 2010b).
In humans, while the absolute risks remain low, assisted reproductive technologies
have been linked to imprinting perturbations that lead to the development of Angelman
Syndrome (AS) and Beckwith-Wiedemann Syndrome (BWS) (Cox et al., 2002; DeBaun
et al., 2003; Maher et al., 2003; Orstavik et al., 2003; Halliday et al., 2004; Chang et al.,
2005; Ludwig et al., 2005; Sutcliffe et al., 2006). In AS patients conceived by assisted
reproduction, imprinting defects at the maternal SNRPN ICR result in loss of maternalspecific SNRPN methylation and the entire maternal imprinted domain acquires a paternal
epigenetic identity (Cox et al., 2002; Orstavik et al., 2003; Ludwig et al., 2005; Sutcliffe
et al., 2006). For BWS patients conceived by assisted reproduction, imprinting defects at
the maternal H19 ICR (2-7% patients) result in a gain of maternal-specific H19
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methylation and overexpression of the paternally-transcribed IGF2 gene, while imprinting
defects at the KCNQ1OT1 ICR (50% patients) result in loss of maternal-specific
methylation at the KCNQ1OT1 ICR and biallelic repression of maternally expressed
genes across the imprinting domain, including CDKN1C (DeBaun et al., 2003; Maher et
al., 2003; Halliday et al., 2004; Chang et al., 2005).

The maternally-transcribed

CDKN1C/Cdkn1c gene is an important inhibitor of the cell cycle through its interaction
with cyclin-CDK complexes (Lee et al., 1995; Matsuoka et al., 1996), and its aberrant
expression generates major pathologies present in BWS (Hatada and Mukai, 1995;
Hatada et al., 1996; Zhang et al., 1997; Yan et al., 1997). Thus, this imprinted cell cycle
regulator provides an important link between embryo development and epigenetic
perturbations in the early embryo.
Imprinting marks acquired during gametogenesis must be maintained during the
preimplantation epigenetic reprogramming period. However, very little is known about
the mechanisms that maintain genomic imprinting in the preimplantation embryo, and
how dysregulation of genomic imprinting during this time period may lead to aberrant
embryonic growth and development.

In mouse, cell divisions from the 2-cell to

blastocyst stage occur approximately every 10-18 hours in vivo, with development from
fertilization to blastocyst stage taking about 3.5 days (Bowman and McLaren, 1970). In
contrast, embryos cultured in vitro to the blastocyst stage generally require an extra day of
development in culture. This has led us to hypothesize that loss of imprinting during
early mouse development will correlate with slower rates of embryonic development. To
test our hypothesis, we separated embryos based on rates of development and examined
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cell number, embryo volume, and embryo sex, together with imprinted methylation and
expression at two key loci, H19 and Snrpn, that are involved in the development of
imprinting disorders observed in the ART population. Given the variable response of
individual embryos to suboptimal culture, these analyses were performed in the same
individual embryo. To explore the connection between rates of development and genomic
imprinting, we also examined expression of the cell cycle inhibitor, Cdkn1c, on the
premise that biallelic Cdkn1c expression will lead to slower rates of embryo development.
In addition, as slower rates of development may be linked with metabolic changes, we
evaluated the expression of three markers of embryonic metabolism, sodium/potassium
transporting ATPase 1a1 (Atp1a1) which is critical for blastocoel formation (Kidder and
Watson, 2005), solute carrier 2a1 (Slc2a1/Glut1), a glucose transporter expressed
throughout preimplantation development (Pantaleon and Kaye, 1998; Augustin et al.,
2001), and mitogen-activated protein kinase 14 (Mapk14/p38 alpha) which is a signaling
molecule involved in embryo response to suboptimal environments (Natale et al., 2004;
Paliga et al., 2005; Fong et al., 2007) and in trophoblast differentiation (Johnstone et al.,
2005; Winger et al., 2007).
This study demonstrates significant differences in cell number, embryo volume,
imprinted methylation of H19 and Snrpn, imprinted expression of H19 and Cdkn1c, and
expression of genes related to embryo metabolism between the four groups of embryos
separated by rates of development in culture, and when compared to in vivo-derived
embryos. Overall, embryos that developed the fastest contained more cells and had the
largest embryo volume. However, they also had increased loss of methylation at both the
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H19 and Snrpn ICRs, and aberrant H19 imprinted expression. Embryos in the slowest
group that developed to the blastocyst stage demonstrated more normal levels of
imprinted methylation at the H19 and Snrpn ICRs, and imprinted expression of H19.
However, nearly 40% embryos in this group arrested prior to the blastocyst stage (data
not shown). Embryos with slow to moderate rates of development were most similar to in
vivo-derived embryos, displaying cell numbers, embryo volume, H19 and Snrpn
methylation, H19 imprinted expression, and Atp1a1 and Slc2a1 expression most similar
to in vivo-derived embryos. We conclude that rates of preimplantation development in
vitro are correlated with genomic imprinting and embryo metabolism, and that embryos
displaying slower rates of development are likely most suitable for embryo transfer.

4.2 Materials and Methods
4.2.1 Embryo Collection
Embryos were obtained from naturally-mated C57BL6(CAST7partial6)
[B6(CAST7p6)] females crossed with C57BL6 (B6) males (Charles River, St Constant,
Canada) as described (Market-Velker et al., 2010a; Market-Velker et al., 2010b). Briefly,
B6(CAST7p6) females were checked for estrus and mated with B6 males. Pregnancy was
determined (vaginal plug) the morning following mating (0.5 days postcoitum; dpc).
Embryos were flushed from isolated oviducts at 1.5 dpc to recover 2-cell stage embryos.
In vivo control blastocysts were recovered from uteri on day 3.5 following natural
matings. Experiments were performed in compliance with guidelines set by the Canadian
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Council for Animal Care, and the policies and procedures approved by the University of
Western Ontario Council on Animal Care.

4.2.2 Embryo Culture
Embryos were flushed at the 2-cell stage, washed twice and cultured in Whitten’s
medium (made in-house) at a concentration 1 embryo per µL of medium in either 10, 15
or 20 µL drops with filter-sterilized mineral oil overlay (Sigma). Embryos in the “Fast”
group were those containing 8 or more cells and were transferred to new culture drops,
while embryos in the “Slow” group contained less than 8 cells and were transferred to
separate culture drops. On day 2 of culture, embryos were again separated at 3 PM +/- 1
hr. Embryos in the “Fast/Fast” (FF) group had begun cavitation, while those in the “Fast/
Slow” (FS) group had not.

Embryos in the “Slow/Fast” (SF) group had reached the

compacted morula stage, while those in the “Slow/Slow” (SS) group had not yet
compacted. All embryo groups were again transferred to new pre-equilibrated culture
drops. Embryos were subjected to image analysis (below) then placed in individual tubes
in approximately 1 µL culture medium at noon on day 3 (107 hours after mid-point of
light:dark cycle), snap frozen on dry ice and stored at -80°C. Culture was performed at
least 10 times, and embryos were analyzed from multiples litters.

4.2.3 Imaging and Cell Counting
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On day 3 of embryo culture prior to freezing, embryos were transferred to culture
drops containing Hoechst 33342. This dye was chosen as it binds in the minor groove of
DNA and does not intercalate between the base pairs. Prior to experimental analysis, we
determined that Hoechst 33342 staining had no effect on downstream methylation
analyses of embryonic DNA (data not shown). Embryos were incubated in Hoechst
33342 for 7-10 minutes, and transferred to fresh drops of Whitten’s medium for imaging.
Images were obtained using Fluoview 1000 laser scanning confocal microscope
(Olympus Corp), using the 20x objective (Olympus superapochromat 0.75), with a band
pass of 425-475 nm for Hoescht. Z-stacks were taken for each embryo with a distance of
4 µm between each slice. Bright field images were also taken of each embryo to facilitate
downstream cell counting.
Cell counting was performed in duplicate from the top and from the bottom of
each Z-stack using the Fluoview V10-ASW 2.1 Software. Embryo volume was
calculated using 2 measurements of embryo length (µm) taken in perpendicular planes
using the Image Pro Analyzer 6.2. Software. These lengths were averaged and then
divided by 2 to generate an average radius for each embryo. Volume of a sphere
(V=4/3π·r3) was used to calculate embryo volumes.

4.2.4 Analysis of Imprinted Methylation and Expression
Bisulfite mutagenesis and imprinted expression analysis was performed as
described previously (Market-Velker et al., 2010a; Market-Velker et al., 2010b), with
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modifications to allow the concurrent analysis of imprinted methylation and expression.
Briefly, stored embryos were quickly thawed on ice, and 10 µL of Dynabead Lysis Buffer
was added to each tube.

This solution was transferred to pre-equilibrated oligo-dT

Dynabeads (Invitrogen) and incubated for 5 minutes at room temperature with shaking.
Supernatant was transferred back to the original embryo tubes for bisulfite mutagenesis as
previously described (Market-Velker et al., 2010a). mRNA-Dynabead complexes were
processed and a cDNA library was generated as previously described (Market-Velker et
al., 2010b). Analysis of imprinted expression of H19 and Snrpn was performed using the
LightCycler Real Time PCR System (Roche Molecular Biochemicals) as previously
described (Market-Velker et al., 2010b).
Following bisulfite mutagenesis, nested PCR, cloning and sequencing was
performed for H19 and Snrpn ICR as previously described (Market-Velker et al., 2010b).
Forty-50 clones per embryo were sequenced. Each sequence was analyzed for location
and number of converted and unconverted non-CpG associated cytosines to obtain
conversion rates (number of converted non-CpG cytosines/total number of non-CpG
cytosines) as well as total number and location of CpG associated cytosines. Sequences
with less than 85% conversion rates were not included.

Identical clones (identical

location and number of unconverted CpG associated cytosines, and identical location and
number of unconverted non-CpG associated cytosines) were included only once.
Polymorphisms present between B6 and CAST sequences at each gene analyzed allowed
discrimination between parental alleles. Hypermethylation of a DNA strand was defined
at >50% methylated CpGs on a given strand.
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4.2.5 Sex Determination in Individual Embryos
The cDNA library generated for each embryo was used for the analysis of embryo
sex. Two PCR reactions were performed for each embryo. The first, a nested PCR for
the Sry gene, located on the Y chromosome, and second, amplification of Xist, a gene
located on the X chromosome (Table 4.1).

Samples were visualized with gel

electrophoresis on a 12% acrylamide gel. The presence of an Sry and Xist amplicon
indicated a male embryo, while amplification of Xist alone indicated a female embryo.
Nested PCR for Sry was performed in duplicate.

4.2.6 Cdkn1c Imprinted Expression Analysis
The analysis of imprinted Cdkn1c expression was performed using the cDNA
library generated for each embryo. PCR primers and parameters can be found in Table
4.1. Amplification was tested using SYBR green to allow determination of the range of
cycles located in log-phase amplification. PCR on subsequent embryos was performed to
ensure that amplification was log-phase upon completion of the PCR program. Following
amplification embryos were digested with the TaqaI restriction enzyme to determine
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Table 4.1: Primers and PCR Protocols
Gene

Primers

PCR Program

Xist

Forward:
5’ - TTG CGG GAT TCG CCT TGAT T - 3’
Reverse:
5’ - TGA GCA GCC CTT AAA GCC AC - 3’

95°C 2 min
95°C 15 sec
60°C 10 sec
72°C 20 sec
45 cycles
72°C 5 min

Sry

First round:
Forward:
5’ - GTG TGG TCC CGT GGT GAG AG - 3’
Reverse:
5’ - TCC AGT CTT GCC TGT ATG TGA TG - 3’
Second Round:
Forward:
5’ - CCC AGC AGA ATC CCA GCA T - 3’
Reverse:
5’ - CTG TGA CAC TTT AGC CCT CCG - 3’

First round:
94°C 2 min
94°C 30 sec
60°C 30 sec
72°C 40 sec
45 cycles
72°C 5 min
Second round:
95°C 2 min
94°C 20 sec
62°C 20 sec
72°C 30 sec
40 cycles
72°C 5 min

Cdkn1c

Forward:
5’ - GCC AAT GCG AAC GAC TTC - 3’
Reverse:
5’ - TAC ACC TTG GGA CCA GCG TAC TCC - 3’

94°C 2 min
94°C 30 sec
58°C 30 sec
72°C 45 sec
40 cycles
72°C 5 min

Atp1a1

Forward:
5’ – TTC AGC CCA GAA GGA CGA CAT G – 3’
Reverse:
5’ – AGG GAA GCC GTA GTA TCC GCC CA – 3’

2nd Strand Synthesis:
94°C 2 min
94 °C 30 sec
56 °C/57 °C (Slc2a1) 30
sec

Slc2a1

Forward:
5’ – CCC AGA AGG TTA TTG AGG AGT T – 3’
Reverse:
5’ – ACG CTT TGG TCT CTC TCC G – 3’

Mapk14

Forward:
5 ‘- AGG CCA TGG TGC ATG TGT GT – 3’
Reverse:
5’ – AGT AGC TGG AGG AGG AGG AG – 3’

Mrpl1

Forward:
5’ – TTG GAT ATG CCA AGT GAC CA – 3’
Reverse:
5’ – GCT TCT GCC GTT TGA GTT TC – 3’
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72 °C 30 sec
94°C 10 min
qRT-PCR:
95°C 4 min
94°C 30 sec
56°C / 57°C (Slc2a1) 30
sec
72°C 30 sec
45 cycles
94°C 2 min
30°C 2 min
Melting curve from 55 –
95 °C, read every 1°C.

allelic identity; only the B6 allele is cleaved. Densitometry was performed using the
Opticon Monitor Software (Biorad).

4.2.7 Expression Analysis of Atp1a1, Slc2a1 and Mapk14
The evaluation of Atp1a1, Slc2a1 and Mapk14 expression was performed using
the cDNA library generated for each embryo, with mitochondrial ribosomal protein L1
(Mrpl1) as the internal control. Primers and PCR parameters can be found in Table 4.1.
Second strand synthesis was performed using the forward primers of both Mrpl1 and the
gene of interest, and amplification products were then split into separate reactions for RTPCR for Mrpl1 and the gene of interest. Amplification was performed on biological
replicates with SYBR green using the BioRad Opticon Monitor Real Time PCR Machine
and Software. Analysis of RT-PCR was performed using the ΔΔCt method, with the
GeneEx (BioRad) software.

4.2.8 Statistical Analysis
To compare between the four culture groups, and between cultured and in vivoderived embryos, a nested two-factor ANOVA was performed using R (The R Foundation
for Statistical Computing (Team, 2011)). The five groups of embryos were compared
with respect to embryo volume; cell number; embryo sex; H19 and Snrpn methylation
levels; H19, Snrpn and Cdkn1c imprinted expression; and Atp1a1, Slc2a1 and Mapk14
expression using the “aov” (analysis of variance) command.
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Expression of the three

metabolic marker genes was normalized for Mrpl1 expression, and analyzed both before
and after normalization for cell numbers. This was done to obtain additional information
about whether the change in expression was attributed to an overall change in expression,
or a change in levels of expression per cell, respectively.

The effect size of each

comparison that generated a significant p-value was estimated using the “lm” (linear
model) function, setting the intercept of the model at zero. This was used to determine
which groups were most similar to in vivo-derived embryos. A p-value less than 0.05 was
taken to be statistically significant.

4.3 Results
4.3.1 Effects of Embryo Culture on Blastocyst Cell Number and Volume
The aim of our study was to determine whether any correlation existed between
rates of preimplantation embryo development and loss of genomic imprinting. To best
evaluate these effects, experiments were done at the individual embryo level, as we
previously reported significant inter-embryo variability in response to ARTs (MarketVelker et al., 2010a; Market-Velker et al., 2010b) and because this is the level of
importance in the human ART clinic. As such, we have developed a novel method to
evaluate both imprinted methylation and expression of multiple loci in the same
individual blastocyst, as well as obtain data about cell numbers, embryo volume, and
embryo sex. This is the first study of its kind to evaluate multiple parameters to correlate
morphological changes with epigenetic changes at the individual embryo level.
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On the premise that individual embryos develop at different rates in culture,
embryos were separated into four groups based on their stage of development at two predetermined time points during the culture time course (Figure 4.1A). These time points
were chosen based on the ability to reproducibly distinguish between “Fast” and “Slow”
at each separation. Whitten’s culture medium was used as we determined from previous
studies that culture in Whitten’s medium produced the most significant perturbations of
genomic imprinting (Market-Velker et al., 2010b), and it allowed us to obtain sufficient
embryo numbers in each group for analysis. Multiple culture time courses were
completed and a total of 68 embryos were collected for analysis, 24 FF, 10 FS, 19 SF, and
15 SS. Of these embryos, 47 (16 FF, 9 FS, 10 SF and 12 SS) were analyzed for each of
the following parameters: cell counts, embryo volume, embryo sex, imprinted
methylation and expression of H19 and Snrpn, and imprinted expression of Cdkn1c
(Figure 4.1B). For the SS group nearly 40% of embryos arrested and did not reach the
blastocyst stage (unpublished data). For all groups only embryos that developed to the
blastocyst stage were analyzed.
To determine whether differences existed in the total cell numbers present in each
of the four culture groups, embryos were stained with Hoechst 33342, Z-stacks were
taken using confocal microscopy, and cells were counted (Figure 4.1B, 4.2A). We
observed that on average the FF group contained 74.3 cells, the FS group 46.8 cells, the
SF group 33.9 cells, the SS group 25.0, and the in vivo-derived group 28.3 cells, which
was similar to previous studies (Bowman and McLaren, 1970; Smith and McLaren,
1977). To evaluate whether differences in cell number were statistically different between
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Figure 4.1: Embryo Separation and Analysis
(A) Graphical representation of the embryo separation scheme. Two-cell embryos were
collected, cultured for 24 hours, at which time the first separation took place. “Fast”
embryos were those that displayed 8 or more cells, while “Slow” embryos were those
containing less than 8 cells. After an additional 24 hours, the second separation was
performed. From the original “Fast” group, those that showed a blastocyst cavity were
classified as “Fast” in the second separation, while those with no evidence of a blastocyst
cavity were classified as “Slow”. From the original “Slow” group, compacted morulae
were classified as “Fast”, and those that were not compacted were classified as “Slow”.
After an additional 24 hours, embryos were individually frozen at -80°C. (B) Individual
blastocyst assay for multiple data sets. Top left: Merge of bright field and Hoechst 33342
staining used to count cell numbers. Blastocyst FF23 contained 48 cells. Top right: Sry
expression analysis used for embryo sex determination. L, ladder; F, Female control; M,
Male control; FF23, blastocyst FF23; -ve, negative control. Blastocyst FF23 was a male
embryo.

Bottom left: Paternal H19 methylation analysis. Filled circles represent

methylated CpGs dinucleotides while unfilled circles represent unmethylated CpGs. Each
row represents one DNA strand. Blastocyst FF23 displayed 70% hypermethylation at the
H19 paternal allele.

Bottom right: LightCycler H19 imprinted expression analysis.

Blastocyst FF23 displayed biallelic expression of H19, with 81% and 19% expression
from the maternal and paternal alleles, respectively.
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Figure 4.2: Cell Numbers, Embryo Volume and Embryo Sex
Graphical representation of cell numbers and embryo volumes of the four groups of
cultured embryos and in vivo-derived embryos.

(A) Left: Cell numbers separated by

embryo group. Each diamond represents one embryo, and black bars indicate mean cell
number of each group. Right: Mean cell numbers in “Fast” and “Slow” groups based on
the first separation. * the “Fast” group had significantly more cells than “Slow” group and
the in vivo-derived group. (B) Left: Embryo volumes separated by embryo group. Black
bars indicate mean embryo volume of each group. Right: Mean embryo volume in “Fast”
and “Slow” groups based on the first separation. * “Fast” embryos had significantly
larger volumes than the “Slow” embryos and in vivo-derived embryos. ** “Slow”
embryos displayed significantly fewer cells than in vivo-derived embryos. (C) Embryos
separated by sex. White bars, male embryos; black bars, female embryos. Error bars
represent standard errors of the mean.
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the “Fast” (FF and FS) and “Slow” (SF and SS) groups at the first separation, and
between groups (FF versus FS, and SF versus SS) in the second separation, we used a
nested two-factor ANOVA.

With respect to the first separation, the number of cells

present in the “Fast” group was significantly greater than those in the “Slow” group. In
addition, a statistically significant difference was observed at the second separation
(Figure 4.2A).

Therefore, not only were the “Fast” groups morphologically more

advanced than the “Slow” groups as determined by embryo stage at the time of
separation, but the cell cycle progressed more quickly in embryos in the “Fast” group
compared to those in the “Slow” group as determined by cell numbers. In vivo-derived
embryos contained significantly fewer cells than the “Fast” group, but failed to show a
difference when compared to the “Slow” group. Therefore, from both statistical analysis
and graphical representation (Figure 4.2A), we observed that the embryos clustered into
three distinct groups. The FF group contained the most cells. The FS group contained
fewer than the FF group. The SF, SS and in vivo-derived groups contained fewer cells
than the FS group, but were indistinguishable from one another. Thus, the SF and SS
groups most closely resembled the in vivo-derived group.
The total volume of each embryo was also calculated using measurements of
length in two dimensions, determining the average of these lengths and using the formula
for the volume of a sphere for calculations. Average volumes for the FF group was
6.7X105 µm3, the FS group 3.8X105 µm3, the SF group 3.3X105 µm3, the SS group
3.5X105 µm3, and in vivo-derived group 4.9X105 µm3 (Figure 4.2B). As before, a nested
two-factor ANOVA was performed to test for differences between embryos in the first and
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second separations. As with cell numbers, both groups at the first (FF and FS versus SF
and SS) and second (FF versus FS, SF versus SS) separations displayed a significant
difference in cell volume. In vivo-derived embryos displayed significantly smaller total
embryo volume than the FF group, but a significantly larger embryo volume than the
other three groups (Figure 4.2B). From the statistical analysis, the embryo volumes
clustered into three separate groups. The FF embryos displayed the largest embryo
volume, followed by in vivo-derived embryos, with the three remaining groups displaying
smaller embryo volumes (FS, SF, SS were not significantly different from one another).

4.3.2 Effects of Embryo Culture on Embryo Sex Ratios
It has been suggested that male embryos develop faster than their female
counterparts. Bovine (Avery et al., 1992) and ovine (Bernardi and Delouis, 1996) male
embryos reach the blastocyst stage earlier than their female counterparts, with variations
in the embryo culture type, and protocol affecting sex ratios (Pegoraro et al., 1998;
Gutierrez-Adan et al., 2001; Iwata et al., 2008). In the mouse, the data are more
contradictory. While some studies reported male to female sex ratio differences (Valdivia
et al., 1993; Peippo and Bredbacka, 1995), another study reported no difference in
embryo sex ratios (Byrne et al., 2006). For human embryos, some studies suggested that
male embryos contain a greater number of cells than their female counterparts after IVF
(Ray et al., 1995) while others report that this increase in cell number occurs with ICSI
and not with IVF alone (Dumoulin et al., 2005), or vice versa (Dean et al., 2010).
Moreover, an increase in the number of male offspring was noted following blastocyst
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stage transfer, (Milki et al., 2003; Luna et al., 2007; Chang et al., 2009), while other
groups have shown no sex differences in rates of development (Kausche et al., 2001;
Richter et al., 2006; Csokmay et al., 2009; Weston et al., 2009). In light of the above
studies, the possibility existed that rates of development were unrelated to adverse affects
of culture but instead were the result of embryo sex. To address this potential bias, a
nested PCR was performed for Sry, which is only present in male embryos, while Xist,
located on the X chromosome, was used as a PCR control and was detected in both male
and female embryos (Figure 4.1B). While we did observe more male embryos in the
overall FF group (10 male, 6 female), and more female embryos in the SS group (6 males,
8 females), this result was not statistically significant (Figure 4.2C).
developmental rates were unrelated to embryo sex in our study.

Thus, different
Furthermore, no

correlation was found between embryo sex and the other parameters examined in this
study.

4.3.3 Effects of Embryo Culture on H19 and Snrpn Imprinting
To test our hypothesis that slower developing embryos will possess greater
imprinting defects, we evaluated the ability of embryos to maintain genomic imprinting
by examining two key loci, H19 and Snrpn, in the four groups of cultured embryos. From
our previous study (Market-Velker et al., 2010a), we showed that imprinted
hypermethylation on the H19 paternal ICR in in vivo-derived embryos was around 80%.
Embryos with hypermethylation levels below 80% were therefore considered to exhibit
“loss of methylation”. At least five embryos from each group were analyzed. The FF
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Figure 4.3: Imprinted Methylation of H19 in FF and FS Groups
Imprinted methylation analysis of the paternal H19 allele in “Fast/Fast” and “Fast/Slow”
groups. Each group of circles represents one embryo, with the embryo name indicated in
the top left. Percent hypermethylation indicated in the top middle. Each row represents
one DNA strand. Filled circles represent methylated CpGs dinucleotides while unfilled
circles represent unmethylated CpGs.
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group displayed a loss of methylation in 3 of 5 embryos (hypermethylation levels 100%,
90%, 67%, 36% and 33%), with an average methylation of 65%, while the FS group
displayed loss of methylation at only 2 of 5 embryos (hypermethylation levels 93%, 81%,
80%, 70% and 53%) with an average methylation of 75% (Figure 4.3).

Two of six

embryos in the SF group displayed loss of methylation (100%, 94%, 91%, 88%, 75%, and
75%), and 2 of 5 embryos in the SS group displayed loss of methylation (100%, 100%,
83%, 78%, and 75%) with an average methylation for both the SF and SS group of 87%
(Figure 4.4). Therefore, the overall “Fast” groups displayed an average methylation of
71%, while the average of the “Slow” groups was much higher at 87%, a statistically
significant difference (p < 0.05) (Figure 4.5).

In addition, while the “Fast” embryos

displayed lower levels of methylation than in vivo-derived controls, no difference was
observed between the “Slow” group and in vivo-derived embryos. This indicates that the
slower developing embryos were better able to maintain H19 imprinted methylation than
their fast developing counterparts.
A similar result was also observed at the Snrpn ICR. From our previous study
(Market-Velker et al., 2010a), we determined the threshold of methylation on the Snrpn
maternal ICR to be 70% hypermethylation. The FF group displayed loss of methylation
in 5 of 6 embryos (75%, 63%, 47%, 45%, 42%, and 36%) with an average methylation of
51%, and the FS group displayed a loss of methylation in 3 of 5 embryos (80%, 75%,
67%, 47%, and 43%) with an average methylation of 62% (Figure 4.6). The SF group
displayed loss of methylation in 0 of the 5 embryos tested (100%, 90%, 88%, 78%, and
70%) with an average methylation of 85%, while the SS group displayed a loss of
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Figure 4.4: Imprinted Methylation of H19 in SF and SS Groups
Imprinted methylation analysis of the paternal H19 allele in “Slow/Fast” and “Slow/
Slow” groups. See Figure 4.3 for details.
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Figure 4.5: Graphical Representation of Levels of H19 and Snrpn Hypermethylation
Top: Paternal H19 hypermethylation levels. Bottom: Maternal Snrpn hypermethylation
levels. Each diamond represents one embryo, and black bars represent mean
hypermethylation levels in each group.
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Figure 4.6: Imprinted Methylation of Snrpn in FF and FS Groups
Imprinted methylation of the maternal Snrpn allele in “Fast/Fast” and “Fast/Slow”
groups. See Figure 4.3 for details.
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Figure 4.7: Imprinted Methylation of Snrpn in SF and SS Groups
Imprinted methylation of the maternal Snrpn allele in “Slow/Fast” and “Slow/Slow”
groups. See Figure 4.3 for details.
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methylation at 3 of the 5 embryos (100%, 100%, 65%, 62%, and 50%) with an average
methylation of 75% (Figure 4.7). Overall, “Slow” embryos (SF and SS) displayed higher
levels of methylation than the “Fast” group (FF and FS) (p < 0.05). No difference was
observed at the second separation. Thus, the “Slow” group was best able to maintain
imprinted methylation.
Next, we analyzed H19 and Snrpn imprinted expression in the in vitro cultured
and in vivo-derived embryos. From our previous study, we have shown that in our mouse
model H19 is expressed from only a small number of in vivo-derived blastocysts
(approximately 1 in 9) (Market-Velker et al, 2010b).

For embryos displaying H19

expression, this expression was solely from the maternal allele. Analysis of imprinted
H19 expression revealed that 12 out of 16 embryos exhibited H19 expression in the FF
group with only 4 of these embryos maintaining monoallelic H19 expression from the
maternal CAST allele (Figure 4.8). In addition, a significant number of embryos in the
FF group displayed a “switched” expression pattern, where monoallelic expression
occurred erroneously from the paternal allele. This was improved in the FS group, where
7 of 9 embryos exhibited H19 expression with 5 maintaining imprinted expression, and
further improved in the SF group, where all embryos displaying H19 expression (6 of 10)
did so exclusively from the maternal allele. H19 expression in the SS group was most
similar to in vivo-derived controls, with 1 of 12 embryos displaying H19 expression, with
the sole embryo expressing H19 exclusively from the maternal CAST allele. Overall,
“Fast” embryos from the first separation expressed H19 in significantly more embryos
than the “Slow” group. No difference was observed at the second separation for FF
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Figure 4.8: H19, Snrpn and Cdkn1c Imprinted Expression
Imprinted Expression in the four groups of cultured embryos. Red bars indicate percent
expression from the maternal allele, and blue bars indicate percent expression from the
paternal allele.

Top: H19 imprinted expression analysis. Middle: Cdkn1c imprinted

expression analysis. Embryo names are indicated on the X-axis.
Bottom: Developmental Cdkn1c imprinted expression in in vivo-derived embryos.
Embryo stage indicated on the X-axis. 4-cell, n=2, 12 pooled embryos each; 8-cell, n=2, 6
pooled embryos each; Early M, early morula, n=2, 3 pooled embryos each; Late M, late
morula, n=2, 1 embryo each; Mid-BL, mid blastocyst; n=7, 1 embryo each; Late BL, late
blastocyst; n=3, 1 embryo each.
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versus FS groups.

However, within the slow group, more embryos in the SF group

expressed H19 than the SS group. Furthermore, as with imprinted H19 methylation, the
overall “Fast” embryos showed a significantly greater loss of imprinted H19 expression
than “Slow” and in vivo-derived embryos. By comparison, “Slow” embryos were more
similar to in vivo-derived controls at maintaining imprinted H19 expression. FF embryos
showed significantly greater loss of imprinted H19 expression compared with the other
groups. Similar to previous experiments (Mann et al., 2004; Market-Velker et al., 2010b),
no effect on Snrpn imprinted expression was observed; all embryos displayed paternalspecific Snrpn expression (data not shown).

4.3.4 Effects of Embryo Culture on Cdkn1c Imprinted Expression
We predicted that embryos with biallelic Cdkn1c expression would exhibit slower
rates of preimplantation development. To assess this, imprinted Cdkn1c expression was
evaluated in the four groups of cultured embryos (Figure 4.8), as well as in in vivoderived controls. All embryos in the FF group showed monoallelic expression, except
one embryo, which lacked Cdkn1c expression. Two embryos in the FS group expressed
Cdkn1c from both the parental alleles, while no embryos exhibited biallelic expression in
the SF group. Two embryos in the SS group displayed biallelic expression, and three
embryos showed Cdkn1c expression exclusively from the normally-silent paternal allele.
Overall, no significant difference in imprinted expression was observed at the first
separation between “Fast” and “Slow” groups. However, a significantly greater number
of “Slow” embryos from the second separation, FS and SS, displayed biallelic Cdkn1c
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expression compared with the “Fast” FF and SF groups, which were not statistically
different from in vivo-derived controls. This result appeared contradictory to the H19
imprinted expression pattern, leading us to question whether the observed data were
related to developmental regulation of imprinted Cdkn1c expression rather than
misregulation of Cdkn1c imprinting. As the time course of Cdkn1c imprinted expression
had not been fully elucidated in preimplantation embryo stages, we evaluated imprinted
Cdkn1c expression in pools of 4-cell, 8-cell and early morula, as well as individual late
morula, and blastocyst stage embryos. Over this developmental time course, we observed
an overall decrease in B6 expression, with 4- and 8-cell embryos displaying nearly equal
levels of maternal and paternal expression, and late blastocysts displaying expression
exclusively from the maternal allele. This data indicate that cultured embryos in the FS
and SS groups displaying biallelic Cdkn1c expression were developmentally delayed
compared with embryos in the FF and SF groups.

4.3.5 Effects of Embryo Culture on Metabolic Marker Expression
According to Leese’s “quiet embryo” theory, embryos more affected by
suboptimal environment will compensate by increasing their metabolic activity (Leese,
2002). We hypothesized that embryos that develop faster and display a more frequent
loss of imprinting will also show an increase in metabolic activity.

To evaluate this

hypothesis, we examined expression of three genes involved in early embryo metabolism:
Atp1a1 encoding the alpha subunit of the Na+/K+ ATPase, Slc2a1 encoding the solute
carrier family 2, and Mapk14 encoding p38 alpha in 11 FF, 9 FS, 10 SF and 11 SS
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Figure 4.9: Expression of Genes Involved in Embryo Metabolism
Relative expression of genes involved in embryo metabolism in cultured and in vivoderived embryos. (A): Left panel: Relative Atp1a1 expression in the four groups of
cultured embryos and in vivo-derived embryos. Embryo group is indicated on the X-axis,
each diamond represents one embryo, and black bars represent the mean relative
expression in each group. Right panel: Mean relative Atp1a1 expression in “Fast” and
“Slow” groups based on the first separation. * “Fast” embryos displayed significantly
higher Atp1a1 expression levels than “Slow” embryos. (B): Left panel: Relative Slc2a1
expression corrected for cell numbers in the four groups of cultured embryos and in vivoderived embryos. Black bars represent the mean relative expression corrected for cell
numbers in each group. Right panel: Mean relative Slc2a1 expression, corrected for cell
numbers, in “Fast” and “Slow” groups based on the first separation. * “Fast” embryos
displayed significantly lower Slc2a1 expression levels than in vivo-derived and “Slow”
embryos, and ** “Slow” embryos displayed significantly lower Slc2a1 expression levels
than in vivo-derived embryos. (C) Left panel: Relative Mapk14 expression in the four
groups of cultured embryos and in vivo-derived embryos. Black bars represent the mean
relative Mapl14 expression in each group. Right panel: Mean relative Mapl14 expression
in “Fast” and “Slow” groups based on the first separation. No difference in mean relative
Mapl14 expression was observed between in vivo-derived, “Fast” and “Slow” embryos.
Error bars represent standard errors of the mean.
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blastocysts, as well as 5 in vivo-derived controls. Atp1a1 expression was significantly
higher in the “Fast” group than the “Slow” group at the first separation (Figure 4.9), while
no significant difference was observed in mean levels of expression at the second
separation, between either the FF and FS, or SF and SS groups. Moreover, a number of
embryos within the FF group displayed very high expression, while a number of embryos
within the SS group exhibited very low expression. Differences of large magnitudes in
the response of individual embryos to the culture environment, in addition to an overall
shift in the mean population response supports the idea that each embryo responds
differently to environmental insult, and that “Fast” embryos are more likely to show
abnormally high levels of expression than their “Slow” or in vivo counterparts.
Comparing in vivo-derived embryos to cultured embryos revealed three distinct
groups. The FF group displayed significantly higher Atp1a1 expression and the SS group
significantly lower expression then the FS, SF and in vivo-derived embryos which
displayed expression levels between the FF and SS groups. The FS, SF and in vivoderived embryos were indistinguishable from one another. Normalization to cell numbers
did not reveal any significant differences in expression between groups.
Atp1a1 expression was also correlated with H19 imprinted expression. As stated
above, in vivo-derived embryos display one of two H19 expression patterns, maternal or
no expression. We compared Atp1a1 expression levels between embryos displaying an in
vivo pattern of H19 expression (maternal CAST or no expression; 32 embryos) to those
displaying an abnormal pattern (biallelic or abnormal B6 paternal expression; 7 embryos).
Significantly, embryos with abnormal H19 imprinted expression possessed higher Atp1a1
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expression levels (2.7 +/-0.4) than those displaying an in vivo pattern of H19 expression
(1.6 +/-0.2). Thus, we observed a relationship between Atp1a1 expression levels and
maintenance of H19 imprinted expression.
Slc2a1 and Mapk14 expression were also evaluated in these same embryos. The
“Slow” group displayed significantly higher levels of Slc2a1 expression than the “Fast”
group at the first separation (Figure 4.9), following normalization for cell numbers. No
difference was observed at the second separation. In vivo-derived embryos displayed
significantly higher expression levels than all four cultured groups, both before and after
correction for cell number. Overall, the Slc2a1 expression analysis revealed three distinct
groups, the FF group with the lowest expression, the FS, SF and SS groups with mid-level
expression that was indistinguishable from one another, and in vivo-derived embryos with
the highest Slc2a1 expression. Strikingly, a difference in the dispersion of the samples in
the five groups is noted, with a decrease in sample variability from in vivo to SS group,
and further on to FF group, suggestive of a “dose” response. No relationship was
observed between Slc2a1 expression and H19 imprinted expression. For Mapk14, while
expression levels were higher in the FF compared with in the other culture groups and in
vivo controls, this difference was not statistically significant. As well, no difference
between groups after cell number correction, and no relationship to H19 imprinted
expression was observed.

4.4 Discussion
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In this study, we set out to determine whether embryos with different
developmental rates differed in their ability to maintain genomic imprinting, with slower
rates of embryonic development correlating with loss of imprinting.

Notably, we

identified a subset of in vitro cultured embryos that, according to all parameters evaluated
in this study, are very similar to in vivo-derived embryos (Figure 4.10).

However,

contrary to our expectation, we observed that embryos with faster developmental rates
possessed greater cell numbers and embryo volume, as well as greater perturbations in
genomic imprinting and metabolic marker expression.

While the slowest developing

embryos displayed lower cell numbers, smaller embryo volumes, and were better able to
maintain genomic imprinting, a proportion of these embryos were developmentally
delayed as determined by Cdkn1c imprinted expression and the presence of

more

arrested embryos prior to the blastocyst stage in this group. Instead, embryos with slow
to moderate development rates (SF embryo group) were most similar to in vivo-derived
embryos, displaying similar cell numbers, embryo volume, H19 and Snrpn methylation,
H19 imprinted expression, and Atp1a1 and Slc2a1 expression.

4.4.1 Relationship between Development Rates and Genomic Imprinting
In this study, we evaluated the differences in the maintenance of genomic
imprinting at two imprinted loci, H19 and Snrpn, which are involved in the development
of the imprinting disorders AS and BWS, and correlated this loss of imprinting with rates
of preimplantation embryo development. Our data suggests that embryos that develop
faster do so at the expense of maintaining epigenetic regulation. It is currently unclear
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how embryo culture can lead to alterations in imprinting. One possibility is that culture
conditions interfere with epigenetic maintenance mechanisms and this in turn deregulates
the embryo’s growth kinetics. Interestingly, embryos with only maternal genomes
(parthenotes) or with only paternal genomes (androgenotes) display developmental
defects that have been attributed to alterations in cell proliferation and differentiation
rates (reviewed in Mann, 2005). We observed that faster developing embryos were more
advanced morphologically, but had a shorter cell division cycle given the greater number
of cells. On the other hand, slow embryos maintained rates of cell division similar to in
vivo-derived embryos, given similar cell numbers. Given a possible relationship between
genomic imprinting, developmental rates and cell cycle progression, we investigated the
imprinted expression of Cdkn1c, a cell-cycle regulator that acts to inhibit cell cycle
progression through its interaction with cyclin-CDK complexes (Lee et al., 1995). We
demonstrated that Cdkn1c expression is biallelic in early cleavage stages, and becomes
maternal-specific as preimplantation development progresses. Interestingly, we observed
more embryos with biallelic expression in the “Slow” groups (FS and SS) at the second
separation than those in the “Fast” groups (FF and SF), suggesting that Cdkn1c may play
a role in regulating progression through the latter phase of preimplantation development.
Lower levels of expression, in the form of monoallelic expression, may result in less cell
cycle inhibition and in turn, increase the rate of cell division. Alternatively, biallelic
expression may result in an increase in cell cycle inhibition, resulting in increased time
required to progress through the cell cycle.
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4.4.2 Relationship Between Development Rates and Embryo Volume
During preimplantation development, the total volume of the embryo remains
relatively constant, while the number of cells increase as development proceeds (Aiken et
al., 2004). With respect to embryo volume, the effect size of the difference between FF
and in vivo-derived embryos was larger than that between in vivo controls and the other
three groups, again indicating that slower embryos were more similar to in vivo-derived
controls. This raises the question as to what mechanisms could lead to a difference in
embryo volume for the FF group. Two possible explanations for the differences observed
in embryo volume between cultured and in vivo-derived controls are an increase in
overall cell volume, or an increase in volume of the blastocoel cavity. An increase in cell
volume may be due to increased transcription, translation and protein processing
necessary to support higher metabolism in response to cell stress as well as changes in the
cell’s ability to regulate intracellular osmotic pressure (Baltz and Tartia, 2010). One
mediator of environmental stress is MAPK14, which regulates embryonic adaptations to
culture such as variations in culture medium osmolarity (Bradham and McClay, 2006;
Fong et al., 2007; Bell et al., 2009). Treatment with MAPK14 inhibitors has
demonstrated a requirement for MAPK14 in early cleavage division embryos (Natale et
al., 2004). As larger FF embryos may respond to environmental stress via MAPK14 with
the end result of producing larger cells, we investigated Mapk14 expression in the five
embryo groups. Our analysis showed no difference in Mapk14 expression between the
four culture groups and in vivo controls, indicating that variations in cell volume do not
likely account for overall variations in blastocyst volume that we observed. MAPK14
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levels and its posttranslationally-modified forms need to be investigated to confirm this
observation.
Alternatively, larger FF embryo volumes may be a result of larger cavity volumes.
Trophectoderm (TE) cells produce a blastocoel cavity through the use of the Na+/K+
ATPase, which generates an ionic gradient across the trophectoderm, facilitating
movement of water from the outside environment to the inside of the embryo (Watson
and Barcroft, 2001; Barcroft et al., 2003). Embryos that contain more TE cells will have
greater levels of the Na+/K+ ATPase, resulting in a greater influx of water into the
blastocoel cavity. This would result in faster production of a larger cavity and therefore a
more morphologically advanced embryo. Our results favour the latter hypothesis, where
an increase in TE cells generates a larger blastocoel cavity via increased Na+/K+ ATPase.
Examination of Atp1a1 expression, the alpha subunit of the Na+/K+ ATPase, revealed
higher levels of expression in the “Fast” group when compared to the “Slow” group. In
addition, as predicted by the above model, this increase in Atp1a1 expression was a
function of cell number, as no difference in expression was observed when corrected for
cell number. Interestingly, we also observed that increased Atp1a1 expression levels
correlated with loss of H19 imprinted expression. Thus, this provides a link between
genomic imprinting and developmental rates.

4.4.3 Relationship between Development Rates and Embryo Metabolism
Changes in Atp1a1 expression in the faster developing embryos suggest that the
metabolism of these embryos is altered compared to in vivo-derived controls. To further
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investigate this, we examined Slc2a1 expression. SLC2A1 is one of the primary glucose
transporters in the preimplantation embryo. In early cleavage division embryos, SLC2A1
is primarily localized to the nucleoli and nuclear membranes. Post-compaction, Slc2a1
expression increases dramatically (Morita et al., 1994; Uechi et al., 1997) and SLC2A1
translocates to the basolateral membrane of TE cells and the plasma membrane of ICM
cells (Pantaleon et al., 2001), permitting shuttling of glucose from the blastocoel cavity to
ICM cells. This differential localization of SLC2A1 coincides with the switch of energy
preferences in the developing embryo, from pre-compaction utilization of pyruvate to
post-compaction utilization of glucose. Before the switch, a transient pulse of glucose is
required.

A complete absence of glucose during the early stages of preimplantation

development results in delay or impaired development to the blastocyst stage (Martin and
Leese, 1995; Pantaleon et al., 2008).

Importantly, multiple groups have shown that

Slc2a1 mRNA expression and protein levels are significantly higher in in vivo-derived
compared to in vitro cultured embryos (Morita et al., 1994; Uechi et al., 1997; LeppensLuisier et al., 2001; Balasubramanian et al., 2007). In our study, we also found much
higher levels of Slc2a1 expression in in vivo-derived compared to cultured embryos.
Interestingly, “Slow” embryos expressed Slc2a1 at significantly higher levels than their
“Fast” counterparts when corrected for cell number, again demonstrating that the “Slow”
group is more similar to controls. No significant difference was observed at the second
separation.
As both Slc2a1 mRNA and protein levels increase at compaction in response to
the increased need for glucose utilization, we hypothesize that the “Fast” embryos are
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unable to adequately upregulate Slc2a1, while the “Slow” embryos respond appropriately
and have levels of Slc2a1 more similar to in vivo-derived embryos. In the “Fast”
embryos, a lack of appropriate increase in Slc2a1 expression would result in decreased
availability of glucose. To maintain their intrinsic rates of development, and support
blastocyst formation as well as all other cellular activities, these embryos would be
required to switch their metabolism to utilize alternate means of ATP generation such as
amino acid catabolism (for glugoneogenesis) and beta oxidation of fatty acids (Sturmey et
al., 2009b). Interestingly, differential uptake of glucogenic and non-glucogenic amino
acids has been noted between developmentally competent and incompetent embryos
cultured in vitro (Houghton et al., 2002; Stokes et al., 2007; Lehninger et al., 2005). In
addition, a large proportion of the ATP generated in the developing blastocyst is utilized
by the Na+/K+ ATPase, for which we demonstrated higher Atp1a1 expression levels in
“Fast” developing embryos (Leese et al., 2007), thereby further reducing the pool of ATP
available for other cellular activities in these embryos. Persistent inadequate ATP
generation, would lead to compromised cellular functions including epigenetic regulation
of genomic imprinting (Hargreaves and Crabtree, 2011). Perhaps this is not surprising as
all known chromatin-remodeling complexes are powered by an ATPase subunit
(Hargreaves and Crabtree, 2011). Interestingly, we observed that increased Atp1a1
expression levels correlated with loss of H19 imprinted expression, lending support to the
attractive idea that culture-induced epigenetic effects may act at the interface of a Na+/K+
ATPase. This study provides a link between genomic imprinting, developmental rates
and metabolism, with increased metabolism of alternate energy sources representing a
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compensation for the maladaptation of the embryo to the suboptimal culture environment.
Thus, future studies should be directed towards the analysis of ATP-driven metabolic
factors and epigenetic regulators in “Fast” and “Slow” developing embryos over their
period of development in culture.
Taken all together, our data indicate that “Slow” embryos maintain a baseline
level of metabolic activity similar to in vivo-derived embryos, while “Fast” embryos
adapt and compensate by increasing the activity of other metabolic pathways,
compromising cellular processes to maintain continued embryo growth and survival.
Moreover, imprinting defects in “Fast” embryos indicate altered epigenetic
reprogramming in response to suboptimal embryo culture, while “Slow” developing
embryos exhibit more in vivo-like reprogramming. Thus, our data lend support to the
quiet embryo hypothesis espoused by Leese and colleagues. This hypothesis suggests
that the most viable embryos are “quiet”, exhibiting lower levels of metabolic activity,
expending less energy repairing damage caused by the suboptimal culture environment,
and possessing slower cell division cycles (Leese, 2002; Baumann et al., 2007; Leese et
al., 2007; Sturmey et al., 2009a). In contrast, embryos that actively adapt to culture will
possess higher metabolic levels and faster cell cycle divisions. Our study is the first to
demonstrate a link between embryo culture, development rates, imprint maintenance and
metabolism.

4.4.4 The Best Embryos for Transfer

185

The term assisted reproductive technologies encompasses many techniques used
to treat human infertility. However, all involve the manipulation of human gametes and
preimplantation embryos, and many involve embryo culture during preimplantation
development.

While the optimal time and number of embryos to transfer after

fertilization and culture has been a source of debate, all are in agreement that only the
“best” or “healthiest” embryos should be transferred (Kallen et al., 2010; Min et al., 2010;
Porat et al., 2010; Sills and Palermo, 2010; Wang et al., 2010). Many algorithms have
attempted to determine the parameters that most accurately predict successful embryo
transfer resulting in implantation and pregnancy (Elizur et al., 2005; Lesourd et al., 2006).
Currently, morphological characteristics and stage of embryo development at a given time
point are the most commonly used criteria for identifying “healthy” embryos that should
be transferred to patients in IVF clinics (Shoukir et al., 1997; Van Montfoort et al., 2004).
Multiple studies have suggested that those embryos attaining the 4-cell stage (cleavagestage transfer) or the blastocyst stage (blastocyst transfer) the fastest are most suitable for
embryo transfer (Claman et al., 1987; Windt et al., 2004; Biezinova et al., 2006; Wang et
al., 2010). However, other studies have suggested that embryos progressing at a moderate
pace are those that should be used, and have cautioned against the use of embryos with
very fast or very slow development (Cummins et al., 1986; Alikani et al., 2000; Weitzman
et al., 2010). It is important to know whether slower developing embryos are indeed
suitable for transfer to patients, especially in situations where a choice between which
embryo(s)
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Figure 4.10: Summary of Multiple Parameter Analysis at the Individual Embryo
Level
Dotted lines indicate significance. The FF group was most different from in vivo controls
in all assays. Embryos in the “Slow” group (specifically SF) were more similar to in vivoderived embryos.
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to transfer can be made. Previously, the relevance of these criteria to the maintenance of
genomic imprinting was unknown.
Results from this study support the transfer of embryos displaying slow to
moderate rates of development. We argue that embryos in the SF group are most suitable
for embryo transfer. These embryos displayed imprinted methylation and expression, cell
numbers, embryo volume, and metabolic marker expression most similar and in some
cases indistinguishable from in vivo-derived embryos (Figure 4.10). Our data also argue
against transfer of the fastest developing embryos. The FF group was most different from
in vivo controls in all assays, and most importantly, showed the highest number of
embryos with loss of imprinted H19 and Snrpn ICR methylation. While the FS group
was more similar to controls than the FF group with respect to embryo volume and H19
imprinted expression, this group still displayed lower levels of H19 and Snrpn imprinted
methylation, greater perturbations of Cdkn1c imprinted expression, greater expression of
Atp1a1 and lower expression of Slc2a1 than controls. By comparison, the slowest (SS)
group displayed levels indistinguishable from controls with respect to cell number,
embryo volume, and H19 imprinted expression. However, the SS group showed levels of
Cdkn1c imprinted expression indicative of delayed development, and lower levels of H19
and Snrpn imprinted methylation than in vivo-derived control embryos. In addition, 40%
of embryos in the slowest (SS) group failed to develop to the blastocyst stage after 3 days
of culture. As such, the SF group is likely the most suitable for embryo transfer in the
human clinic.
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Our group and others have previously reported that the response of
preimplantation embryos to in vitro culture with respect to genomic imprinting is
stochastic (Doherty et al., 2000; Mann et al., 2004; Market-Velker et al., 2010b; Lim et
al., 2009; Rossignol et al., 2006). Here, we show that this can partly be attributed to a
differential response of embryos to culture, with the fastest developing embryos acquiring
the greatest perturbations in imprinted gene regulation and metabolic gene expression.
We propose that embryos that undergo reprogramming to counter the stresses of
suboptimal culture are the least healthy for embryo transfer. Therefore, selecting embryos
with slow rates of development is one step towards choosing a more “healthy” embryo.
Determining the differences between slowest, slow to moderate and fast developing
embryos, and developing non-invasive methods to more easily identify them in the
human clinic will be critical to choosing the “best” or “healthiest” embryos for transfer,
thereby maximizing pregnancy rates.
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Chapter 5 - The Effects of Superovulation and Embryo Culture at the Peg1/Mest
Locus

The work in this chapter originates from the following manuscript:
Market Velker, B. A., Denomme, M. M., Mann, M. R. ‘A comprehensive evaluation of
the effects of superovulation and embryo culture on the acquisition and maintenance of
genomic imprinting of Peg1/Mest’ submitted for publication in the journal Biology of
Reproduction, in June 2011.

5.1 Introduction

Genomic imprinting is an epigenetic phenomenon where gene expression is
regulated according to parent-of-origin; one parental allele is expressed while the other is
repressed (Reik and Walter, 2001; Rodenhiser and Mann, 2006). To date, approximately
150 genes have been identified whose expression is regulated in such a manner (http://
www.har.mrc.ac.uk/research/genomic_imprinting/maps.html) (Morison et al., 2005).
Many of these imprinted genes play critical roles in the development of the embryo and
placenta, or influence behaviour after birth (Ono et al., 2006; Varrault et al., 2006;
Wilkinson et al., 2007; Bressan et al., 2009; Broad et al., 2009), and their dysregulation
has been linked to a group of human diseases called imprinting disorders. Two important
time periods have been identified with respect to genomic imprinting: acquisition (during
gametogenesis) and maintenance (during preimplantation development). Numerous
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assisted reproductive technologies take place during these two critical periods, and as
such have the potential to disrupt acquisition and/or maintenance of genomic imprinting.
The development and increased use of assisted reproductive technologies (ARTs)
for the treatment of infertility/subfertility, led to the observation that genomic imprinting
may be affected by ex vivo manipulation of the early embryo. In addition to BWS and
AS, studies have suggested a relationship between Silver-Russell Syndrome (SRS), and
dysregulation of imprinted genes by ARTs. SRS is an imprinting disorder characterized
by intrauterine and post-natal growth retardation (Wollmann et al., 1995). Up to 44% of
SRS cases are associated with hypomethylation of the H19 ICR within the 11p15 region
(Eggermann et al., 2010), which harbours the imprinted genes H19 and Igf2, while
maternal uniparental disomy of chromosome 7 has been implicated in approximately 5%
of cases of SRS (Kotzot et al., 1995; Eggermann et al., 2010), a region that contains the
Peg1/Mest gene.
Peg1/Mest has been proposed as one of the causative agents of SRS (Hannula et
al., 2001; Chou et al., 2004; Kagami et al., 2007). Paternal inheritance of a targeted Peg1/
Mest allele results in severe IUGR in the offspring, while maternal inheritance of the
deleted allele does not (Lefebvre et al., 1998). On the other hand, high levels of Peg1/
Mest expression has been found in adipocytes from obese mice, and transgenic
overexpression of Peg1/Mest results in enlargement of adipocytes (Takahashi et al.,
2005). This suggests a key role for Peg1/Mest in regulating fetal growth.
Genomic imprinting of Peg1/Mest, which is located on mouse chromosome 6 and
human chromosome 7, was identified through subtractive hybridization comparing
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normal and parthenogenetic mouse embryos (Kaneko-Ishino et al., 1995). Paternal
monoallelic expression of Peg1/Mest has been confirmed in adult tissues (Reule et al.,
1998), and in a number of other species including humans (Kobayashi et al., 1997;
Riesewijk et al., 1997), tammar wallaby (Suzuki et al., 2005), and sheep (Feil et al.,
1998). A CpG island spanning the putative promoter region and exon 1 is methylated in a
parent-of-origin specific manner: the maternal allele is methylated while the paternal
allele is unmethylated (Riesewijk et al., 1997; Nishita et al., 1999). Acquisition of
imprinted DNA methylation at the maternal differentially methylated region (DMR)
occurs at the tertiary/early antral follicle stage, after the majority of other imprinted genes
have already acquired their methylation (Obata and Kono, 2002; Hiura et al., 2006), and
continues after ovulation (Imamura et al., 2005). This has led to suggestions that the
Peg1/Mest imprint may be more vulnerable to perturbation by environmental insult
(Anckaert et al., 2010). A number of studies have demonstrated differences in the
response of Peg1/Mest to various environmental insults during oocyte development,
including superovulation and in vitro maturation when compared to other imprinted
genes, such as H19 and Snrpn (Khosla et al., 2001; Liang et al., 2008; Tveden-Nyborg et
al., 2008; Anckaert et al., 2010).
In this study, we characterize the effects of two commonly used procedures in
ART, superovulation and embryo culture, on the acquisition and maintenance of genomic
imprinting at the Peg1/Mest locus. Superovulation, also known as ovarian
hyperstimulation, is used to recover large numbers of mature oocytes, while embryo
culture facilitates the development of embryos through preimplantation stages. To
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provide a comprehensive allelic analysis of the response of the Peg1/Mest locus to these
procedures, and to avoid confounding factors that have prevented detailed analysis in
other studies such as intrinsic patient subfertility, and the use of pooled oocytes/embryos,
our analysis was performed using a mouse model on individual oocytes and blastocyst
stage embryos. We demonstrate that DNA methylation at the maternal Peg1/Mest DMR
is maintained in ovulated metaphase II (MII) oocytes following low or high dose
superovulation, indicating that acquisition of Peg1/Mest imprinted methylation in the
developing oocyte is not affected by hormonal stimulation. However, a significant loss of
maternal methylation at the Peg1/Mest DMR was observed at the blastocyst stage
following superovulation or embryo culture, indicating that maintenance of genomic
imprinting was disrupted by these interventions, although no correlation to rates of
preimplantation development was observed.

5.2 Methods
5.2.1 B6(CAST7p6) Mouse Model

Previous studies from our lab utilized a mouse model ideally suited for imprinting
analyses, C57BL/6(CAST7) (B6(CAST7) that contain two Mus musculus casteneus
chromosome 7s on a B6 background. Polymorphisms between B6(CAST7) and C57BL/6
(B6) mice allow for subsequent identification of maternal and paternal alleles.
Investigation of Peg1/Mest was not possible using this model, as Peg1/Mest is located on
chromosome 6 in the mouse. To identify C57BL6(CAST7partial6) [B6(CAST7p6)]
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mice, we screened our original B6(CAST7) colony by microsatellite marker mapping and
found a subset of mice that harboured the same partial region of M.m. castaneus
chromosome 6. Using microsatellite markers, D6Mit140 and D6Mit34, as well as allelic
PCR-restriction digest of published polymorphisms, crossover events were mapped to
22.8-23.7 and 31.02-32.05 MB, a 9.25 MB region that contained the entire Peg1/Mest
imprinted domain (Figure 5.1). The proximal crossover was mapped to between SNP#4
(rs3090864) and SNP #5 (rs3088527). The PCR primers for SNP#4 were F: 5’GTGCCAGATTGTCTTCCC-3’, and R: 5’-ACCCTCAGGACAGTTCG-3’, and for
SNP#5 were F: 5’-ATGCCTCATTTGGAGTCTG-3’, and R: 5’AGCATCCTCTGGGAGTGTA-3’. For SNP#4, a polymorphic A/G restriction site
between B6 (A) and CAST (G) distinguished the parental alleles, as the CAST (G) allele
is cleaved by the HpyCH4III restriction enzyme (B6: 181 and 12 bp, CAST: 101, 80 and
12 bp). For SNP#5, a polymorphic A/C restriction site between B6 (C) and CAST (A)
distinguished parental alleles, with the CAST allele cleaved by the restriction enzyme
CviKI-1 (B6: 74, 54, and 38 bp, CAST: 112 and 54 bp). The distal crossover was mapped
to a region between the MapPairs D6Mit341 and D6Mit140. To determine if the Peg1/
Mest imprinted domain was within the CAST region, another polymorphism, SNP#10
(rs6183467), outside the domain was investigated using the following primers F: 5’CAGGATGGGTCTGGAGTGA-3’ and R: 5’-CTTAGTAGCAACTGGGTGGTG-3’. A
polymorphic T/G restriction site between B6 (T) and CAST (G) was observed, and
restriction digest with the enzyme HincII resulted in cleavage of the CAST allele. All
polymorphisms were confirmed by sequencing of the PCR products. SNP#4 was used for
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Figure 5.1: Crossover Sites in the B6(CAST7p6) Mouse Model
Graphical representation of chromosome 6 in our B6(CAST7p6) mouse model. Genes in
red are located within the known M. m. castaneus region, genes in blue are located within
the known B6 region, and genes in purple fall within the crossover region. Green boxes
represent MapPairs that were used to genotype the mice. Yellow boxes represent sites of
single nucleotide polymorphisms (SNPs) that were used as restriction sites to determine
genotypes.

The Peg1/Mest imprinted domain was found to reside within the M. m.

castaneus region.
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the allelic PCR-restriction digestion genotyping assay to identify B6(CAST7p6) mice.
B6(CAST7p6 intercrosses were used to generate a B6(CAST7p6) mouse colony. This
B6(CAST7p6) mouse model was used for all subsequent experiments.

5.2.2 Oocyte and Embryo Collection and Culture
Ovulated oocytes were collected from B6(CAST7p6)xB6 F1 females following
superovulation, or spontaneous ovulation for controls. F1 females have one CAST
chromosome 7 and a partial CAST chromosome 6 on a B6 background inherited from the
mother, and a B6 chromosome set inherited from the father, allowing for identification of
grandparental inheritance at the Peg1/Mest locus within the oocyte following meiosis.
Superovulated females were injected with either 6.25 IU or 10 IU Pregnant
Mare’s Serum Gonadotropin (PMSG, Intervet Canada) followed 40-44 hours later by the
same dose of human Chorionic Gonadotropin (hCG, Intervet Canada). Oocyte-cumulus
cell complexes were flushed from the oviducts at approximately 12 PM the following day
(22 hours post-hCG) into M2 media (Sigma). MII stage oocytes were dissociated from
surrounding cumulus cells using 0.3 mg/ml Hyaluronidase (Sigma) and were washed
three times in 30 µl of M2 media. Diameter and volume measurements were recorded for
each individual oocyte using the Olympus IX81 microscope. Oocytes were treated with
Acidic Tyrode’s solution (Sigma) at room temperature for removal of the zona pellucida,
washed twice more in M2 media, and individually placed on a glass slide in minimal
media. Oocytes were gently mixed with a small amount of 2:1 agarose:lysis solution [20
µl 3% low melting point agarose (Sigma)], 8 µl Dynabead lysis buffer (see below), 1µl 2
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mg/ml proteinase K (Sigma), 1 µl 10% IPEGAL (Sigma) at 70ºC, embedded in 10 µl of
this solution and placed in an eppendorf tube containing 300 µl of mineral oil. Following
a 10 minute incubation on ice to allow the agarose bead to harden, mineral oil was
removed and 500 µl of Dynabead lysis buffer was added [100 mM Tris–HCl pH 7.5
(Bioshop), 500 mM LiCl (Sigma), 10 mM EDTA pH 8.0 (Sigma), 1% LiDS (Bioshop), 5
mM DTT (Sigma)]. Individual samples were incubated overnight in a 50ºC waterbath.
The following morning (~20 hours later), Dynabead lysis buffer was removed and
300 µl mineral oil was again added to the bead. Samples were incubated at 90ºC for 2.5
minutes (Proteinase K inactivation), and were then placed on ice for 10 minutes. Bisulfite
mutagenesis was performed as described (Market-Velker et al., 2010a) with the following
exception: each oocyte sample was directly added as a solid agarose bead to a ready-to-go
PCR bead (GE) containing Peg1/Mest specific primers and 1 µl of 240 ng/ml tRNA in a
15 µl solution, with 25 µl mineral oil overlay. Negative controls (agarose bead without
oocyte) were processed alongside each sample. The first round nested PCR was
performed with an annealing temperature of 50ºC. For the second round, 5 µl of first
round product was added to a second 25 µl ready-to-go PCR bead, with Peg1/Mest
specific primers but without tRNA, with 25 µl mineral oil overlay. The second round
nested PCR was performed using an annealing temperature of 54ºC.
Embryos were obtained from B6(CAST7p6) females crossed with B6 males
(Charles River, St Constant, Canada). For in vivo-derived embryos, female
B6(CAST7p6) mice were checked for estrus, and mated with B6 males. For the
superovulated group, females were injected with either 6.25 or 10 IU of PMSG, followed
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by the same dose of hCG, 40-44 hours later. Females were mated with B6 males the
same day as hCG injection. In both groups, pregnancy was determined by the presence of
a vaginal plug at 0.5 days postcoitum (dpc). F1 hybrid 2-cell embryos were flushed from
the oviducts of B6(CAST7p6) females at 1.5 dpc, washed twice and cultured in Whitten’s
medium (made in-house) (Whitten, 1971). Embryo culture drops were prepared prior to 9
AM the morning of embryo collection or embryo separation, and allowed to equilibrate.
Embryos were cultured in either 10, 15 of 20 µL drops, with filter-sterilized mineral oil
overlay (Sigma), at a concentration of 1 embryo per microliter. Embryos were separated
into four groups based on rates of development over the course of the 3 day culture period
as described in Chapter 4.
Control blastocyst stage embryos were flushed from uteri of B6(CAST7p6)
females in M2 Medium (Sigma) at 3.5 dpc (~96 hours post-hCG). Cultured embryos and
embryos collected at the blastocyst stage were frozen in individual tubes, snap frozen on
dry ice and stored at -80˚C.

5.2.3 Analysis of Peg1/Mest Imprinted Methylation and Expression
The combined analysis of imprinted methylation and expression in individual
blastocysts was performed as previously described using the cDNA library generated for
each embryo (Market-Velker et al., 2010b). The following primers were used for the
analysis of imprinted expression of Peg1/Mest (NM_008590; 1380-1920): Forward 5’CACATTGGTGAACAAACTACAGG-3’(1PG2), Reverse 5’AGAGTGCTGGGAACTGAACC-3’(1PG5). Amplification of a 541 bp fragment
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containing an allelic polymorphism between B6 (C) and CAST (A) (position 1679,
NM_008590) was tested using SYBR green to allow determination of the range of cycles
located in log-phase amplification. PCR on subsequent embryos was performed to ensure
that amplification was log-phase upon completion of the PCR program. Following
amplification using ready-to-go PCR Beads, embryos were digested with the BsiHKA1
restriction enzyme to determine allelic identity; the B6 allele is cleaved into 270 and 271
bp fragments, while the CAST allele is uncut. Densitometry was performed using the
Opticon Monitor Software.
For imprinted methylation, bisulfite mutagenesis, nested PCR, cloning and
sequencing was performed as described previously (Chapter 3) (Market-Velker et al.,
2010b). Analysis of 15 CpGs in the Peg1/Mest DMR (AF017994; 1309-1651) was
performed using the following primers: outer primers; Peg1B 5’TTTTAGATTTTGAGGGTTTTAGGTTG-3’, and Peg1E 5’TCATTAAAAACACAAACCTCCTTTAC-3’, 50˚C annealing temperature; inner
primers; Peg1C 5’-GGTGTTGGTATTTTTAGTGTTAGTTG-3’, and Peg1D 5’AATCCCTTAAAAATCATCTTTCACAC-3’, 57.5˚C annealing temperature. Primers
were designed within the region described by Anckaert et al (Anckaert et al., 2010). At
least 40 clones per embryo were sequenced, and each sequence was analyzed as described
previously (Chapter 3) (Market-Velker et al., 2010b). Hypermethylation of a DNA strand
was defined as > 50% methylated CpGs on a given strand.
For each oocyte, 5 clones were sequenced. Since individual oocytes are expected
to have a single strand of DNA amplified, any samples having more than one methylation
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pattern were excluded from analysis, due to implied cumulus cell contamination.
Sequences with conversion rates < 85% were not included.

5.2.4 Statistical Analysis
Statistical analysis was performed comparing loss of methylation between in vivoderived embryos, superovulated embryos (6.25 IU and 10 IU) and in vitro cultured
embryos. The Fisher’s exact test was used to compute the significance of non-random
association between these groups of embryos. A one-sided test was utilized as
methylation changes were anticipated to be only in one direction. P-values less than 0.05
were considered to be significant, and were calculated using the following online
software: http://faculty.vassar.edu/lowry/fisher.html

5.3 Results

5.3.1 Effects of Superovulation on Peg1/Mest Imprinted Methylation in Oocytes
In this study, we set out to determine the effects of superovulation on Peg1/Mest
imprinted methylation in ovulated oocytes. Furthermore, we wanted to determine
whether the original maternal and paternal Peg1/Mest alleles displayed differential
sensitivity to hormone treatment. During oogenesis, imprinted methylation acquisition
may occur differentially between the parental alleles as evidence indicates that
methylation of the Snrpn grand-maternal allele is established prior to that on the
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grandpaternal allele (Lucifero et al., 2004). By using B6(CAST7p6) F1 females, we can
distinguish between the Peg1/Mest grandmaternal (CAST7p6) and grandpaternal (B6)
alleles within individual oocytes.
To assess effects of superovulation on imprinted methylation, our recently
developed single cell bisulfite mutagenesis assay was used to determine the methylation
status of 15 CpGs located in the Peg1/Mest DMR. Amplification was successful in 36%
of individual oocytes (10/28) from spontaneously ovulating B6(CAST7p6) females, all of
which displayed 100% hypermethylation (Figure 5.2).
To investigate the effects of superovulation on the acquisition of genomic imprints
at the Peg1/Mest DMR, we analyzed oocytes from B6(CAST7p6)XB6 females
superovulated with either 6.25 IU or 10 IU hormone treatment. Following bisulfite
mutagenesis amplification was successful for 38% of 6.25 IU individual oocytes (17/45)
and 40% of 10 IU individual oocytes (20/50). Following exclusion of samples with
cumulus cell contamination (1/16 6.25 IU, 5/20 10 IU oocytes), all individual oocytes
from hormone-treated females showed 100% Peg1/Mest DMR hypermethylation (Figure
5.2). Thus, we conclude that superovulation does not alter acquisition of genomic
imprinting at the Peg1/Mest DMR, even at higher hormone treatment levels. In addition,
as both grandmaternal (CAST7p6) and grandpaternal (B6) alleles displayed similar
hypermethylation patterns, our results do not demonstrate differential allelic susceptibility
of maternal imprint acquisition to perturbations by superovulation, at this point of
analysis. Analysis of oocyte diameter and volume revealed no difference between
oocytes derived from spontaneously and superovulated females (data not shown).
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Figure 5.2. Methylation of Peg1/Mest in Oocytes
Methylation of the Peg1/Mest DMR in individual oocytes derived from spontaneously
ovulated

and superovulated

B6(CAST7p6)xB6 F1 females

(6.25

and

10

IU).

Unmethylated CpGs are represented as empty circles while methylated CpGs are depicted
as filled circles. Each line denotes an individual strand of DNA from a single oocyte.
Oocyte designations are indicated on the left of each DNA strand, allele is indicated on
the right of each strand (B-B6, C-CAST). All oocytes displayed 100% hypermethylation.
Hypermethylated DNA strands were those displaying >50% methylated CpGs.
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5.3.2 In Vivo Patterns of Imprinted Methylation at the Peg1/Mest DMR in
Blastocysts
Methylation patterns of in vivo-derived embryos have not been described at the
Peg1/Mest DMR in blastocyst stage embryos. As such, prior to our investigation of
superovulated or cultured embryos, we set out to determine the imprinted Peg1/Mest
DNA methylation pattern in in vivo-derived blastocyst stage embryos in our mouse
model. Using a modified bisulfite mutagenesis protocol to obtain information for
individual blastocysts (Chapter 4), we determined the Peg1/Mest imprinted methylation
patterns for 10 in vivo-derived B6(CAST7p6)xB6 embryos. We observed that 7 of the 10
embryos displayed high hypermethylations levels at the maternal Peg1/Mest DMR (E011
70%; E023 100%; E010 92%; E033 86%; E076%; E090%; E031 80%) while the
remaining three embryos displayed lower levels of hypermethylation (E018 30%; E020
40%; E014 67%) (Figure 5.3). Using data from these embryos, we set our threshold for
loss of methylation at 70% (74% average hypermethylation of the maternal allele),
similar to Snrpn (Chapter 2; Market-Velker et al., 2010a). In our previous analysis of
H19, Kcnq1ot1 and Peg3 methylation (Chapter 2; Market-Velker et al., 2010a), we
observed that 10-20% of in vivo-derived blastocysts exhibited a loss of imprinted
methylation (as evidenced by levels of methylation below our set thresholds). Notably
for Peg1/Mest, three embryos show this pattern of hypermethylation. As Peg1/Mest has
been reported to acquire methylation later in oocyte development, perhaps its methylation
is more labile.
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Figure 5.3: Methylation of the Peg1/Mest DMR B6
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blastocyst. Unmethylated CpGs are represented as empty circles while methylated CpGs
are depicted as filled circles. Each line denotes an individual strand of DNA, and each
group of strands denotes an individual blastocyst. Blastocyst designations are indicated at
the top left of each group, and % hypermethylation is indicated at the top center of each
group. Percentages were calculated as the number of hypermethylated DNA strands/total
number of DNA strands. Hypermethylated DNA strands were those displaying >50%
methylated CpGs.
212

95.6%
95.6%
95.6%
94.5%
95.6%
94.5%
98.9%
97.8%
96.7%
100%
97.5%
96.3%

5.3.3 Effects of Superovulation on Imprinted Methylation at the Peg1/Mest DMR in
Blastocysts
To determine the effects of superovulation on Peg1/Mest imprinted methylation in
embryos, we investigated methylation at the Peg1/Mest DMR in blastocysts from
superovulated females treated with either 6.25 IU (low dose) or 10 IU (high dose). In the
low dose hormone group, using 70% hypermethylation as our threshold, 5/9 embryos
displayed loss of methylation (E62 38%; E63 13%; E617 40%; E626 50%; E624 50%),
with a mean maternal hypermethylation level 56% (Figure 5.4). At the high hormone
dosage, loss of methylation was observed in 9/11 embryos (E102 33%; E1018 0%, E1031
63%; E1034 58%; E101 67%; E1033 70%; E1032 20%; E105 63%; E104 13%), with a
mean maternal hypermethylation level of 51% (Figure 5.5). Overall, an increase in the
number of embryos displaying loss of methylation was observed in the low hormone
treatment group compared to in vivo-derived controls, with a further increase observed in
the high hormone treatment group, which was statistically significant (p = 0.02). This is
consistent with the behaviour of other imprinted loci in response to superovulation
(Chapter 2; Market-Velker et al., 2010a).

5.3.4 Effects of Embryo Culture on Imprinted Methylation at the Peg1/Mest DMR in
Blastocysts
Embryo culture is another technique commonly used in the treatment of infertility.
To evaluate the effects of embryo culture on imprinted methylation at the Peg1/Mest
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DMR, we analyzed 23 individual embryos cultured from the 2-cell to the blastocyst stage
in Whitten’s medium (Figures 5.6-5.9). Embryos were separated based on rate of
preimplantation development, as described in Chapter 4. In the FF group 7/8 embryos
displayed loss of imprinting methylation (68%, 67%, 61%, 50%, 44%, 42%, 35%), 3/5 in
the FS group (70%, 56%, 38%), 5/6 in the SF group (64%, 57%, 50%, 50%, 33%) and 3/5
in the SS group (56%, 50%, 43%). The average hypermethylation in each group were as
follows: 56% FF, 63% FS, 55% SF, and 61% SS. Overall, the “Fast” group displayed loss
of methylation in 10/13 embryos, corresponding to an average hypermethylation of 58%,
and the “Slow” group displayed a loss of methylation in 8/11 embryos, also
corresponding to an average hypermethylation of 58%. Unlike our previous study
showing more severe loss of methylation in “Fast” developing embryos than the “Slow”
group at the H19 and Snrpn ICRs, no statistical difference was observed between the
embryo culture groups at the Peg1/Mest DMR. In addition, no difference was observed
when comparing embryos at the second separation (FF and SF vs FS and SS). Overall,
significantly more cultured embryos (18/24) displayed levels of imprinted methylation
below the 70% threshold (p = 0.02), compared to the in vivo group (3/10).

5.3.5 Effects of Superovulation and Embryo Culture on Peg1/Mest Imprinted
Expression
We also analyzed imprinted expression of Peg1/Mest in the same in vivo-derived
embryos used for methylation analysis, using our technique for combined imprinted
methylation and expression analysis in individual embryos (Market-Velker et al., 2010b).
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Peg1/Mest was expressed in 12 of 15 (80%) of in vivo-derived embryos, all of which
displayed monoallelic expression from the paternal B6 allele (Figure 5.10). Similar to in
vivo-derived embryos, both the 6.25 IU and 10 IU groups displayed paternal monoallelic
expression, with 20/21 embryos (95%) showing expression from each of the two groups
(Figure 5.10).
Imprinted expression of Peg1/Mest was evaluated in 14 FF, 8 FS, 9 SF and 8 SS
embryos. All embryos displayed paternal monoallelic expression with the exception of
the FF group; three embryos lacked any detectable Peg1/Mest expression (Figure 5.11).
Expression of Snrpn was also analyzed in all samples as a control for generation of the
cDNA library, and was monoallelically expressed in all samples. Thus, similar to
previous experiments with Snrpn and Peg3 (Mann et al., 2004; Market-Velker et al.,
2010b), no effect was observed on imprinted expression, even through alteration in
imprinted methylation were present in these same embryos.

5.4 Discussion
In this study, we present a comprehensive evaluation of the effects of
superovulation and in vitro culture on genomic imprinting at Peg1/Mest. Superovulation
resulted in disruption of imprinted methylation at the blastocyst stage, in a dosedependent manner, similar to other loci previously examined (Chapter 2; Market-Velker et
al., 2010a). Our analysis of individual oocytes provides evidence that this disruption was
not due to a failure of imprint acquisition during oogenesis, as superovulated oocytes
displayed methylation patterns identical to their in vivo-derived counterparts. With
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Embryo

respect to embryo culture, no difference was observed in Peg1/Mest imprinted
methylation between “Fast” and “Slow” embryos, while a significant loss of methylation
was observed when compared to in vivo-derived controls. This suggests that mechanisms
regulating maintenance of genomic imprinting during the early preimplantation stages at
the Peg1/Mest DMR were not affected by rates of embryo development.

5.4.1 Maintenance, Not Acquisition, is Affected by Superovulation

We have previously shown that, at the blastocyst stage, superovulation results in
loss of imprinted methylation on the repressed maternal allele of Snrpn, Peg3, and
Kcnq1ot1, and a gain of methylation on the active maternal H19 allele. Loss of
methylation on the paternal H19 allele was also observed, which first led us to speculate
that superovulation may disrupt maintenance of genomic imprinting, rather than, or in
addition to, acquisition. Here, we show that acquisition of genomic imprinting at the
Peg1/Mest locus was not affected by superovulation, consistent with another study
demonstrating normal imprinted methylation at the Peg1/Mest DMR in the oocyte
following superovulation (Sato et al., 2007). Furthermore, greater loss of methylation in
the high hormone group compared to the low dosage group indicates a dose-dependent
effect.
In a previous study, imprinted methylation at the Peg1/Mest DMR was
investigated in fully grown GV oocytes, freshly ovulated MII oocytes, and MII oocytes
cultured for either 8 or 24 hours (22 and 42 hours after hCG, respectively), all derived
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from superovulated females. Peg1/Mest methylation acquisition was completed in MII
oocytes following culture for 8 hrs (22 hours post-hCG), but not in earlier stages of
oocyte maturation, indicating that acquisition of methylation at this locus continued after
ovulation. Our oocytes were collected at approximately 22 hours post-hCG, and fully
hypermethylated alleles were observed in both spontaneously and induced ovulated
oocytes.
Two theories concerning the effects of superovulation on acquisition of genomic
imprints have been put forth. First, hormonal stimulation may lead to rapid oocyte
maturation, or it may induce ovulation of immature oocytes that have not completely
acquired their imprints (Paoloni-Giacobino and Chaillet, 2004; Ludwig et al., 2005). As
we observed no change in oocyte diameter or volume, nor a delay in imprint acquisition,
our data indicate that immature oocyte were not recovered in this analysis. Secondly,
ovarian stimulation may accelerate oocyte maturation (Baerwald et al., 2009), resulting in
an inability of the oocyte to synthesize and store high enough amounts of these maternal
factors. In this case, imprint acquisition would proceed normally but imprint maintenance
would be compromised during preimplantation development. Our results support the
latter hypothesis.
Studies of human oocytes have suggested that acquisition of imprinted
methylation is affected by superovulation, however in all of these studies, intrinsic
subfertility is a confounding factor. Loss of methylation at the Peg1/Mest locus was
observed in oocytes collected from infertile women undergoing hormonal stimulation,
however mouse oocytes from the same study in which intrinsic subfertility is not a
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confounding factor showed no loss of methylation (Sato et al., 2007). Subfertility in male
patients has also been associated with alteration at the Peg1/Mest locus. The Peg1/Mest
DMR is unmethylated from fetal spermatogonia to mature spermatozoa (Kerjean et al.,
2000). Hypermethylation of this region has been associated with idiopathic male
infertility as well as infertility due to low sperm counts (Poplinski et al., 2010).
Therefore, although mechanisms in the sperm and in the oocyte vary, alterations of
acquisition of genomic imprinting observed in human studies at the Peg1/Mest locus may
be a result of intrinsic subfertility of the patient, and not only a result of hormonal
stimulation.

5.4.2 In Vitro Culture, but not Rates of Early Development Affect Methylation of
Peg1/Mest

Embryo culture has been shown to cause perturbation of imprinted methylation
and expression of a number of imprinted genes (Doherty et al., 2000; Mann et al., 2004;
Rivera et al., 2008; Market-Velker et al., 2010b). Consistent with data from the previous
chapters, here we report loss of imprinted methylation at the Peg1/Mest DMR following
in vitro culture to the blastocyst stage in Whitten’s medium. This is in contrast to two
other studies which show no loss of methylation at the 2-cell or blastocyst stage following
in vitro culture in M16 medium (Imamura et al., 2005), or M16 medium supplemented
with serum (Khosla et al., 2001). However neither of these were performed allelically, or
on individual embryos.
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Moreover, we separated in vitro cultured embryos into groups based on their rates
of preimplantation development, as previously described in Chapter 4. Contrary to our
previous observations, where loss of methylation was more severe in the “Fast” group at
the H19 and Snrpn ICRs, loss of methylation at the Peg1/Mest DMR was not different
between “Fast” and “Slow” embryos. Therefore, unlike Snrpn and H19, methylation at
the Peg1/Mest DMR does not correlate with rates of early cleavage.
This difference could be due to a number of factors. First, the regions of H19 and
Snrpn analyzed in our previous study were known imprinting control regions (ICRs),
while the region of Peg1/Mest analyzed in this study consisted of 15 CpGs within the
known DMR. Until this DMR is investigated for its ability to regulate domain
imprinting, it is not certain whether this region represents the Peg1/Mest ICR. Once
identified, analysis of the Peg1/Mest ICR may show a similar association with rates of
embryo development as do Snrpn and H19.
Alternatively, many other groups have described a differential response of Peg1/
Mest to environmental insult when compared to other imprinted loci (Khosla et al., 2001;
Liang et al., 2008; Tveden-Nyborg et al., 2008; Anckaert et al., 2010), suggesting that
slightly different mechanisms regulate genomic imprinting at this locus. Different
mechanisms operating at these imprinted loci during early cleavage stages would explain
the altered susceptibility of Peg1/Mest to the differences between “Fast” and “Slow”
embryos at early stages of preimplantation development.
Furthermore, the Peg1/Mest locus was not protected from the detrimental effects
of long term in vitro culture. We observed a significant increase in the number of cultured
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embryos displaying loss of imprinted methylation when compared to in vivo-derived
controls. Due to the late acquisition of methylation in the oocyte, slow rates of
development may not confer the same advantage to oocytes’ ability to maintain levels of
methylation at the Peg1/Mest locus early in preimplantation development, as it had for
H19 and Snrpn. Thus, a persistent suboptimal culture environment, together with later
acquisition of Peg1/Mest methylation, would result in de-regulation of factors necessary
throughout subsequent cell cycles for maintenance of genomic imprinting.

5.4.4 Imprinted Expression of Peg1/Mest is Unaffected by Superovulation, and
Embryo Culture

In addition to imprinted methylation, we examined Peg1/Mest imprinted
expression in blastocysts derived from superovulated females, as well as those subjected
to in vitro culture. Neither procedure affected imprinted expression of Peg1/Mest.
Previous studies have shown disrupted imprinted expression of H19 following embryo
manipulation (Doherty et al., 2000; Mann et al., 2004; Market-Velker et al., 2010b),
however, no change in imprinted expression was observed for Snrpn, and Peg3 under the
same conditions at the blastocyst stage (Doherty et al., 2000; Market-Velker et al.,
2010b). Having said this, analysis of imprinted expression at post-implantation stages of
these same genes revealed biallelic expression, especially in extraembryonic tissues
(Mann et al., 2004; Rivera et al., 2008). Thus, we predict that Peg1/Mest will behave in a
similar manner with disruption of imprint methylation maintenance during
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preimplantation development resulting in dysregulation of imprinted expression in postimplantation tissues.
To date, many groups have attempted to characterize the changes in expression
(Wang et al., 2005; Zheng et al., 2005; Hamatani et al., 2006; Zheng et al., 2007;
Giritharan et al., 2010), and in localization of chromatin modifiers (Doherty et al., 2000;
Ooga et al., 2008; Kim and Ogura, 2009) throughout normal preimplantation
development, and in response to different ARTs. These studies, and others specifically
targeting known regulators of epigenetic phenomena will be invaluable in pinpointing the
specific factors involved in global maintenance of genomic imprinting during
preimplantation development. Our data suggest that investigation of epigenetic factors
that are produced as maternal effect products may hold the most promise for identifying
those factors involved in imprinted maintenance during preimplantation development.
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Chapter 6 - Discussion

Genomic imprinting is a complex process that depends on both the proper
acquisition and maintenance of imprinting marks throughout preimplantation
development, and adult life. Assisted reproductive technologies, namely superovulation
and embryo culture, take place during the critical periods of imprint acquisition and
maintenance, providing an window for deregulation of these processes.

To date, our

ability to investigate the effects of ARTs on embryos has been limited by our technical
abilities. To properly evaluate the effects at a level relevant to the human clinic studies
must be performed on individual embryos, to obtain information about the degree of
perturbation in each embryo, as well as the frequency of perturbation under each
environmental condition.

The methodology developed (outlined in Appendix 1)

represents a technical advancement in the field. Prior to the experiments in this thesis, the
effects of ARTs were known only for a select number of imprinted loci, from studies
using pools of embryos, and investigations of individual embryos at post-implantation
stages of development.

Here, I provide a comprehensive analysis of ART-induced

imprinting errors at the single embryo level, in preimplantation embryos. Experiments
investigate the effects of superovulation alone and of culture alone in various
commercially-available media, on both imprinted methylation and expression at key loci.
In addition, as this has not been previously investigated, I report the effects of embryo
culture on Peg3 and Kcnq1ot1 at the blastocyst stage, and comprehensive evaluation of
the response of the Peg1/Mest locus to ARTs.
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In addition, these studies aim to provide some insight into the mechanism of
imprinting dysregulation.

Much work remains to be done before distinct molecular

pathways are elucidated, however the work presented in this thesis narrows the search: (1)
both maternal and paternal imprints are disrupted by superovulation, indicating that
superovulation perturbs a maternal-effect gene product required for imprint maintenance
during preimplantation development; (2) multiple imprinted loci are affected in the same
embryo by ARTs, although the misregulated loci vary between embryos, indicating that
the response to adverse effects of ARTs is stochastic; (3) the use of multiple procedures
increases the number of affected embryos, suggesting that pathways disrupted by various
ARTs are the same, or converge at common point; and (4) faster developing embryos
exhibited a greater loss of imprinting, greater changes in metabolic activity and are least
similar to in vivo-derived controls, suggesting that higher metabolic levels and faster cell
cycle divisions represent maladaptations to the culture environment.

6.1 ARTs Affect Genomic Imprinting

6.1.1 Superovulation

The timing of superovulation coincides with the development of oocytes from MI
to arrested MII, when the acquisition of methylation imprints occurs. Due to this timing,
we and others have hypothesized that superovulation disrupts the acquisition of genomic
imprints. Therefore, any disruption in genomic imprinting that occurred as a result of
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superovulation would be evident at the MII stage, and after fertilization and
preimplantation development, would be present at blastocyst stage.

As well, only

maternal imprints should be affected, as the paternal imprint is acquired in developing
spermatocytes and would not be affected by hormonal treatment used for superovulation.
A number of hypotheses attempt to explain how superovulation disrupts imprint
acquisition.

The first suggests that superovulation rescues subordinate follicles that,

under normal circumstances, would undergo atresia and not develop into fully mature
oocytes (Van der Auwera and D'Hooghe, 2001).

Superovulated oocytes override the

atretic program, leading to ovulation of oocytes that have not properly acquired their
maternal imprints. Variations on this hypothesis state that superovulation simply results
in ovulation of immature oocytes that have not had enough time to acquire their genomic
imprints (Paoloni-Giacobino and Chaillet, 2004; Ludwig et al., 2005). In both of these
cases, superovulation does not affect epigenetic processes in the oocyte, it simply allows
continued development of oocytes with aberrant genomic imprinting, or accelerates
development preventing completion of acquisition prior to ovulation.

The second

hypothesis suggests that administration of exogenous hormones results in modulation of
molecular signaling pathways. These molecular pathways may result in misregulation of
genes important for acquisition of genomic imprinting (ex: DNMT and its binding
partners), perhaps disrupting the ability of the cell to target epigenetic machinery to
proper locations resulting in lack of de novo methylation at certain loci. This would result
in disruption of methylation acquisition at maternally methylated loci, and potentially, in
a gain of methylation of paternally methylated (maternally unmethylated) loci if
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mechanisms blocking methylation at a given locus were also disrupted. However, this
hypothesis does not provide an explanation for loss of methylation at paternally-inherited
loci, that acquire their methylation in male germ cells. The third hypothesis states that
superovulation accelerates the growth rate of ovarian follicles, allowing for normal
maternal imprint acquisition, but instead disrupts one or more maternal-effect genes or
gene products.

This maternal-effect gene would play a key role in maintenance of

genomic imprinting throughout preimplantation development. Experiments in this thesis
support the third hypothesis, as no change in Peg1/Mest imprint acquisition was observed
following superovulation. In addition, superovulation resulted in loss of methylation on
maternal alleles, gain of methylation on maternal alleles, and most importantly, loss of
methylation on paternal alleles, in blastocyst stage embryos.
Further evidence has begun to support the third hypothesis. Other groups have
reported no adverse effects of superovulation on maternal imprinted methylation in
oocytes; fully methylated alleles are noted at imprinted loci (Sato et al., 2007; Anckaert et
al., 2009).

Studies from our lab (by M. Denomme) confirm this; following

superovulation, fully methylated maternal alleles are observed in MII oocytes.
Therefore, I propose that superovulation acts to disrupt genomic imprinting
potentially through acceleration of ovarian follicle growth leading to disruption of one or
more maternal-effect genes or gene products. This accelerated growth may result in a
decrease in maternal mRNA stores, which are critical for maintenance of genomic
imprinting. A decrease in these stores would not affect acquisition of genomic imprinting,
as the molecular components necessary for this transient act of de novo methylation (and
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potentially histone modifications, etc...) would be synthesized prior to their function
during the arrested MI to MII period, and are not required to exhibit long-term activity.
However, the level of maternal mRNAs necessary for maintenance may fall below a
necessary threshold to maintain imprinting at certain loci.

As such, maintenance of

maternal methylation would be affected, causing levels of maternal methylation to
decline. In addition, mechanisms that protect paternally methylated loci from acquiring a
maternal profile would also be depleted, accounting for the gain of methylation that we
and others (Borghol et al., 2006; Sato et al., 2007) have observed following
superovulation. Finally, it would be expected that these same maternal mRNAs would be
required to maintain imprinted marks during the drastic epigenetic changes undergone by
the paternal genome following fertilization. As such, a deficiency in these factors may
result in disruption of paternal imprints during the active wave of demethylation after
fertilization, consistent with our report of loss of paternal methylation at the H19 allele in
blastocysts following superovulation. With the model outlined above, loss of methylation
on the maternal alleles of paternally expressed genes, gain of methylation on the paternal
alleles of maternally expressed genes, as well as loss of methylation on the paternal allele
of maternally expressed genes is expected, all of which I report in Chapters 2-5.

6.1.2 Embryo Culture

The second ART investigated was embryo culture. Depending on the protocol
employed, embryo culture takes place from the 1- or 2-cell stage, up to the 4- to 8-cell, or
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blastocyst stage.

Many studies have identified ARTs, of which embryo culture is an

integral component, as a means to disrupt genomic imprinting, however the majority of
studies did not evaluate embryo culture alone (Doherty et al., 2000; Khosla et al., 2001;
Mann et al., 2004; Li et al., 2005; Fauque et al., 2007). As such, separating out the effects
of each individual technique using these studies is nearly impossible. Our studies focused
on embryo culture alone, demonstrating a significant effect on genomic imprint
maintenance.
Comparisons of studies of embryo culture have proven difficult as type of culture
media, type of oil overlay, culture volume, oxygen tension, and associated ARTs, to name
only a few, vary between labs and clinics. In Chapter 3, I aimed to accurately compare
multiple embryo culture media currently used in the field and determine if one media was
superior to another with respect to the maintenance of genomic imprinting. Contrary to
my expectations, I did not observe drastic differences between media; all media were
suboptimal in their ability to maintain genomic imprinting. However, genomic imprinting
at certain loci was better maintained in some media than others. Overall more recently
developed media (ex: Global) appeared superior to the less optimized types (ex; HTF and
Whitten’s).

As well, the use of sequential media showed no advantage over non-

sequential media. These findings lead us to speculate that embryo culture, the act of
maintaining preimplantation embryos out of the female reproductive tract, is the most
significant factor. In addition, as all loci were affected by all media, I speculate that the
factor(s) that is affected by embryo culture is a universal one, and the mechanism
underlying the dysregulation is a global mechanism rather than a locus specific binding
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factor. Differences in embryo culture media are then due to the degree of perturbation of
these factors, and to the extent of compensatory mechanisms in each embryo.
One candidate through which global methylation may be affected is DNMT1.
Two isoforms of DMT1 have been described in preimplantation stage embryos, the
somatic form DNMT1s, and the oocyte-specific form DNMT1o (Ding and Chaillet,
2002). During preimplantation development, DNMT1s is localized predominantly to the
cytoplasm, (Carlson et al., 1992), while DNMT1o localizes to the nucleus at the 8-cell
stage (Ding and Chaillet, 2002). Disruptions in DNMT1 itself are unlikely, as a number
of imprinted genes in the embryo and placenta do not appear to require DNMT1 for
monoallelic expression (Li et al., 1993; Caspary et al., 1998; Lewis et al., 2004), those
that do vary in their response to reduced levels of DNMT1 (Weaver et al., 2010) and no
differences in DNMT1 localization or activity have been noted following embryo culture
(Doherty et al., 2000).
The passive demethylation of the maternal genome suggests that although
DNMT1 is present in the nucleus during preimplantation stages, its activity is tightly
regulated and targeted to DMRs.

Some studies have suggested that this targeting

mechanism may involve Zfp57, a DNA binding protein that recruits the histone methylase
complex SETDB1, which provides repressive histone marks (Ayyanathan et al., 2003), or
Stella, another similar histone modification targeting factor (Nakamura et al., 2007).
Histone methylation may provide binding sites for proteins such as HP1, which in turn
can recruit DNMTs (Lehnertz et al., 2003). Disruption in one or many of these targeting
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mechanisms, or their associated protein complexes, may be cause of the loss of
methylation that we and others have observed at the blastocyst stage.
Imprinted loci may not be the only regions disrupted by ARTs. Many studies have
shown global changes in epigenetic modifications following embryo culture. The effect
of assisted reproduction on DNA methylation was assessed at more than 700 genes in
placenta and cord blood from children of assisted and unassisted conceptions using a sitespecific CpG methylation assay (Katari et al., 2009).

A significant change in DNA

methylation was observed with lower mean methylation levels in the placenta, and higher
mean methylation levels in cord blood from children conceived in vitro when compared
to children conceived naturally, indicating the broad effects of ART on DNA methylation.
Global changes in genes involved in glucose metabolism, glucose transporters and insulin
signaling (Zheng et al., 2007), and changes in genes involved in DNA repair, and cell
cycle regulation (Zheng et al., 2005) have been shown following embryo culture, again
indicating that embryo culture has the potential to affect many different cellular systems.
In addition, we cannot rule out the possibility that mechanisms regulating
individual loci are also disrupted by ARTs. As different imprinted loci are regulated
through different mechanisms (Wan and Bartolomei, 2008; Koerner et al., 2009), with
different domain specific proteins involved in their acquisition and maintenance, it is
possible that a common factor involved in the regulation of some, but not all, imprinted
loci, is dysregulated by ARTs.
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6.1.3 Multiple ARTs

The effects of multiple ARTs is additive, resulting in more embryos with
disruptions at more imprinted loci. Examination of different loci did not reveal genespecific, nor ART type-specific effects, as one locus was not more likely to show loss of
methylation in one media type, or following one type of ART than another locus. This
suggests that superovulation and genomic imprinting affect the same epigenetic pathways,
or that their effects converge on a single pathway. While one technique may results in
some depletion or overexpression of important factors, the use of multiple ARTs
exacerbates this effect leading to more affected embryos.

My data indicates that

superovulation results in depletion of maternal mRNA used for maintenance of genomic
imprinting.

Embryo culture may result in perturbation of the same oocyte-specific

mRNA(s) if it persists through early cleavage division or the same gene(s) if is also
transcribed from the embryonic genome.

6.2 Stochastic Effects of ARTs

The first studies to identify perturbations of genomic imprinting were performed
on pools of embryos (Sasaki et al., 1995; Doherty et al., 2000). While these studies were
integral to uncovering the fact that in vitro culture caused dysregulation of genomic
imprinting, they were unable to provide specific information about the frequency and
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severity of this dysregulation. Development and utilization of single embryo protocols
(Appendix 1) was necessary to obtain this information.
One common finding from these experiments is the stochastic nature of imprint
disruption by superovulation and embryo culture. In the case of superovulation, some
embryos were severely affected at a given locus, showing very low levels of imprinted
methylation, while others showed no loss of methylation at that same locus with levels of
imprinted methylation comparable to in vivo-derived embryos.

In addition, embryos

displaying severe loss of imprinted methylation at one locus did not necessarily show loss
at other imprinted loci, and no consistent patterns emerged. This indicates that the effects
of superovulation are not locus specific, supporting the idea that more global epigenetic
mechanisms are disrupted.
In the case of embryo culture, the same phenomenon was observed.

Loss of

methylation was observed in some, but not all embryos, and at some, but not all loci. In
those embryos that remained unaffected at all the loci examined, further analysis of
additional imprinted loci would likely reveal that genomic imprinting is affected in every
embryo, while the extent of the disruption varies with different embryo manipulations.
The question then becomes what differentiates those embryos that better maintain
genomic imprinting from those that do not.
To shed light on this phenomenon, I investigated the relationship between rates of
preimplantation development and genomic imprinting.

We attempted to determine if

there were non-invasive characteristics that would lead us to predict which embryos
would be more severely affected by embryo culture, and which were more similar to in
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vivo-derived control embryos. This question has significant importance to the selection of
embryos for transfer in the human clinic. Often a number of oocytes are fertilized and
become viable embryos, but how to choose the best embryo(s) to transfer to the patient is
often unclear.

Morphological staging and assessment are commonly used, with fast

development most often equated with the healthiest embryos (Claman et al., 1987;
Shoukir et al., 1997; Van Montfoort et al., 2004; Windt et al., 2004; Biezinova et al.,
2006). Here, I argue against the use of the fastest developing embryos, supporting other
studies in humans suggesting that a slow to moderate rate of development (neither too
slow, nor too fast) is a marker of embryo health (Cummins et al., 1986; Alikani et al.,
2000; Weitzman et al., 2010).

6.3 The Mouse Model and Application to the Human Clinic

There are many barriers to a thorough evaluation of ARTs, including the ethical
dilemma of using human embryos and the difficulties with long term follow up, to name a
few. As such, our studies were carried out using the mouse model system, as the
protocols employed for superovulation and embryo retrieval are simple, standardized
procedures. In addition, the mouse embryo has been historically used to optimize culture
conditions for the human embryo and is still used as a quality control assay for every
batch of embryo culture media. The mouse is still advocated as the model system of
choice for studies of early embryo development and its molecular regulation (Quinn and
Horstman, 1998; Summers and Biggers, 2003). Studies using the mouse model have been
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integral in the development and refinement of various ARTs, and in the future, thorough
evaluation of new techniques in animal model systems such as the mouse should be
undertaken prior to widespread acceptance and use of these new techniques in humans.
While the immediate applicability of these studies to the human clinic may be
debated, from the data presented in this thesis I am able to make a number of general
recommendations with respect to the manipulation of preimplantation stage embryos.
First, the number and prolonged use of ARTs should be minimized, as I have shown that
the effects of multiple ARTs are additive. Avoidance of superovulation through single
embryo transfer techniques is one way to minimize ARTs that can be put into practice
immediately. Secondly, if multiple embryos are available for transfer, those displaying
moderate rates of development should be chosen over those with very fast, or very slow
rates of development. Third, as we showed no advantage of sequential media over nonsequential medium with respect to genomic imprinting, my data advocate the use of nonsequential media to avoid additional embryo manipulation occurring with transfer of
embryos to different culture drops. Fourth, all embryos are affected by manipulation
during ARTs, however some are affected more than others. Patients undergoing ART
should be made aware of this fact, and more patient education outlining the risks of ART
should be instituted. Most importantly, findings from these and other studies indicate that
it is possible to generate blastocysts that appear morphologically normal, but are in reality
severely epigenetically compromised.
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6.4 Future Directions
From these and other studies, it is evident that ARTs, in their many forms, perturb
genomic imprinting at multiple loci. The next step is to determine ways to prevent these
perturbations from occurring, or develop ways to correct them. These objectives can only
be carried out once the mechanisms responsible for imprinting acquisition and
maintenance are known, and how the environmental insult of ARTs affects these
mechanisms.

Therefore, future studies in the field should focus on elucidating these

pathways, and developing non-invasive ways to detect these mal-adaptations to
environmental insult.

In addition, studies should focus on moving the knowledge

obtained from animal studies to the human clinic.

6.4.1 Superovulation

To confirm the hypothesis of disruption of the maintenance of genomic
imprinting, imprinted methylation at multiple loci (those that acquire methylation early as
well as those that acquire it later on in oocyte development) in individual embryos
throughout the various stages of preimplantation development is required. These studies
will determine when loss of methylation occurs, and if the loss is progressive over the
entire course of preimplantation development. Pinpointing the stage of preimplantation
development at which methylation imprints are lost will provide important insight into the
mechanism of this disruption.
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Essential to future studies will be the identification of the maternal-effect gene(s)
disrupted by superovulation. Maternal-effect genes are transcribed and accumulate in the
growing oocyte (Schultz, 1993), and are necessary for the early stages of preimplantation
development prior to embryonic genome activation (Flach et al., 1982; Conover et al.,
1991; Bellier et al., 1997).

A maternal effect on early development has been well

described in Xenopus (Droin, 1992) and Drosophila (Akam, 1987; Morisato and
Anderson, 1995) and many maternal-effect genes have also been identified in the mouse,
including Mater (Tong et al., 2000; Tong et al., 2002), Zar1 (Wu et al., 2003), Hsf1
(Christians et al., 2000), Gdf9 (Dong et al., 1996), Ces5 (Tashiro et al., 2010) Filia
(Zheng and Dean, 2009) and Stella (Payer et al., 2003).
The maternal-effect gene(s) involved in the effects of superovulation should
exhibit a number of characteristics. First, as with other maternal-effect genes, it should be
transcribed and stored in the developing oocyte. Mutation or deletion may or may not
lead to arrest prior to embryonic genome activation, as uniparental embryos (parthenotes,
androgenotes, gynogenotes), which lack a parental genome complement, are able to
develop past the 2-cell stage (Markert, 1982; McGrath and Solter, 1984; Surani et al.,
1984).

This gene should have a known role in epigenetic regulation, and levels,

localization or post-translational modification of this gene product should be altered by
superovulation.
Therefore, to identify our maternal-effect gene(s), first, a list of genes expressed
and stored in the developing oocyte is needed.

From this list, genes involved in

epigenetic regulation should be identified, generating an list of epigenetic-specific
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maternal-effect genes.

Final candidates would be those genes displaying differential

expression, localization or post-translational modification between spontaneous and
superovulated oocytes. Attractive candidates are maternal-effect genes whose functions
in epigenetic regulation are well known such as Stella (Nakamura et al., 2007), and Zpf57
(Li et al., 2008), indicated above as potential targeting mechanisms for DNMT1 in
preimplantation embryos (Ayyanathan et al., 2003) (Nakamura et al., 2007).
Investigation of global levels of transcription in oocytes and preimplantation
embryos has been performed, and a subset of genes have been identified that demonstrate
distinct expression patterns (Hamatani et al., 2004; Wang et al., 2004; Zeng et al., 2004;
Hamatani et al., 2006).

Following embryonic genome activation, maternal mRNAs

expressed in the oocyte may either persist with no reactivation from the embryonic
genome, or be degraded. Those that show degradation of maternal mRNA may (1) be
reactivated in the embryonic genome, or (2) maternal transcripts may be degraded
without reactivation. Genes transcribed in the oocyte may also (3) be degraded early in
development but be reactivated later, creating a window where no gene product is present
in the early embryo. As I hypothesize that the maternal-effect gene(s) of interest is likely
involved in the maintenance of genomic imprinting throughout preimplantation
development, it is likely that it would be present in the oocyte and in the preimplantation
embryo. Arguments can be made as to whether expression originates from the oocyte,
and maternal mRNAs persist throughout preimplantaion development, or whether
maternal mRNAs are degraded and reactivated from the embryonic genome. Both are
plausible explanations, however as both superovulation and embryo culture appear to

248

affect the same pathway, I hypothesize the the gene(s) of interest do display degradation
of maternal mRNA and reactivation from the embryonic genome, and therefore follow the
first pattern of expression.

In the study by Hamatani et al, genes demonstrating

degradation followed by an early pattern of reactivation of expression include Oct4, Ecadherin, Dnmt1, Dnmt2, Dnmt3b, Lefty2, Spp1, Mecp2, Cbx1, Morf4l1, Tex20, Fragilis,
Pelo and Sfrs3 (Hamatani et al., 2004). Many of these genes, including Dnmt1, Dnmt2,
Dnmt3b, Mecp2, Morf4l1, and Cbx1 are known to be involved in epigenetic regulation
(Aagaard et al., 1999; Nakao et al., 2001; Pardo et al., 2002; Turek-Plewa and
Jagodzinski, 2005), and therefore satisfy two of the three criteria of our maternal-effect
gene, as outlined above. Demonstration of differences in the levels, localization or posttranslational modifications of these gene products in spontaneous and superovulated
embryos would fulfill the additional criterion.
Alternatively, the reverse approach could be taken, using genome-wide
comparison of expression between spontaneous and superovulated oocytes. Candidates
could then be narrowed by identifying genes involved in epigenetic regulation, and
determining the pattern of expression following fertilization. Once a candidate list was
assembled, involvement could be confirmed by analyzing their expression, localization
and post-translational modifications in spontaneous and superovulated oocytes. Levels
more similar to spontaneously ovulated oocytes and embryos would be expected in
superovulated oocytes and embryos with preserved imprinted methylation, while aberrant
levels would be expected those that had lost imprinted methylation.
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Once the maternal-effect gene products disrupted by superovulation have been
identified, the next step will be to determine non-invasive ways to determine which
oocytes display improper expression, activity or localization of these products, and
exclude the oocytes from use in the human clinic. One possible technique is through
sampling of the polar body, provided that this does not have any negative developmental
consequences for the oocyte. Alternatively, indirect methods of evaluating the status of
the maternal effects genes may prove useful, such as measurements of by-products of the
pathway involving the maternal-effects gene in the medium used to culture oocytes prior
to fertilization.

6.4.2 Embryo Culture

While we hypothesize that maternal-effects gene products are affected by ARTs,
further investigation of how embryo culture disrupts genomic imprinting should also
focus on how overall epigenetic mechanisms like DNA methylation and histone
modifications, which are the marks of genomic imprinting, may be disrupted by the
culture environment. For example, S-adenosyl methionine (SAM) is widely known as the
universal methyl donor, responsible for donating methyl groups for use in DNA
methylation, histone methylation, and a number of other important cellular processes
(Loenen, 2006). A complex pathway results in breakdown and regeneration of SAM,
involving important molecules such as methionine, glutathione, homocysteine and folate
(Chiang et al., 1996).

Altered concentrations of these components and/or altered
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expression of enzymes responsible for their synthesis and degradation may underlie the
epigenetic defects during embryo culture (Steele et al., 2005).

Investigation of these

pathways should also be undertaken in cultured and in vivo-derived embryos.
In addition, continued identification of epigenetic mechanisms, both general and
specific to each imprinted loci will provide invaluable information.

With respect to

specific pathways, studies such as those being conducted in our lab by Lauren Magri
focus on determining the different epigenetic mechanisms at work in embryonic versus
extraembryonic tissues using siRNA based screening. Differential effects of ARTs on TE
and ICM cells has been observed as evidenced by loss of methylation in extraembryonic,
but not embryonic tissues at E9.5 (Mann et al., 2004). An understanding of the different
regulatory molecules controlling imprint maintenance in these various cell lineages will
provide additional insight into the identity of the maternal-effects gene(s) disrupted by
ARTs and their downstream effectors.

Additional investigations into the specific

regulatory molecules at each imprinted domain are also needed. A number of imprinted
loci are regulated in part by DNA binding proteins such as CTCF or YY1 (Kim et al.,
2007; Kim and Kim, 2008; Li et al., 2008; Kim et al., 2009; Nativio et al., 2009).
Identification of genes and proteins such as these, necessary for imprint maintenance
across multiple imprinted domains provide additional candidates for the maternal-effects
gene(s).

Knowledge of these specific mechanisms will facilitate the development of

targeted therapies aimed at correcting those pathways disrupted by ARTs.
With respect to rates of embryo development and metabolism, the quiet embryo
hypothesis states that embryos with the greatest developmental potential exhibit a lower
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level of metabolic activity (Leese, 2002). A more thorough investigation of the metabolic
differences between embryos that maintain genomic imprinting and those that do not
should be undertaken.

Studies evaluating the quiet embryo hypothesis employed a

technique for profiling metabolic byproducts such as amino acids, pyruvate, and glucose,
and correlated this with embryo viability. Similar studies correlating profiles of the above
metabolic products with genomic imprinting will help to further clarify the relationship
reported in these studies.

6.4.3 Application to the Human Clinic

Strict guidelines for clinical trials, elucidating side effects, toxicity levels and
safety in specific patient populations have been put in place for the development of
medications and medical techniques used to treat human disease, however a rigorous
examination of techniques used in the treatment of infertility is lacking. As different
human clinics employ a wide variety of treatment programs including the number and
dosage of FSH injections, gonadotropin receptor hormone agonists or antagonists, and the
conditions used for oocyte and embryo culture and in vitro fertilization, standardized
comparisons between centers and in turn large-scale trials remain difficult. Significant
advancements in the field leading to increase safety and efficacy of ARTs will need to
come from studies of human embryos. While prospective studies are likely not morally
defensible, or practically possible, more detailed record-keeping of protocols employed
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during fertility treatments will facilitate retrospective studies which have already, and will
continue to provide invaluable information.
Advanced maternal age and intrinsic subfertility of the couples must be taken into
consideration when evaluating fertility treatment outcomes, including detailed analysis of
maternal and paternal epigenomes to clarify the role of subfertility in adverse events
following ARTs. Male infertility has begun to emerge as an important factor with respect
to epigenetic abnormalities following ART. Loss of imprinting at certain key loci was
observed more frequently in men with oligozoospermia than in those with normal semen
(Marques et al., 2004), and for some embryos, displaying aberrant genomic imprinting
following embryo culture, aberrant methylation was present in sperm prior to
manipulation in culture (Kobayashi et al., 2009). Moreover, detailed follow up of the
health of children born through ARTs is necessary moving forward. This will become
especially crucial in the upcoming decades, as the first wave of ART-born children
become older and into the age where conditions such as heart disease, diabetes and cancer
begin to emerge.
Since loss of genomic imprinting following embryo culture is stochastic, but not
random, and distinct groups of embryos are more likely than others to show severe
imprinting defects, further investigations should focus on determining additional noninvasive characteristics that correlate with the epigenetic health of the preimplantation
embryo. Correlation of other characteristics routinely evaluated in the embryo such as
degree of fragmentation and blastomere size (Graham et al., 2000; Scott et al., 2000;
Nagy et al., 2003; Borini et al., 2005) with genomic imprinting in cleavage stage embryos
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and blastocysts may reveal additional ways to identify embryos with preserved genomic
imprints.
Lastly, in the human clinic, the measure of a successful ART cycle is a clinical
pregnancy, and correlation of imprinting status with implantation and pregnancy rates has
not been done. Studies such as these are necessary to solidify the importance of the
epigenetic status of the embryo with respect to clinical practice.

6.5 Conclusions

Assisted reproductive technologies are important medical treatments that have
enabled previously infertile couples to achieve successful pregnancies, and produce
biological children.

However, while these techniques are, on the whole, very safe

procedures, it is important to realize that the manipulation of gametes and embryos is not
without risks and potential consequences. Some of the consequences identified to date
include an increased incidence of imprinting disorders, along with low birth weight and
prematurity, and the long term effects on adult health have yet to be fully determined.
The studies presented in this thesis further elucidate the effects of two of the most
common ARTs, superovulation and embryo culture, on genomic imprinting. We have
determined that superovulation alone can have a significant impact on genomic
imprinting at multiple loci, and that this effect worsens with increased dose of hormones.
We have also demonstrated that embryo culture, in media used today in the human clinic,
results in disruption of genomic imprinting at multiple loci. We also show that the effects
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of superovulation and genomic imprinting are additive; a greater number of embryos and
imprinted loci are affected following multiple ARTs than with the use of a single
intervention, suggesting that both techniques disrupt the same overall mechanisms.
Lastly, we show that embryos displaying moderate rates of development are most similar
to in vivo-derived embryos, a finding that supports the quiet embryo hypothesis (Leese,
2002), and that will hopefully prompt further exploration into correlation of non-invasive
parameters with the epigenetic health of embryos in the human clinic. It will be up to
those pursuing further research in this field to elucidate the mechanisms by which
environmental insult affects the epigenetic health of the embryo, to determine accurate,
repeatable and non-invasive techniques to detect these compromised embryos, and to
continue to improve our current techniques to minimize the amount of adaptation that
embryos will require to survive and grow outside the female reproductive tract. The
ultimate goal of these studies is a decreased incidence of disease and improved long-term
health of children born following ARTs.
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Appendices
Appendix 1: Single Embryo Methodology

Limitations of the blastocyst
The analysis of the imprinted methylation status of individual blastocysts has proved
challenging due to the very small amounts of DNA present.

Mouse blastocysts on

average contain 64 cells but we have found that this can range from 20-120 cells, Each
cell contains approximately 6 pg of genomic DNA. Each blastocyst will therefore contain
120-720 pg of genomic DNA. This amount of DNA is a barrier to DNA isolation and
PCR amplification. Furthermore for methylation analyses, bisulfite treatment of genomic
DNA is a relatively harsh technique, during which DNA degradation will occur. To get an
accurate picture of the methylation status of an imprinting center, information from
approximately 10 different alleles of both the maternal and paternal alleles is necessary.
Thus, methodology for the analysis of DNA methylation in blastocyst-stage embryos
must overcome all of these challenges. Simply stated, it must protect the DNA from
degradation, efficiently isolate DNA, and amplify the small amount of DNA remaining to
a detectable level while still maintaining enough variation to recover the necessary
number of maternal and paternal DNA strands. On top of this, our goal is to recover both
DNA and RNA from individual blastocysts to determine both imprinted methylation and
expression status in the same embryo.
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Bisulfite Conversion
The first step in the development of the technique was to optimize the bisulfite
conversion i.e. to ensure complete conversion of unmethylated cytosines (>85%) while
maintaining the integrity and quantity of DNA. We first employed a pre-released bisulfite
conversion kit, the EZ-DNA Methylation Kit (Zymo Research), asserting to be the most
sensitive bisulfite kit.

Multiple conversion times and temperatures were tested, and

optimized parameters were found to be 50°C and 3.5 hours, respectively.

While

amplification from all four genes using a nested PCR strategy was possible with this kit, it
was inconsistent. We concluded that this kit resulted in insufficient recovery of DNA to
consistently recover PCR products for multiple genes. Our next attempt used a modified
technique in which DNA was treated with sodium bisulfite while embedded in an agarose
bead in an effort to protect the DNA from degradation. DNA was then isolated from the
agarose bead using the Qiagen gel extraction buffer (Buffer QG, Qiagen) followed by
DNA isolation using the columns provided in the EZ-DNA methylation kit. Nested PCR
was performed after bisulfite treatment using this method and it was determined that
amplification of PCR product from all four genes was repeatable, although too little
DNA was recovered to allow for amplification of multiple alleles of each imprinting
center. Furthermore, an insufficient number of clones were obtained for each imprinting
center
While working on a separate project that used the Methyl Detector Kit (Active
Motif) for large cell numbers, I performed multiple elutions as less than the expected
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amount of DNA was recovered. I determined that large amounts of DNA remained in the
column after the first, second and even the third DNA elution.

This prompted us to

consider that DNA recovery from the EZ-DNA columns was suboptimal. A new protocol
was developed in which following bisulfite conversion in the agarose bead, the bead itself
was split and added to individual PCR reactions for each gene. We determined via PCR
followed by allele- and methylation-specific restriction digest, that this method allowed
for sufficient DNA recovery for both parental alleles of all imprinting centers of interest
to be PCR amplified and a sufficient number of clones to be obtained for sequence
analysis.

PCR Optimization
Typically following bisulfite mutagenesis, a nested PCR is performed to enrich the
region of interest and allow for amplification of many DNA strands of each imprinting
center. In the first round, primers are specific for a larger area encompassing a region
within the imprinting center of interest. In the second round, primers are designed within
the enriched sequence to generate a smaller final PCR product.

As a diagnostic,

following the nested PCR, samples are digested using restriction enzymes that cut the
methylated allele but not the unmethylated allele to ensure enough variability in the
amplified sequences.

It was found that using the agarose bead method followed by

column DNA extraction, PCR bias was observed for all genes tested; either the majority
of alleles obtained were methylated or unmethylated. Subsequent PCR optimization was
performed.

Parameters that were changed include: multiplex or individual PCR,
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annealing time, annealing temperatures, extension time, extension temperatures, number
of cycles, volume and type of elution buffer used in EZ-DNA column, volume of starting
material added to PCR reactions, primer concentrations, MgCl2 concentrations, presence
or absence of DMSO, and total PCR reaction volume.

Multiple gradient PCRs were

performed for individual genes as well as various combinations of multiplexed genes.
The optimal state of each of the above parameters was obtained. Optimization of the
nested PCR in combination with the agarose bead bisulfite conversion method produced a
sufficient numbers of clones for sequencing.

Crossover Events
Crossover events are thought to occur during PCR amplification when there is a
high concentration of very similar sequences, and the annealing temperature of the PCR
reaction is such that these similar sequence can bind to one another. After receiving
sequence data for the agarose bead protocol alone, multiple crossover events were
observed in Snrpn, H19 and Peg3. To alleviate this problem, annealing temperatures were
increased for first round PCR to increase stringency and prevent binding of similar
sequences. Increasing the annealing temperature of the first round PCR of Snrpn, H19
and Peg3 resulted in decreased crossover events and successful recovery of sufficient
numbers of sequences.

Cloning of PCR Products
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Once DNA is isolated and PCR amplified, we initially employed a clean-up step
prior to cloning. Following second round PCR, gel extraction of the desired bands was
performed using the Qiagen Gel Extraction Kit (Qiagen), then the extracted DNA was
TA-cloned.

Our subsequent analysis determined that gel extraction decreased the

variability of DNA strands recovered and introduced a bias towards the unmethylated
alleles. To resolve this issue, amplified DNA was cloned directly from the 2nd round PCR
product.
One problem arising from the direct cloning of PCR products was a decrease in the
number of correct inserts recovered. This is due to primer-dimer and non-specific
amplicon insertion.

To reduce the number of unnecessary miniplasmid preparations

(minipreps), a strategy for screening colonies was developed. Individual colonies were
picked, quickly dipped into the PCR reaction, and put into tubes containing LB/AMP to
grow up overnight. M13 forward and reverse primers that flank the insertion site were
used to amplify the cloned insert then agarose gel analysis was used to assess the size of
the inserted DNA. Those colonies that did not contain the appropriate size insert were
discarded while minipreps were performed for colonies with the appropriately sized
insert. This strategy worked well for all genes except Snrpn, whose recovery of correct
amplicon sizes decreased to <30% due to the lack of gel extraction of DNA. In lieu of
column purification, PCR reactions were electrophoresed on an agarose gel, and thin
bands containing the amplicon of interest were excised. Gel fragments were incubated
overnight in TE to allow DNA to diffuse from the gel. The DNA solution was then used
directly for ligation and subsequent transformation. Nearly all clones obtained through
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this method contained the appropriate sized insert.
To develop a more high-throughput protocol, we bypassed the minipreps, and
amplicons obtained from bacterial colonies using M13 primers were sent directly to be
sequenced. No cross contamination, and good chromatogram results were observed. Thus
this method is an equally accurate way to obtain sequence information from individual
colonies. Minipreps are no longer performed before clones were sent for sequencing.
Instead following nested PCR and gel electrophoresis, DNA isolated via gel diffusion was
ligated and transformed, bacterial colonies were picked directly into a PCR reaction
containing M13 primers, then the resulting amplicon was sent directly for sequencing.

Analysis of Methylation and Allele-Specific Expression
After it was found that enough clones of both methylated and unmethylated alleles
from all 4 genes could be obtained from individual blastocysts, we developed a protocol
to analyze both expression and methylation from individual blastocysts. The protocol
previously developed isolated RNA and produced a reusable cDNA-Dynabead library
(Dynal Biotech). To combine the protocols for DNA isolation/bisulfite conversion and
RNA isolation/cDNA-Dynabead library synthesis, I made the following modifications.
Individual blastocysts were lysed in Dynabead lysis buffer using a decreased volume of
lysis buffer, an increased time for lysis and annealing of RNA to Dynabeads, and
modified the lysis procedure by combining vortexing and mixing followed by gentle
centrifugation of samples. Lastly, since the Dynal lysis buffer does not completely and
consistently break open the nuclear membrane, after lysis and annealing of RNA to
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Dynabeads as described above, supernatant containing cell debris and nuclei were
removed to a new tube.

To liberated genomic DNA, Protease K and NP40 (final

concentration of 0.1%) were added and the samples were incubated for 1 hour at 50°C.
Bisulfite conversion and cDNA-Dynabead library synthesis were unchanged for the rest
of the protocol.

I have determined that there was no difference in data obtained for

imprinted methylation and expression using this new protocol versus either protocol
alone.

This protocol was employed for embryo analysis in Chapter 2-5. The final protocol with
notes can be found below.

Full Protocol: Single Embryo Analysis of Methylation and Expression
(A) Pre-Wash Dynabeads
1. Vortex Dynabeads on medium speed to re-suspend. Change gloves.
2. Label one 0.2 mL thin walled PCR tube per sample plus an additional tube for a
negative control.
3. Transfer 10 µl of Dynabeads to each 0.2 mL thin walled PCR tube.
4. Place into Magnetic Particle Concentrator (MPC). Remove supernatant.
5. Add 100 µl Dynabead Lysis Buffer to each sample.
6. Vortex on low for 5-10 seconds, place on MPC, then remove buffer. Repeat.

(B) Embryo Lysis
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1. Retrieve individually frozen embryos from storage at -80oC (see Note 2).
2. Centrifuge briefly to ensure embryo is at bottom of tube (~5 seconds at
10,000-13,000 rpm).
3. Add 10 µl of Dynabead lysis buffer to each sample.
4. Prior to adding embryo, place in MPC and remove lysis buffer from pre-washed
Dynabeads from Step 6 above.
5. Transfer entire contents of lysed embryo sample from Step 3 to pre-washed
Dynabeads.
6. Mix gently by flicking, then centrifuge briefly at 4000 rpm.
7. Incubate with slow agitation on vortex for 5-10 min at room temperature to allow
for hybridization of mRNA to Dynabead.
8. Centrifuge briefly at 4000 rpm.
9. Place mRNA-Dynabead tube in MPC. Remove supernatant containing DNA to
original embryo tubes, taking care not to remove any mRNA-Dynabeads.
10. Add 200 µL of Dynabead Wash Buffer A to mRNA-Dynabeads. Place in MPC and
set aside until 3.3 RNA isolation.
11. Centrifuge tubes containing DNA/supernatant for 5-10 seconds at 13,000 rpm to
remove bubbles.
12. Add 1 µl Protease K (Sigma, Oakville, Canada) and 1 µl of 10% Igepal (see Note
3) to each DNA/supernatant tube.
13. Centrifuge briefly at 13,000 rpm to remove any bubbles.
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14. Add 300 µl of DNAse-, RNAse- and protease-free mineral oil (Sigma, Oakville,
Canada) to each tube (see Note 4).
15. Lyse embryo by incubating for 1 hour in waterbath at 50oC.

(C) RNA Isolation
1. Retrieve mRNA-Dynabead tube containing 200 µL of Wash Buffer A.
2. Vortex on low speed for approximately 5 seconds. Centrifuge briefly. Place in
MPC, then remove Wash.
3. Repeat washing step with Wash Buffer A once, and Wash Buffer B three times.

(D) Reverse Transcription and Generation of a Solid-Phase cDNA Library (see Note 5)
1. Prepare reverse transcription by mixing 2 µl 5x First Strand Buffer, 1 µl 0.1M
DTT, 0.5 µl 10 mM dNTP, 0.5 µl 40 units/µl RNaseOut (Invitrogen, Burlington,
Canada), 0.25 µl Superscript II (Invitrogen, Burlington, Canada), 5.75 µl H2O, for
a 10 µl reaction.
2. Remove all of Wash Buffer B from mRNA-Dynabead tube.
3. Add 10 µl of RT mix to each sample.
4. Mix gently by flicking.
5. Centrifuge briefly. Repeat mixing and spin.
6. Incubate for 1-2 hours at 42oC rotating in hybridization oven.

(E) Agarose Bead Embedding of DNA
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1. Remove Protease K-treated DNA tubes from waterbath. Place in heating block at
> 95oC.
2. Add 24 µl 2% LMP agarose (pre-warmed at >95oC) under mineral oil.
3. Mix gently by pipetting. Ensure the bead is well mixed.
4. Incubate for 3 minutes > 95oC to inactivate the Protease K.
5. Incubate for 10 minutes on ice to allow agarose bead to harden.

(F) Denaturation of DNA
1. Remove oil from chilled, hardened agarose bead.
2. Add 1 mL 0.1 M NaOH to each tube. Invert 5-6 times (see Note 6).
3. Incubate for 15 minutes at 37oC in a waterbath, inverting every 3-4 min.

(G) Bisulfite Treatment of DNA
1. Spin gently (< 4000 rpm) (see Note 7).
2. Remove NaOH solution.
3. Add 500 µl of Bisulfite Solution.
4. Add 300 µl of mineral oil. Ensure that agarose bead is floating in solution (see
Note 8).
5. Incubate at 50oC in a waterbath for 3.5 hours (see Note 1).

(H) Clean-up of cDNA-Dynabead Library
1. Remove cDNA-Dynabead samples from hybridization oven.

271

2. Centrifuge briefly then place in MPC.
3. Remove all RT mix.
4. Add 10 µl of ITT Buffer, flick gently to mix, centrifuge briefly, place in MPC,
remove ITT Buffer. Repeat.
5. Add 10 µl of ITT Buffer, flick gently to mix, centrifuge briefly.
6. Incubate 1 minute at 95oC in block of pre-warmed PCR machine.
7. Working with one sample at a time, centrifuge briefly, place in MPC, remove ITT
buffer.
8. Add 100 µl of ITT Buffer, flick gently to mix, centrifuge briefly, place in MPC,
remove ITT Buffer. Repeat.
9. Store cDNA-Dynabead Library at 4oC (see Note 9)

(I) Second strand synthesis
1.

Remove cDNA-Dynabead library from storage at 4oC, add 100 µl of ITT Buffer,
flick gently to mix, centrifuge briefly, place in MPC, remove ITT Buffer. Repeat.

2. Prepare separate forward and reverse reactions according to protocols for your
gene of interest.
3. Place cDNA-Dynabead library in MPC, remove ITT buffer (make sure all of
liquid is removed).
4. Add forward reaction, flick gently to mix.
5. Place reaction in PCR machine, run PCR program for one cycle, according to your
gene of interest.
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6. Remove samples one at a time, spin down quickly in benchtop centrifuge, place in
MPC and remove all of 2nd strand product to new tube.
7. Transfer an equivalent amount of forward-2nd strand mix to tubes containing prealiquoted reverse Mix.
8. Run PCR as per your gene of interest.
9. Rehydrate cDNA-Dynabead library by adding 100 µl of ITT Buffer, flick gently to
mix, centrifuge briefly, place in MPC, remove ITT Buffer. Repeat.
10. Store cDNA-Dynabead Library at 4oC (see Note 10).

(J) Desulfonation of Bisulfite Treated DNA
1. Remove DNA-agarose tubes from 50oC waterbath.
2. Incubate on ice for 3 minutes.
3. Remove Bisulfite solution and mineral oil.
4. Centrifuge briefly (<4000 rpm).
5. Add 1 mL of TE, invert 1-2 times, centrifuge briefly then remove TE.
6. Add 1 mL 0.3 M NaOH, flick gently to mix, invert 5-6 times.
7. Incubate at 37oC in a waterbath for 15 minutes, inverting every 3-4 minutes.
8. Centrifuge briefly (<4000 rpm).

(K) Washing of Desulfonated DNA
1. Remove NaOH.
2. Add 1 mL of TE.
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3. Incubate for 5-10 minutes at room temperature with shaking.
4. Spin gently, remove TE, repeat wash once more with TE.
5. Repeat wash twice more with H2O.
6. Check pH of washes. The last H2O wash should have approximate pH 5.

If

solution is more basic, perform two addition washes with H2O.
7. Samples are now ready for amplification of gene(s) of interest with bisulfitespecific primers (see Note 11).

Notes
1. BS is light sensitive. Cover Bisulfite solutions, Parts I and II, with foil until ready
to use. Cover all samples in foil once Bisulfite mixture is added, and keep covered
until after the 3.5 hour incubation.
2. Embryos should be stored in a minimal amount of culture medium (1-2 µL).
3. The use of 10% Igepal is to ensure lysis of nuclear membrane as well as cell
membrane.
4. Mineral oil is used to ensure that solutions do not evaporate and condense on the
top of the tubes during the procedure.
5. Generation of a solid-phase library is important as it allows for re-use of
Dynabeads and amplification of an essentially unlimited number of genes.
6. Invert samples gently. The agarose bead should be mixed but vigorous shaking
can cause the agarose bead to break up into pieces.
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7. Centrifugation of the agarose bead should not exceed 4000 rpm to prevent
breakage of agarose bead.
8. The agarose bead should be floating prior to incubation with the Bisulfite solution
to ensure that all sides of the agarose bead are exposed to the Bisulfite solution. If
the bead does not float, use a pipette tip to release it from the bottom of the tube.
9. For best results, use cDNA-Dynabead library as soon as possible.

Consistent

amplification has been obtained for cDNA libraries stored up to 8 months.
10. Caution: Dynabeads can be easily lost during each washing step; ensure all
Dynabeads are localized to the magnetic side of the tube before removing any
supernatant. Also, following repeated heating (multiple second strand syntheses),
Dynabeads may clump. If this occurs consider performing an additional washing
step.
11. Set up PCR reactions. To increase PCR efficiency, add 1 µl 240 ng/ml tRNA as a
carrier to PCR reaction. At 70oC, add to the 30 µl-agarose bead the required
amount of water to make up 20 µl per gene(s) of interest (up to 4 genes). Mix
agarose and water by gently pipetting. Keeping the solution at 60-70oC, mix by
gently pipetting, then split the PCR reaction in two by removing 12.5 µl into a
new 0.2 mL thin walled PCR tube. Add 12.5 µl mineral oil overlay. This allows
for two independent PCR reactions. PCR amplification from the agarose bead
should be performed immediately. If this is not possible, the agarose bead can be
stored at 4oC up to one week. However, efficient amplification will decrease
dramatically with each day of incubation.
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Appendix 2: Perl Program for Sequencing Analysis

The following perl program was designed to facilitate the analysis of sequencing
data obtained through the course of these experiments. The initial work on the program
was done during the Bioinformatics graduate course taught by Dr. G. Gloor and was
designed to read in and analyze each sequence individually.

The program was then

expanded to all 5 genes analyzed: H19, Snrpn, Peg3, Kcnq1ot1, and Peg1/Mest.

To

further increase the efficiency of the analysis I enlisted the help of a colleague, Mr. Robert
Moreland, a classmate at the Schulich School of Medicine, who made some modifications
to the program to allow for analysis of all sequences with only one line of input code
required, rather than one line of input per sequence.

The file entitled “Market-

Velker_Brenna_A_201106_PhD_appendix.pl” represents the perl programming currently
used for sequence analysis.
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Appendix 3: Supplementary Material - Chapter 2
The following figures were presented as supplemental data to the experiments presented
in Chapter 2, published as:
Market-Velker, B.A., Zhang, L., Magri, L.S., Bonvissuto, A.C. & Mann, M.R. Dual
effects of superovulation: loss of maternal and paternal imprinted methylation in a dosedependent manner. Hum Mol Genet 19, 36-51 (2010).
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Supplementary Figure 2.1. Methylation of the Maternal Snrpn ICR in B6(CAST7)
X B6 F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Snrpn ICR (maternal, CAST strands
shown) in blastocysts derived from spontaneously ovulated females as determined by
bisulfite mutagenesis and sequencing analysis. Unmethylated CpGs are represented as
empty circles while methylated CpGs are depicted as filled circles. Each line denotes an
individual strand of DNA. Clones with identical methylation patterns and non-CpG
conversion rates representing the same DNA strand were included once. Each group of
DNA strands represents data from a single embryo, with the embryo designation indicated
at the top left. Percent CpG methylation is indicated above each set of DNA strands, and
was calculated as the number of methylated CpGs / total number of CpG dinucleotides.
The region analyzed contains 15 CpGs; a base pair change in the maternal CAST allele
eliminates CpG dinucleotide 1.
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Supplementary Figure 2.2. Methylation of the Maternal Peg3 DMR in B6(CAST7)
X B6 F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Peg3 DMR (maternal, CAST strands
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed
contains 24 CpGs. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.3. Methylation of the Maternal Kcnq1ot1 ICR in
B6(CAST7) X B6 F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (maternal, CAST
strands shown) in blastocysts derived from spontaneously ovulated females. Details are
as described in Supplementary Figure 2.1.
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Supplementary Figure 2.4. Methylation of the Maternal H19 ICR in B6(CAST7) X
B6 F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the H19 ICR in blastocysts derived from
spontaneously ovulated females. Maternal, CAST strands are shown. The region of the
maternal CAST H19 allele analyzed contains 17 CpGs. Details are as described in
Supplementary Figure 2.1.
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Supplementary Figure 2.5. Methylation of the Maternal Snrpn ICR in B6 X CAST
F1 Blastocyst Stage Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Snrpn ICR (maternal, B6 strands
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed
contains 16 CpGs. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.6. Methylation of the Maternal Peg3 DMR in B6 X CAST
F1 Blastocyst Stage Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Peg3 DMR (maternal, B6 strands
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed
contains 23 CpGs; a polymorphism eliminates CpG 22 on the B6 allele. Details are as
described in Supplementary Figure 2.1.
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Supplementary Figure 2.7. Methylation of the Maternal Kcnq1ot1 ICR in B6 X
CAST F1 Blastocyst Stage Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (maternal, B6 strands
shown) in blastocysts derived from spontaneously ovulated females. Details are as
described in Supplementary Figure 2.1. E83 displayed a reverse pattern of imprinted
methylation as indicated by the asterisk (*).
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Supplementary Figure 2.8. Methylation of the Maternal H19 ICR in B6 X CAST F1
Blastocyst Stage Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the H19 upstream ICR (maternal, B6
strands shown) in blastocysts derived from spontaneously ovulated females. Details are
as described in Supplementary Figure 2.1. The region of the maternal B6 H19 allele
analyzed contains 16 CpGs due to a polymorphism that eliminates CpG 8.
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Supplementary Figure 2.9. Comparison of CpG Methylation Levels of the Maternal
Snrpn ICR in Embryos Derived from Spontaneously and Induced Ovulated
Females.
Percent methylation at each individual CpG dinucleotide was calculated as the number of
methylated CpGs / total number of CpG dinucleotides, and is represented graphically; top
(yellow) embryos derived from spontaneously ovulated females; middle (green) embryos
from low dosage superovulated females; and bottom (blue) embryos from high dosage
superovulated females. A reduction in CpG methylation was observed in the hormone
treatment groups. The region analyzed contains 16 CpGs. A base pair change in the
maternal CAST allele eliminates CpG dinucleotide 1 in B6(CAST7) X B6 F1 Embryos.
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Supplementary Figure 2.10. Comparison of CpG Methylation Levels of the
Maternal Peg3 DMR in Embryos Derived from Spontaneously and Induced
Ovulated Females.
Percent methylation at each individual CpG dinucleotide was calculated as the number of
methylated CpGs / total number of CpG dinucleotides, and is represented graphically; top
(yellow) embryos derived from spontaneously ovulated females; middle (green) embryos
from low dosage superovulated females; and bottom (blue) embryos from high dosage
superovulated females. A shift in CpG methylation was observed with lower methylation
levels in the hormone treatment groups. The region analyzed contains 23 CpGs; a
polymorphism eliminates CpG 22 on the maternal B6 allele in B6 X CAST F1 Embryos.
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Supplementary Figure 2.11. Comparison of CpG Methylation Levels of the
Maternal Kcnq1ot1 ICR in Embryos Derived from Spontaneously and Induced
Ovulated Females.
Percent methylation at each individual CpG dinucleotide was calculated as the number of
methylated CpGs / total number of CpG dinucleotides, and is represented graphically; top
(yellow) embryos derived from spontaneously ovulated females; middle (green) embryos
from low dosage superovulated females; and bottom (blue) embryos from high dosage
superovulated females. A downward shift in CpG methylation was observed in the
hormone treatment groups. The region analyzed contains 20 CpGs.
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Supplementary Figure 2.12. Comparison of CpG Methylation Levels of the
Maternal H19 ICR in Embryos Derived from Spontaneously and Induced Ovulated
Females.
Percent methylation at each individual CpG dinucleotide was calculated as the number of
methylated CpGs / total number of CpG dinucleotides, and is represented graphically; top
(yellow) embryos derived from spontaneously ovulated females; middle (green) embryos
from low dosage superovulated females; and bottom (blue) embryos from high dosage
superovulated females. A gain in CpG methylation was observed in the hormone
treatment groups. The region analyzed contains 17 CpGs; a polymorphism eliminates
CpG 8 on the maternal B6 allele in B6 X CAST F1 Embryos.
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Supplementary Figure 2.13. Comparison of CpG Methylation Levels of the Paternal
H19 ICR in Embryos Derived from Spontaneously and Induced Ovulated Females.
Percent methylation at each individual CpG dinucleotide was calculated as the number of
methylated CpGs / total number of CpG dinucleotides, and is represented graphically; top
(yellow) embryos derived from spontaneously ovulated females; middle (green) embryos
from low dosage superovulated females; and bottom (blue) embryos from high dosage
superovulated females. A shift in CpG methylation was observed with lower methylation
levels in the hormone treatment groups. The region analyzed contains 17 CpGs; a
polymorphism eliminates CpG 8 on the paternal B6 allele in B6(CAST7) X B6 F1
Embryos.
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Supplementary Figure 2.14. Methylation of the Paternal H19 ICR in B6(CAST7) X
B6 F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the H19 upstream ICR (paternal, B6
strands shown) in blastocysts derived from spontaneously ovulated females. Details are
as described in Supplementary Figure 2.1. The region of the paternal B6 H19 allele
analyzed contains 16 CpGs due to a polymorphism that eliminates CpG 8.
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Supplementary Figure 2.15. Methylation of the Paternal H19 ICR in B6 X CAST F1
Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the H19 upstream ICR (paternal, CAST
strands shown) in blastocysts derived from spontaneously ovulated females. Details are
as described in Supplementary Figure 2.1. The region of the paternal CAST H19 allele
analyzed contains 17 CpGs.
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Supplementary Figure 2.16. Methylation of the Paternal Snrpn ICR in B6(CAST7)
X B6 F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Snrpn ICR (paternal, B6 strands
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed
contains 16 CpGs. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.17. Methylation of the Paternal Snrpn ICR in B6 X CAST
F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Snrpn ICR (paternal, CAST strands
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed
contains 15 CpGs; a base pair change in the paternal CAST allele eliminates CpG
dinucleotide 1. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.18. Methylation of the Paternal Snrpn ICR in B6(CAST7)
X B6 F1 Embryos Derived from Low Dosage Superovulated Females.
Methylation status of individual DNA strands in the Snrpn ICR (paternal, B6 strands
shown) in blastocysts derived from females superovulated with a 6.25 IU hormone
dosage. The region analyzed contains 16 CpGs. Details are as described in Supplementary
Figure 2.1.
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Supplementary Figure 2.19. Methylation of the Paternal Snrpn in B6(CAST7) X B6
F1 Embryos Derived from High Dosage Superovulated Females.
Methylation status of individual DNA strands in the Snrpn (paternal, B6 strands shown)
in blastocysts derived from females superovulated with a 10 IU hormone dosage. The
region analyzed contains 16 CpGs. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.20. Methylation of the Paternal Peg3 DMR in B6(CAST7)
X B6 F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Peg3 DMR (paternal, B6 strands
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed
contains 23 CpGs; a polymorphism eliminates CpG 22 on the B6 allele. Details are as
described in Supplementary Figure 2.1.
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Supplementary Figure 2.21. Methylation of the Paternal Peg3 DMR in B6 X CAST
F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Peg3 DMR (paternal, CAST strands
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed
contains 24 CpGs. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.22. Methylation of the Paternal Peg3 DMR in B6(CAST7)
X B6 F1 Embryos Derived from Low Dosage Superovulated Females.
Methylation status of individual DNA strands in the Peg3 DMR (paternal, B6 strands
shown) in blastocysts derived from females superovulated with a 6.25 IU hormone
dosage. The region analyzed contains 23 CpGs; a polymorphism eliminates CpG 22 on
the B6 allele. Details are as described in Supplementary Figure 2.1.

299

Supplementary Figure 2.23. Methylation of the Paternal Peg3 DMR in B6(CAST7)
X B6 F1 Embryos Derived from High Dosage Superovulated Females.
Methylation status of individual DNA strands in the Peg3 DMR (paternal, B6 strands
shown) in blastocysts derived from females superovulated with a 10 IU hormone dosage.
The region analyzed contains 23 CpGs; a polymorphism eliminates CpG 22 on the B6
allele. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.24. Methylation of the Paternal Kcnq1ot1 ICR in
B6(CAST7) X B6 F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Kcnq1ot1ICR (paternal, B6 strands
shown) in blastocysts derived from spontaneously ovulated females. Details are as
described in Supplementary Figure 2.1.
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Supplementary Figure 2.25. Methylation of the Paternal Kcnq1ot1 ICR in B6 X
CAST F1 Embryos Derived from Spontaneously Ovulated Females.
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (paternal, CAST
strands shown) in blastocysts derived from spontaneously ovulated females. Details are as
described in Supplementary Figure 2.1. E83 displayed a reverse pattern of imprinted
methylation as indicated by the asterisk (*).
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Supplementary Figure 2.26. Methylation of the Paternal Kcnq1ot1 ICR in
B6(CAST7) X B6 F1 Embryos Derived from Low Dosage Superovulated Females.
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (paternal, B6 strands
shown) in blastocysts derived from females superovulated with a 6.25 IU hormone
dosage. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.27. Methylation of the Paternal Kcnq1ot1 ICR in
B6(CAST7) X B6 F1 Embryos Derived from High Dosage Superovulated Females.
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (paternal, B6 strands
shown) in blastocysts derived from females superovulated with a 10 IU hormone dosage.
Details are as described in Supplementary Figure 2.1.
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Appendix 4: Supplementary Material - Chapter 3
The following figures were presented as supplementary data in the following peerreviewed article:
Market-Velker, B. A., Fernandes, A. D. and Mann, M. R. Side-by-side comparison of five
commercial media systems in a mouse model: suboptimal in vitro culture interferes with
imprint maintenance. Biol Reprod 83(6): 938-50 (2010)
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Supplementary Table 3.1: Regions and Conditions for PCR Analysis for Imprinted
Methylation and Expression
Supplementary Table 1. Regions and condition for PCR analyses for imprinted methylation and expression.
Gene

Accession

Primer
/Probe

Primer Sequence (5'-3')

Annealing
Temp

Reference

Imprinted Methylation Analysis
H19
U19619
OF
GAG TAT TTA GGA GGT ATA AGA ATT
55
Mann et al.,
OR
ATC AAA AAC TAA CAT AAA CCT CT
2004;
IF
GTA AGG AGA TTA TGT TTA TTT TTG G
50
Market-Velker
IR
CCT CAT TAA TCC CAT AAC TAT
et al., 2010
Snrpn
AF081460
OF
TAT GTA ATA TGA TAT AGT TTA GAA ATT AG
52
Mann et al.,
OR
AAT AAA CCC AAA TCT AAA ATA TTT TAA TC
2004;
IF
AAT TTG TGT GAT GTT TGT AAT TAT TTG G
54
Market-Velker
IR
ATA AAA TAC ACT TTC ACT ACT AAA ATC C
et al., 2010
Peg3 NT_039413.7 OF
TTT TGA TAA GGA GGT GTT T
50
Mann et al.,
OR
ACT CTA ATA TCC ACT ATA ATA A
2004;
IF
AGT GTG GGT GTA TTA GAT T
53
Market-Velker
IR
TAA CAA AAC TTC TAC ATC ATC
et al., 2010
Imprinted Expression Analysis
H19
AF049091
F
CCT CAA GAT GAA AGA AAT GGT
55
Mann et al.,
R
AA CAC TTT ATG ATG GAA CTG C
2004
a
Sensor CCA CCT GTC GTC CAT CTC C-FL
Anchor LC640-TCT GAG GGC AAC TGG GTG TGG-P
Snrpn
MMSMN
F
CTC CAC CAG GAA TTA GAG GC
52
Mann et al.,
R
TAT AGT TAA TGC AGT AAG AGG
2004
Sensor GAA GCA TTG TAG GGG AAG AGA A-FL
Anchor LC640-GGC TGA GAT TTA TCA ACT GTA TCT TAG GGT C-P
Peg3
AF038939
F
CAG GAG AAA GTT GAA GAT GCT AC
53
This study
R
TTC GTG AAC TCT CTG GTG CT
Sensora CCA GAG CAC TTT TTC TCA AAT TCG-FL
Anchor LC640-TGA CGG AGT GGG CAT GAA CTT CAG-P
OF Outer Forward, OR Outer Reverse, IF Inner Forward, IR Inner Reverse, F Forward, R Reverse, aSensor and Anchor Probes were
purchased from TIB MolBiol.
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Supplementary Table 3.2: Ability of Media System to Support Development to the
Blastocyst
Stage
Supplementary
Table 2. Ability of media systems to support development to the blastocyst stage for
embryos derived from spontaneously ovulated and superovulated (6.25 IU) females.

Experimental Groupa
Whittens
KSOMaa
HTF
Global
P1/MB
G1.5/G2.5
6.25 IU/Whittens
6.25 IU/KSOMaa
6.25 IU/HTF
6.25 IU/Global
6.25 IU/P1/MB
6.25 IU/G1.5/G2.5

# Blastocystb
54
53
51
70
49
44
46
48
34
31
19
44

2-Cell
56
54
56
72
53
44
50
50
38
32
22
46

a

% Blastocystc
96
98
91
97
92
100
92
96
89
97
86
96

Multiple culture experiments were performed for each group. Data from each group were pooled.
Development to the blastocyst stage was scored before freezing on day 4 (see Figure 1), and was
defined as the presence of a blastocoel cavity.
c
Percent development to the blastocyst stage was calculated as # embryos developed to blastocyst
stage / total number of embryos cultured.
b
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Supplementary Table 3.3: Gene and Imprinted Expression Analysis from Embryos
Derived
from Spontaneously Ovulated Females
Supplementary Table 3. Gene and imprinted expression analysis for H19, Snrpn and Peg3 from B6(CAST7) X B6
in vivo-derived embryos from spontaneously ovulated females.

Gene

a

# Analyzed # Expressed % Expresseda

# LOI

% LOIb

H19

68

9

13

0

0

Snrpn

130

130

100

0

0

Peg3

24

23

96

1

4

Percent expressed was calculated as # embryos with gene expressed / total number of embryos analyzed.
Percent LOI was calculated as # embryos with loss of imprinted expression / total number of embryos analyzed.

b

308

a of Imprinted H19 Expression
Supplementary
Table
3.4: Statistical
Analysis
Supplementary Table
4. Statistical
analysisa of
imprinted H19
expression between in vivo-derived and cultured

embryos for spontaneous and superovulated treatment.
Superovulatedc
b

Spontaneous
In Vivo
Whittens
KSOMaa
Global
HTF
P1/MB
G1.5/G2.5

In Vivo
1.2 x 10
3.5 x 10
2.6 x 10
8.0 x 10
6.8 x 10
8.3 x 10

Whittens

KSOMaa

1.2 x 10

1.6 x 10
0.058

-7

-11
-9
-5
-9

-10

0.52
0.27
0.18
0.30
0.094

-11

-12

0.26
0.0043
0.25
0.64

Global
1.6 x 10
0.52
0.76

-12

0.040
0.61
0.34

HTF
1.1 x 10
0.27
0.51
0.52

P1/MB
-13

9.9 x 10
0.29
0.54
0.54
1.0

0.049
0.0096

a

-13

G1.5/G2.5
2.1 x 10
0.37
0.22
0.22
0.08
0.09

-10

0.32

Fisher’s exact test was used to compute the significance in number of embryos with imprinted and nonimprinted H19
expression between groups. P< 0.05 was considered statistically significant.
b
c

Purple, bottom left half, Spontaneously ovulated versus spontaneously ovulated treatment.
Pink, top right half, Superovulated versus superovulated treatment.

309

a

a of H19
Supplementary Table
Statistical
analysisAnalysis
of imprinted
between in vivo-derived and
Supplementary
Table5. 3.4:
Statistical
H19expression
Expression

cultured embryos for spontaneous and superovulated treatment.
Superovulatedc
b

Spontaneous
In Vivo
Whittens
KSOMaa
Global
HTF
P1/MB
G1.5/G2.5

In Vivo
0.029
0.002
0.009
0.018
0.007
0.029

Whittens

KSOMaa

Global

HTF

P1/MB

G1.5/G2.5

0.00005

0.00005
0.17

0.0003
0.36
0.36

0.00014
0.5
0.5
0.5

0.0001
0.59
0.59
0.43
0.57

0.0008
0.24
0.24
0.5
0.37
0.31

0.65
0.38
0.48
0.32
0.6

0.38
0.33
0.44
0.21

0.56
0.56
0.41

0.5
0.52

0.36

a

Fisher’s exact test was used to compute the significance in number of embryos with and without H19 expression
between groups. P< 0.05 was considered statistically significant.
b
c

Purple, bottom left half, Spontaneously ovulated versus spontaneously ovulated treatment.
Pink, top right half, Superovulated versus superovulated treatment.
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Supplementary Table 6. Comparison of percentage of embryos with H19 expression and with loss of H19 imprinted
Supplementary
Table 3.6: Comparison of H19 Expression and Imprinted Expression
expression in B6(CAST7) X B6 in vivo-derived embryos from spontaneously ovulated females, and from cultured
embryos derived from spontaneously ovulated or superovulated females.

Experimental Groups

Total

# Expressed % Expresseda

# LOI

% LOIb

In Vivo

68

9

13

0

0

Spontaneous
Ovulation /Culture

147

111

75

52

47

Superovulation/
Culture

120

113

94

82

73

a

Percent expressed was calculated as # embryos with H19 expression / total number of embryos analyzed.
Percent LOI was calculated as # embryos with loss of H19 imprinted expression / total number of embryos analyzed.

b
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dose-dependent manner, Gordon Research Conference: Mammalian Gametogenesis
and Embryogenesis, Waterville Valley, New Hampshire, August 2-7, 2009, Poster.
6. Market-Velker B.A., Zhang L., Magri L.S., Bonvissuto A.C., and Mann M.R., Dual
Effects of Superovulation: Loss of maternal and paternal imprinted methylation in a
dose-dependent manner, Gordon Research Conference: Epigenetics, Holderness, New
Hampshire, August 9-14, 2009, Poster.
7. Market-Velker BA, Zhang L, Magri LS, Bonvissuto AC, and Mann MR, Investigating
the molecular effects of superovulation and embryo culture on genomic imprinting in a
mouse model system, 42nd Annual Society for the Study of Reproduction Meeting,
Pittsburgh, PA, July 18-22, 2009, Poster.
8. Al Sorkhy M., Craig, R., Ard, R., Market, B., and Porter, L.A.,. The CDK activator,
Spy1, is Targeted for Degradation by the Ubiquitin Ligase Nedd4 . Gordon Cell
Growth and Proliferation Conference. Maine, July 2009.
9. Market-Velker BA, Zhang L, Magri LS, Bonvissuto AC, Mann MR. Investigating the
Molecular Effects of Assisted Reproductive Technologies on Genomic Imprinting in a
Mouse Model System, Department of Obstetrics and Gynaecology Paul Harding
Research Day, London, Ontario, May 13th, 2009, Oral Presentation.
10.Lubanska, D., Market, B., and Porter, L.A., Role of Spy1 in Neurogenesis; Potential
Implications in Glioma Development. Apr. 2009 Southern Ontario Neuroconference
Meeting. Hamilton, ON.
11.Market-Velker BA, Zhang L, Magri LS, Bonvissuto AC, Mann MR, Effects of
Assisted Reproductive Technologies on Genomic Imprinting, 2009 Great Lakes
Developmental Biology Conference, The University of Toronto, Toronto, Ontario,
March 6th, 2009, Oral Presentation.
12.Market-Velker BA, Zhang L, Magri LS, Golding MC, Mann MR. Investigating the
Molecular and Developmental Effects of Various Culture Regimes in a Mouse Model
System, The Canadian Society for Clinical Investigation Young Investigator's Forum,
MaRS Centre, Toronto, Ontario, September 25th, 2008, Oral Presentation.
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13.Market B.A., Zhang L., Magri L.S., Golding M.C., Mann M.R., Investigating the
Molecular and Developmental Effects of Various Culture Regimes in a Mouse Model
System, Department of Obstetrics and Gynaecology Paul Harding Research Day,
London, Ontario, May 14th, 2008, 1st Place Graduate Student Oral Presentation.
14.Lubanska, D., Market, B., Chen, L., and Porter, L.A., Role of Spy1 in Neurogenesis;
Potential Implications in Glioma Development. Apr. 2008 Southern Ontario
Neuroconference Meeting. London, ON.
15.Al Sorkhy M., Craig, R., Market, B., Ard, R., and Porter, L.A., The CDK Activator,
Spy1A, is Targeted for Degradation by the Ubiquitin Ligase Nedd4. Mar. 2008
IRCM Signaling Meeting. Banff, Alberta.
16.Market B, Chen L, Porter LA. Implications of SPY1 in Neurogenesis and Brain
Cancer, Ontario Biology Day, McMaster University, Hamilton, Ontario, March 18th,
2007, Poster Presentation.

TEACHING
Mentorship
• Rachael Pettapiece-Phillips, 4th Year Thesis Student, University of Western Ontario,
09/09-04/10
• Malaika Miles, Co-op High School Student and Summer Student, 03/09-08/09.
• Fatima Ba’abbad, Co-op High School Student and Summer Student, 02/08-08/08.
• Lauren Magri, McMaster University Co-op Student, 05/07-12/07.
Teaching Assistantships
• Proctor, Department of Biochemistry, The University of Western Ontario, 2007-2009.
• Teaching Assistant, University of Windsor, Immunology, 2007.
• Teaching Assistant, University of Windsor, Biotechnology Laboratory, 2007.
• Teaching Assistant, University of Windsor, Genetics, 2006.
• Teaching Assistant, University of Windsor, Introductory Molecular Biology, 2006.
• Teaching Assistant, University of Windsor, Cell Biology, 2005.

SERVICE
Committees
• Vice President, Meds 2013 Class Council, Schulich School of Medicine, 2010Present.
• Director, Meds 2013 Class Charity Committee, Rotholme Women and Family Shelter,
2010-Present.
• Meds 2013 Musculoskeletal System Block Student Representative, 2009.
• CIHR Trainee Excellence Committee, 2009.
• Meds 2013 Tachycardia Committee, 2009.
• Department of Biology Council, 4th Year Representative, University of Windsor,
2006-2007.
• Advisor, University of Windsor Undergraduate Biology Society, 2006-2007.
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•
•
•

President/Founder, University of Windsor Undergraduate Biology Society,
2005-2006.
Member of University of Windsor Chemistry and Biochemistry Association,
2005-2006.
Student Council Prime Minister, EJ Lajeunesse, 2002-2003.

Professional Associations
• Ontario Medical Association, 2009-Present.
• Canadian Medical Association, 2009-Present.
• American Society of Human Genetics, 2009-Present.
• Society for the Study of Reproduction, 2008-Present.
Outreach
• University of Western Ontario Pre-Med Symposium, 2011.
• Change Bandits, Children’s Health Research Institute, 2007-2010
• Schulich School of Medicine Sun Safety Program, 2010.
• Volunteer, Windsor Regional Cancer Center, 2006-2007.
• Coach, Holy Name of Jesus Elementary School Senior Girl’s Volleyball, 2004/2006.
• Tour Guide, Experience UWindsor, 2006.
• Volunteer, Knight of Columbus Hockey Skills Competition, 2005-2006.
• Coordinator, Mr. Kersey’s Karate School Karate Sleepover for children 4-12yrs, 2005.
• Coordinator, Windsor Welcome Week and Head Start, 2004-2005
• Volunteer, Shinerama, 2004-2005.
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